%PDF-1.3
%‚„œ”
1 0 obj
<<
/Length 4841
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 134.5 531.6514 Tm
0 0 0 1 k
0.029 Tw
(The proven pharmacotherapies for smoking cessation are nicotine)Tj
-3.45 -1.2 TD
[(gum, inhaler)50(, nasal spray)73(, and patch \(Hughes, 1996; Hughes )]TJ
ET
BT
/F1 1 Tf
10 0 0 10 384.7914 519.6514 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 406.7287 519.6514 Tm
-0.0001 Tc
(, 1999\))Tj
-30.67287 -1.2 TD
0 Tc
0.029 Tw
(and the non-nicotine therapies bupropion \(Hughes )Tj
ET
BT
/F1 1 Tf
10 0 0 10 343.4278 507.6514 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 365.3651 507.6514 Tm
0 Tc
0.029 Tw
(, 1999\), and per-)Tj
-26.53651 -1.19999 TD
(haps nortriptyline \(Prochazka )Tj
ET
BT
/F1 1 Tf
10 0 0 10 242.1595 495.6515 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 264.0967 495.6515 Tm
-0.0001 Tc
(, 1998\). All of these methods have been)Tj
-16.40967 -1.2 TD
0 Tc
0.029 Tw
(shown to double quit rates compared to placebo in several randomized con-)Tj
-0.0004 Tc
(tr)'
0.75464 0 TD
0 Tc
(olled trials (Hughes, 1996). Because the nicotine nasal spray has had limit-)Tj
-0.75464 -1.19999 TD
(ed sales, the inhaler has just been marketed, and nortriptyline has not been)Tj
0 -1.2 TD
(marketed for cessation, the current analyses will focus on nicotine gum, the)Tj
T*
(nicotine patch, and bupropion. Nicotine gum was originally approved in)Tj
T*
(the United States as prescription only (Rx) medication in 1984 as a 2 mg)Tj
0 -1.19999 TD
[(form, and 4 mg nicotine patches were appr)-1(oved as Rx only in 1993. In)]TJ
0 -1.2 TD
(April 1996, the nicotine gum became available for over-the-counter (OTC))Tj
T*
(sales. Nicotine transdermal patches, which became available as a prescrip-)Tj
0 -1.19999 TD
(tion device in 1992, were approved for OTC sale in 1996. In May of 1997,)Tj
0 -1.2 TD
(bupropion became available as an Rx-only medication.)Tj
1.8 -1.92 TD
-0.0001 Tc
0.0287 Tw
(This paper will pr)Tj
8.25061 0 TD
(esent two sets of data that estimate the population-)Tj
-10.05061 -1.2 TD
0 Tc
0.029 Tw
(based extent of medication use for smoking cessation. The first data are)Tj
0 -1.19999 TD
[(from the 1996 California T)71(obacco Sur)-12(vey (CTS), a large population-based)]TJ
0 -1.2 TD
[(sur)-12(vey of California adults (see Chapter 2). This sur)-12(vey asked all smokers)]TJ
-0.0001 Tc
0.0287 Tw
(over the age of 25 whether they had tried to stop smoking in the last year)'
0 -1.19999 TD
0 Tc
0.029 Tw
[(and, if so, whether they had used nicotine gum or patch. The sur)-12(vey was)]TJ
0 -1.2 TD
[(conducted from September 1996 through Januar)-12(y 1997. Thus, depending)]TJ
T*
[(on when a smoker was sur)-12(veyed, the gum would have been available OTC)]TJ
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(for 5-10 months prior to the sur)Tj
15.07887 0 TD
-0.0002 Tc
(vey)Tj
1.53369 0 TD
-0.0001 Tc
(, the patches would still have been Rx-)Tj
-16.61256 -1.20001 TD
-0.0002 Tc
(only)Tj
2.0415 0.00001 TD
(, and bupr)Tj
4.87794 0.00001 TD
-0.0001 Tc
(opion would not have been available yet.)Tj
-5.11944 -1.92001 TD
(The second data set is fr)Tj
11.2931 0.00001 TD
-0.0002 Tc
(om nationally r)Tj
7.33399 0.00001 TD
0 Tc
0.029 Tw
(epresentative prescription and)Tj
-20.42709 -1.20002 TD
(OTC sales data and physician prescribing data obtained in the last 6)Tj
0 -1.19999 TD
[(months of 1997 from audits done by)74(, or for)49(, the pharmaceutical companies.)]TJ
0 -1.2 TD
-0.0001 Tc
0.0287 Tw
(In this data set, the gum would have been available OTC for 14-20 months,)Tj
T*
0 Tc
0.029 Tw
(two patches would have been available OTC for 10-17 months, and bupro-)Tj
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(pion would have been available Rx-only for 5-10 months. Both sales and)Tj
0 -1.2 TD
0 Tc
0.029 Tw
[(physician audit allow one to estimate the number of new pur)18(chases.)]TJ
ET
BT
/F2 1 Tf
10 0 0 10 48 530.6514 Tm
0 Tw
[(OVER)18(VIEW)]TJ
ET
0 0 0 0 k
404 30 55 15 re
f
BT
/F0 1 Tf
10 0 0 10 440.7808 36.6514 Tm
0 0 0 1 k
(155)Tj
ET
0 0 0 0 k
45 576 314 72 re
f
BT
/F2 1 Tf
24 0 0 24 46 629.3635 Tm
0 0 0 1 k
(I)Tj
18 0 0 18 56.8926 629.3635 Tm
-0.0001 Tc
0.0315 Tw
(mpact of )Tj
24 0 0 24 151.5201 629.3635 Tm
0 Tc
(M)Tj
18 0 0 18 175.5201 629.3635 Tm
-0.0001 Tc
(edications on)Tj
24 0 0 24 46 600.5635 Tm
0 Tc
(S)Tj
18 0 0 18 60.2031 600.5635 Tm
-0.0001 Tc
(moking )Tj
24 0 0 24 142.7852 600.5635 Tm
0 Tc
(C)Tj
18 0 0 18 159.918 600.5635 Tm
-0.0001 Tc
(essation)Tj
ET
BT
/F0 1 Tf
10 0 0 10 46 582.0516 Tm
0 Tc
0.029 Tw
(John R. Hughes, David M. Burns)Tj
ET
0 0 0 0 k
45 45 414 24 re
f
BT
/F0 1 Tf
7 0 0 7 94.24 62.856 Tm
0 0 0 1 k
[(W)64(riting of this article was supported by a Resear)17(ch Scientist Development A)30(ward from the National Institute)]TJ
0.8229 -1.2 TD
-0.0002 Tc
0.0287 Tw
(on Dr)Tj
2.736 0 TD
-0.0001 Tc
(ug Abuse (DA 00109).)Tj
ET
0.125 w 
0 0 0 1 K
99 75.024 m
243 75.024 l
S
/GS0 gs
Q
endstream
endobj
2 0 obj
<<
/SA false
/OPM 1
/Type/ExtGState
/OP false
>>
endobj
3 0 obj
<<
/SA false
/OPM 1
/Type/ExtGState
/OP true
>>
endobj
4 0 obj
<<
/Length 5737
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 118 639.6514 Tm
0 0 0 1 k
0.029 Tw
[(T)72(o examine population-based efficacy of these medications, this chapter)]TJ
-1.8 -1.20001 TD
-0.0001 Tc
0.0287 Tw
(will use cessation data among users in the 1996 CTS. In addition, since sales)Tj
0 -1.2 TD
0 Tc
0.029 Tw
(data for 1997 do not provide cessation data, we will review Current)Tj
0 -1.19999 TD
[(Population Sur)-12(vey (CPS) data (see Chapter 2), meta-analyses (Fiore, 2000))]TJ
0 -1.2 TD
(and recent scientific studies in prescription (Rx) and over-the-counter)Tj
0 -1.20001 TD
-0.0001 Tc
0.0287 Tw
(\(OTC\) settings \(Hughes )Tj
ET
BT
/F1 1 Tf
10 0 0 10 212.2644 579.6516 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 234.2017 579.6516 Tm
-0.0001 Tc
(, 1999\). )Tj
-5.27017 -1.92 TD
0 Tc
0.029 Tw
[(T)72(able 5-1 presents the 1996 CTS data on the use of patch,)]TJ
0 -1.19999 TD
(gum, and counseling in various combinations among dif-)Tj
0 -1.2 TD
[(ferent groups. In the 1996 CTS, 45 per)17(cent of those over)]TJ
0 -1.20001 TD
[(age 25 who were daily smokers 1 year prior to the sur)-12(vey)]TJ
-8.15 -1.2 TD
(reported making a quit attempt that lasted more than 24 hours during the)Tj
T*
[(prior year)74(. Of those who made a quit attempt, 21 per)17(cent reported using)]TJ
T*
[(either patch or gum. Patch and gum use was more common in older)50(, white,)]TJ
0 -1.19999 TD
(more educated, and higher income smokers. The 1996 estimates for patch)Tj
0 -1.2 TD
[(and gum use represent a substantial increase fr)-1(om those recorded in a prior)]TJ
T*
(CTS in 1993, when patch and gum were available only as Rx products. In)Tj
-0.0002 Tc
0.0287 Tw
(that sur)'
3.6366 0 TD
(vey)Tj
1.53369 0 TD
0 Tc
0.029 Tw
[(, 47 per)18(cent of smokers repor)-1(ted quitting in the prior year)50(, but)]TJ
-5.17029 -1.2 TD
[(only 10 per)18(cent used a patch, and 3 per)17(cent used gum \(Pier)18(ce )]TJ
ET
BT
/F1 1 Tf
10 0 0 10 391.758 428.4519 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 413.6953 428.4519 Tm
-0.0001 Tc
(, 1995\).)Tj
-29.56953 -1.92 TD
-0.0002 Tc
(A dif)Tj
2.25989 0 TD
(fer)Tj
1.22656 0 TD
-0.0001 Tc
(ent estimate can be derived using national phar)Tj
22.41029 0 TD
-0.0002 Tc
(maceutical com)Tj
7.36633 0 TD
0 Tc
(-)Tj
-35.06308 -1.20001 TD
-0.0001 Tc
(pany sales data. A r)Tj
9.06592 0 TD
-0.0002 Tc
(ecent ar)Tj
3.71155 0 TD
-0.0001 Tc
(ticle estimated that in 1997, 5.8 million quit)Tj
-12.77747 -1.19999 TD
0 Tc
0.029 Tw
(attempts were made with OTC gum and patch and 0.5 million were made)Tj
0 -1.2 TD
-0.0001 Tc
0.0287 Tw
(with Rx gum and patch \(Gilpin and Pier)Tj
18.89686 0 TD
(ce, 1994\). The number of smokers)Tj
-18.89686 -1.2 TD
(over age 18 nationally was estimated at 47 million in 1995 by the CDC and)Tj
(44 million by the CPS (see Chapter 2). If one uses the CDC definition of a)'
0 -1.19999 TD
0 Tc
0.029 Tw
(quit attempt, requiring 24 hours of abstinence, then about 17 million of)Tj
0 -1.2 TD
-0.0001 Tc
0.0287 Tw
(those smokers made a quit attempt in 1995 (see Chapter 2). Assuming that)Tj
(the number of smokers and the incidence of quitting have not changed)'
0 -1.19999 TD
(between 1995 and 1997 (see Chapter 2), and that smokers do not make)Tj
0 -1.2 TD
-0.0003 Tc
(mor)Tj
1.92236 0 TD
-0.0001 Tc
(e than one quit attempt using patch or gum per year)Tj
24.75612 0 TD
0 Tc
0.029 Tw
[(, then 36 per)18(cent)]TJ
-26.67848 -1.20001 TD
-0.0001 Tc
0.0287 Tw
(of all quits in 1997 involved gum or patch. Since it is likely that smokers)Tj
0 -1.19999 TD
0 Tc
0.029 Tw
[(who are tr)-12(ying to quit may make more than one attempt per year and may)]TJ
0 -1.2 TD
(use patch or gum on one or more of those attempts, it is likely that the 36)Tj
T*
[(per)18(cent figur)-1(e represents an overestimate of the fraction of quit attempts in)]TJ
0 -1.19999 TD
[(which patch or gum was utilized. In the 1990 California T)71(obacco Sur)-12(vey)74(,)]TJ
0 -1.2 TD
[(approximately 36 per)17(cent of those smokers who made a quit attempt in the)]TJ
0 -1.20001 TD
(prior 12 months made more than 1 quit attempt in that 12-month period,)Tj
0 -1.2 TD
[(and some had made as many as 15 attempts each \(Gilpin and Pier)18(ce, 1994\).)]TJ
0 -1.19999 TD
[(A minimum of 57 per)18(cent of the quit attempts occurred among those who)]TJ
0 -1.2 TD
(made more than one attempt. These data would suggest that the ratio)Tj
-0.0001 Tc
0.0287 Tw
(between the total number of quit attempts and the number of individuals)'
0 -1.19999 TD
0 Tc
0.029 Tw
(who have made a quit attempt in the last year may be approximately 1.5.)Tj
-0.0001 Tc
0.0287 Tw
(Dividing the number of quit attempts estimated fr)'
23.63002 0.00001 TD
(om sales data by this)Tj
-23.63002 -1.20001 TD
-0.0002 Tc
(ratio would r)Tj
6.09204 0.00001 TD
-0.0001 Tc
(educe the 36 per)Tj
7.77528 0.00001 TD
(cent pr)Tj
3.31482 0.00001 TD
(esented above to 24 per)Tj
11.10303 0.00001 TD
-0.0002 Tc
(cent of all quit)Tj
-28.2852 -1.2 TD
0 Tc
0.029 Tw
(attempts that are accompanied by nicotine patch and gum\321a number)Tj
-0.0001 Tc
0.0287 Tw
(closely matching the estimate fr)'
15.04346 0.00001 TD
-0.0002 Tc
(om population-based sur)Tj
11.68189 0.00001 TD
-0.0001 Tc
(vey data \(21 per)Tj
7.53187 0.00001 TD
0 Tc
(-)Tj
-34.2572 -1.2 TD
-0.0001 Tc
(cent; T)Tj
3.14905 0.00001 TD
-0.0002 Tc
(able 5-1\).)Tj
ET
BT
/F2 1 Tf
10 0 0 10 48 559.4515 Tm
0 Tc
0.032 Tw
[(USE OF MEDICA)76(TIONS)]TJ
0 -1.91999 TD
-0.0001 Tc
0.0315 Tw
(Nicotine Gum )Tj
0 -1.2 TD
(and Patch)Tj
ET
0 0 0 0 k
45 32 48 13 re
f
BT
/F0 1 Tf
10 0 0 10 46 36.6514 Tm
0 0 0 1 k
0 Tc
(156)Tj
ET
0 0 0 0 k
45 677 233 12.5 re
f
BT
/F1 1 Tf
10 0 0 10 46 681.151 Tm
0 0 0 1 k
0.029 Tw
[(Smoking and T)72(obacco Contr)7(ol Monograph No. 12)]TJ
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
/GS0 gs
Q
endstream
endobj
5 0 obj
<<
/Length 14795
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
0 0 0 0 k
367 678 92 12.249 re
f
q
BT
/F1 1 Tf
10 0 0 10 414.6955 681.9003 Tm
0 0 0 1 k
-0.0002 Tc
0.0287 Tw
(Chapter 5)Tj
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
0 0 0 0 k
45 49.992 421 600.002 re
f
BT
/F11 1 Tf
0 10 -10 0 52.9336 50.992 Tm
0 0 0 1 k
0 Tc
(T)Tj
0.541 0 TD
0.025 Tw
(able 5-1)Tj
ET
BT
/F12 1 Tf
0 10 -10 0 64.9335 50.992 Tm
(Cessation Methods Repor)Tj
11.04951 0 TD
(ted by Daily Smokers 1 )Tj
10.22706 0 TD
(Y)Tj
0.61133 0 TD
(ear)Tj
1.64463 0 TD
(prior)Tj
2.47862 0 TD
(to the Survey )Tj
5.97295 0 TD
(Who Made a Quit )Tj
7.98965 0 TD
(Attempt in the Last 12 Months. 1996 CTS*)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 83.7587 187.6577 Tm
-0.0002 Tc
0.0278 Tw
(Single )Tj
3.269 0 TD
(Aid Only)Tj
24.92674 0 TD
(Combination of )Tj
7.62734 0 TD
-0.0001 Tc
(Aids**)Tj
-34.17455 -1.2 TD
-0.0002 Tc
(Self-Help)Tj
6.19445 0 TD
(Nicotine)Tj
5.77778 0 TD
(Nicotine)Tj
11.80554 0 TD
(Self-Help)Tj
5.76342 0 TD
-0.0001 Tc
(Nic Patch)Tj
13.95872 0 TD
-0.0002 Tc
(Pop)Tj
2.9438 0 TD
-0.0001 Tc
(Samp)Tj
-57.0827 -1.2 TD
-0.0002 Tc
(None)Tj
ET
0.45 w 
106.2587 106.7442 m
106.2587 129.2398 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3587 146.4958 Tm
(Counseling)Tj
ET
106.2587 146.4958 m
106.2587 195.4882 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3587 202.4902 Tm
(Materials)Tj
ET
106.2587 202.4902 m
106.2587 241.4939 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3587 263.7411 Tm
-0.0001 Tc
(Patch)Tj
ET
106.2587 263.7411 m
106.2587 288.2429 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3586 317.7429 Tm
-0.0002 Tc
(Gum)Tj
ET
106.2587 317.7429 m
106.2587 338.2411 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3586 359.4958 Tm
(Counseling)Tj
ET
106.2587 359.4958 m
106.2587 408.4883 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3586 416.4902 Tm
(Materials)Tj
ET
106.2587 416.4902 m
106.2587 455.4939 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3586 472.8687 Tm
(or Gum)Tj
ET
106.2587 472.8687 m
106.2587 505.1153 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3586 519.7464 Tm
(Unknown)Tj
ET
106.2587 519.7464 m
106.2587 560.2376 l
S
BT
/F13 1 Tf
0 9 -9 0 105.3586 592.9854 Tm
-0.0001 Tc
(Size)Tj
3.77777 0 TD
(Size)Tj
-58.9993 -1.2 TD
0 Tc
(%)Tj
2.2495 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.44417 0 TD
0 Tc
(%)Tj
2.13839 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.55528 0 TD
0 Tc
(%)Tj
2.36061 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.2775 0 TD
0 Tc
(%)Tj
2.19394 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.55528 0 TD
0 Tc
(%)Tj
2.2495 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.44416 0 TD
0 Tc
(%)Tj
2.13839 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.55528 0 TD
0 Tc
(%)Tj
2.13839 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.55528 0 TD
0 Tc
(%)Tj
2.2495 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
2.44417 0 TD
0 Tc
(%)Tj
2.36061 0 TD
<B1>Tj
1.19522 0 TD
-0.0002 Tc
(CI)Tj
5.16786 0 TD
-0.0003 Tc
((N))Tj
3.88887 0 TD
((n))Tj
ET
BT
/F14 1 Tf
0 9 -9 0 130.5586 50.992 Tm
0 Tc
(T)Tj
0.5 0 TD
-0.0001 Tc
(otal)Tj
4.27707 0 TD
(72.3)Tj
3.4448 0 TD
-0.0002 Tc
(2.0)Tj
3 0 TD
(1.7)Tj
2.88889 0 TD
(0.7)Tj
3 0 TD
(2.5)Tj
2.83333 0 TD
(0.7)Tj
3 0 TD
(4.6)Tj
2.94444 0 TD
(0.8)Tj
3 0 TD
(3.3)Tj
2.88889 0 TD
(0.8)Tj
3 0 TD
(7.1)Tj
2.88889 0 TD
(1.1)Tj
3 0 TD
(9.3)Tj
2.88889 0 TD
(1.3)Tj
2.44409 0 TD
-0.0001 Tc
(21.0)Tj
3.4448 0 TD
-0.0002 Tc
(1.8)Tj
3 0 TD
(0.7)Tj
2.88889 0 TD
(0.3)Tj
2.44222 0 TD
-0.0001 Tc
(1,266,663)Tj
5.72333 0 TD
(2,680)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 144.9586 50.992 Tm
-0.0002 Tc
(Gender)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 155.7586 50.992 Tm
(Male)Tj
4.77707 0 TD
-0.0001 Tc
(75.2)Tj
3.4448 0 TD
-0.0002 Tc
(2.7)Tj
3 0 TD
(1.3)Tj
2.88889 0 TD
(0.8)Tj
3 0 TD
(2.4)Tj
2.83333 0 TD
(1.0)Tj
3 0 TD
(4.7)Tj
2.94444 0 TD
(1.1)Tj
3 0 TD
(2.7)Tj
2.88889 0 TD
(1.0)Tj
3 0 TD
(5.6)Tj
2.88889 0 TD
(1.4)Tj
3 0 TD
(8.0)Tj
2.88889 0 TD
(1.7)Tj
2.44409 0 TD
-0.0001 Tc
(19.2)Tj
3.4448 0 TD
-0.0002 Tc
(2.3)Tj
3 0 TD
(0.6)Tj
2.88889 0 TD
(0.5)Tj
3.27597 0 TD
-0.0001 Tc
(707,535)Tj
4.88958 0 TD
(1,377)Tj
-63.49853 -1.20002 TD
(Female)Tj
4.77707 0 TD
(68.5)Tj
3.4448 0 TD
-0.0002 Tc
(3.4)Tj
3 0 TD
(2.2)Tj
2.88889 0 TD
(1.1)Tj
3 0 TD
(2.7)Tj
2.83333 0 TD
(1.1)Tj
3 0 TD
(4.4)Tj
2.94444 0 TD
(1.2)Tj
3 0 TD
(3.9)Tj
2.88889 0 TD
(1.4)Tj
3 0 TD
(8.9)Tj
2.88889 0 TD
(1.6)Tj
2.51807 0 TD
0 Tc
(1)Tj
0.48193 0 TD
-0.0002 Tc
(1.0)Tj
2.88889 0 TD
(1.9)Tj
2.44409 0 TD
-0.0001 Tc
(23.4)Tj
3.4448 0 TD
-0.0002 Tc
(2.9)Tj
3 0 TD
(0.7)Tj
2.88889 0 TD
(0.5)Tj
3.27597 0 TD
-0.0001 Tc
(559,127)Tj
4.88958 0 TD
(1,303)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 180.9585 50.992 Tm
(Age \(Y)Tj
3.13911 0 TD
-0.0002 Tc
(ears\))Tj
ET
BT
/F14 1 Tf
0 9 -9 0 191.7585 50.992 Tm
-0.0001 Tc
(25\32044)Tj
4.77707 0 TD
(74.6)Tj
3.4448 0 TD
-0.0002 Tc
(2.1)Tj
3 0 TD
(1.9)Tj
2.88889 0 TD
(0.9)Tj
3 0 TD
(2.9)Tj
2.83333 0 TD
(0.9)Tj
3 0 TD
(3.9)Tj
2.94444 0 TD
(0.8)Tj
3 0 TD
(2.7)Tj
2.88889 0 TD
(0.9)Tj
3 0 TD
(6.0)Tj
2.88889 0 TD
(1.2)Tj
3 0 TD
(9.0)Tj
2.88889 0 TD
(1.7)Tj
2.44409 0 TD
-0.0001 Tc
(18.2)Tj
3.4448 0 TD
-0.0002 Tc
(2.0)Tj
3 0 TD
(0.9)Tj
2.88889 0 TD
(0.5)Tj
3.27597 0 TD
-0.0001 Tc
(797,986)Tj
4.88958 0 TD
(1,661)Tj
-63.49853 -1.2 TD
(45\32064)Tj
4.77707 0 TD
(69.3)Tj
3.4448 0 TD
-0.0002 Tc
(4.2)Tj
3 0 TD
(1.7)Tj
2.88889 0 TD
(1.4)Tj
3 0 TD
(2.0)Tj
2.83333 0 TD
(1.0)Tj
3 0 TD
(5.7)Tj
2.94444 0 TD
(1.8)Tj
3 0 TD
(3.6)Tj
2.88889 0 TD
(1.5)Tj
3 0 TD
(9.2)Tj
2.88889 0 TD
(2.6)Tj
2.44409 0 TD
-0.0001 Tc
(10.0)Tj
3.44479 0 TD
-0.0002 Tc
(2.6)Tj
2.44409 0 TD
-0.0001 Tc
(24.1)Tj
3.4448 0 TD
-0.0002 Tc
(3.5)Tj
3 0 TD
(0.3)Tj
2.88889 0 TD
(0.4)Tj
3.27597 0 TD
-0.0001 Tc
(365,166)Tj
5.72333 0 TD
(803)Tj
-64.33228 -1.2 TD
(65+)Tj
4.77707 0 TD
(64.3)Tj
3.4448 0 TD
-0.0002 Tc
(7.7)Tj
3 0 TD
(0.4)Tj
2.88889 0 TD
(0.8)Tj
3 0 TD
(1.3)Tj
2.83333 0 TD
(1.8)Tj
3 0 TD
(6.3)Tj
2.94444 0 TD
(2.8)Tj
3 0 TD
(6.6)Tj
2.88889 0 TD
(5.1)Tj
3 0 TD
(7.7)Tj
2.88889 0 TD
(3.8)Tj
3 0 TD
(9.1)Tj
2.88889 0 TD
(4.8)Tj
2.44409 0 TD
-0.0001 Tc
(32.5)Tj
3.4448 0 TD
-0.0002 Tc
(7.5)Tj
3.55591 0 TD
0 Tc
(.)Tj
2.88889 0 TD
(.)Tj
2.72006 0 TD
-0.0001 Tc
(103,509)Tj
5.72333 0 TD
(216)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 227.7584 50.992 Tm
(Race/Ethnicity)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 238.5584 50.992 Tm
(NH White)Tj
4.77707 0 TD
(68.4)Tj
3.4448 0 TD
-0.0002 Tc
(2.2)Tj
3 0 TD
(1.2)Tj
2.88889 0 TD
(0.6)Tj
3 0 TD
(2.6)Tj
2.83333 0 TD
(0.7)Tj
3 0 TD
(6.1)Tj
2.94444 0 TD
(1.1)Tj
3 0 TD
(3.5)Tj
2.88889 0 TD
(1.1)Tj
3 0 TD
(6.8)Tj
2.88889 0 TD
(1.1)Tj
3 0 TD
(9.7)Tj
2.88889 0 TD
(1.4)Tj
2.44409 0 TD
-0.0001 Tc
(25.1)Tj
3.4448 0 TD
-0.0002 Tc
(2.1)Tj
3 0 TD
(0.7)Tj
2.88889 0 TD
(0.4)Tj
3.27597 0 TD
-0.0001 Tc
(806,518)Tj
4.88958 0 TD
(1,930)Tj
-63.49853 -1.20001 TD
(Hispanic)Tj
4.77707 0 TD
(80.6)Tj
3.4448 0 TD
-0.0002 Tc
(4.6)Tj
3 0 TD
(2.7)Tj
2.88889 0 TD
(2.1)Tj
3 0 TD
(2.0)Tj
2.83333 0 TD
(1.6)Tj
3 0 TD
(2.0)Tj
2.94444 0 TD
(1.6)Tj
3 0 TD
(2.5)Tj
2.88889 0 TD
(1.8)Tj
3 0 TD
(6.5)Tj
2.88889 0 TD
(3.0)Tj
3 0 TD
(7.6)Tj
2.88889 0 TD
(2.9)Tj
2.44409 0 TD
-0.0001 Tc
(13.2)Tj
3.4448 0 TD
-0.0002 Tc
(4.0)Tj
3 0 TD
(0.4)Tj
2.88889 0 TD
(0.7)Tj
3.27597 0 TD
-0.0001 Tc
(224,058)Tj
5.72333 0 TD
(332)Tj
-64.33228 -1.20001 TD
(Afric-Am)Tj
4.77707 0 TD
(79.5)Tj
3.4448 0 TD
-0.0002 Tc
(6.2)Tj
3 0 TD
(1.8)Tj
2.88889 0 TD
(2.9)Tj
3 0 TD
(3.6)Tj
2.83333 0 TD
(2.6)Tj
3.55591 0 TD
0 Tc
(.)Tj
2.94444 0 TD
(.)Tj
2.44409 0 TD
-0.0002 Tc
(2.4)Tj
2.88889 0 TD
(2.2)Tj
3 0 TD
(9.5)Tj
2.88889 0 TD
(4.9)Tj
2.44409 0 TD
-0.0001 Tc
(10.7)Tj
3.44479 0 TD
-0.0002 Tc
(4.1)Tj
2.51807 0 TD
0 Tc
(1)Tj
0.48193 0 TD
-0.0002 Tc
(1.4)Tj
2.88889 0 TD
(4.9)Tj
3 0 TD
(2.1)Tj
2.88889 0 TD
(2.3)Tj
3.42391 0 TD
0 Tc
(1)Tj
0.48193 0 TD
(1)Tj
0.48193 0 TD
-0.0001 Tc
(1,550)Tj
4.61152 0 TD
(185)Tj
-64.33228 -1.19999 TD
(Asian/PI)Tj
4.77707 0 TD
(77.9)Tj
3.4448 0 TD
-0.0002 Tc
(7.7)Tj
3 0 TD
(2.6)Tj
2.88889 0 TD
(4.1)Tj
3 0 TD
(2.2)Tj
2.83333 0 TD
(2.4)Tj
3 0 TD
(5.7)Tj
2.94444 0 TD
(4.1)Tj
3 0 TD
(2.9)Tj
2.88889 0 TD
(2.9)Tj
3 0 TD
(8.0)Tj
2.88889 0 TD
(6.4)Tj
3 0 TD
(5.9)Tj
2.88889 0 TD
(3.9)Tj
2.44409 0 TD
-0.0001 Tc
(15.5)Tj
3.4448 0 TD
-0.0002 Tc
(6.1)Tj
3.55591 0 TD
0 Tc
(.)Tj
2.88889 0 TD
(.)Tj
3.27596 0 TD
-0.0001 Tc
(70,309)Tj
5.16743 0 TD
(135)Tj
-64.33228 -1.2 TD
(Nativ )Tj
2.52828 0 TD
-0.0002 Tc
(Am)Tj
2.24879 0 TD
-0.0001 Tc
(72.5)Tj
2.88889 0 TD
(13.7)Tj
3.55591 0 TD
-0.0002 Tc
(2.9)Tj
2.88889 0 TD
(4.2)Tj
3 0 TD
(1.3)Tj
2.83333 0 TD
(2.5)Tj
3 0 TD
(1.8)Tj
2.94444 0 TD
(2.1)Tj
3 0 TD
(4.6)Tj
2.88889 0 TD
(8.3)Tj
3 0 TD
(7.4)Tj
2.88889 0 TD
(4.7)Tj
2.44409 0 TD
-0.0001 Tc
(12.0)Tj
3.44479 0 TD
-0.0002 Tc
(6.5)Tj
2.44409 0 TD
-0.0001 Tc
(20.7)Tj
2.96286 0 TD
0 Tc
(1)Tj
0.48194 0 TD
-0.0002 Tc
(1.1)Tj
3.55591 0 TD
0 Tc
(.)Tj
2.88889 0 TD
(.)Tj
3.27596 0 TD
-0.0001 Tc
(54,227)Tj
5.72333 0 TD
-0.0002 Tc
(98)Tj
-64.88818 -1.2 TD
(Other)Tj
5.88889 0 TD
0 Tc
(.)Tj
2.88889 0 TD
(.)Tj
3 0 TD
(.)Tj
2.88889 0 TD
(.)Tj
3 0 TD
(.)Tj
2.83333 0 TD
(.)Tj
3 0 TD
(.)Tj
2.94444 0 TD
(.)Tj
3 0 TD
(.)Tj
2.88889 0 TD
(.)Tj
3 0 TD
(.)Tj
2.88889 0 TD
(.)Tj
3 0 TD
(.)Tj
2.88889 0 TD
(.)Tj
3 0 TD
(.)Tj
2.88889 0 TD
(.)Tj
3 0 TD
(.)Tj
2.88889 0 TD
(.)Tj
5.77742 0 TD
(0)Tj
3.77777 0 TD
(0)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 306.9583 50.992 Tm
-0.0001 Tc
(Education \(Y)Tj
6.0832 0 TD
-0.0002 Tc
(ears\))Tj
ET
BT
/F14 1 Tf
0 9 -9 0 317.7582 50.992 Tm
-0.0001 Tc
(<12)Tj
4.77707 0 TD
(77.2)Tj
3.4448 0 TD
-0.0002 Tc
(5.6)Tj
3 0 TD
(3.8)Tj
2.88889 0 TD
(2.5)Tj
3 0 TD
(1.5)Tj
2.83333 0 TD
(1.2)Tj
3 0 TD
(2.1)Tj
2.94444 0 TD
(1.4)Tj
3 0 TD
(3.3)Tj
2.88889 0 TD
(2.0)Tj
3 0 TD
(8.3)Tj
2.88889 0 TD
(3.1)Tj
3 0 TD
(7.2)Tj
2.88889 0 TD
(3.0)Tj
2.44409 0 TD
-0.0001 Tc
(15.8)Tj
3.4448 0 TD
-0.0002 Tc
(4.8)Tj
3 0 TD
(1.0)Tj
2.88889 0 TD
(0.8)Tj
3.27597 0 TD
-0.0001 Tc
(299,599)Tj
5.72333 0 TD
(312)Tj
-64.33228 -1.2 TD
-0.0002 Tc
(12)Tj
4.77707 0 TD
-0.0001 Tc
(72.0)Tj
3.4448 0 TD
-0.0002 Tc
(3.1)Tj
3 0 TD
(1.1)Tj
2.88889 0 TD
(0.6)Tj
3 0 TD
(2.7)Tj
2.83333 0 TD
(1.0)Tj
3 0 TD
(6.1)Tj
2.94444 0 TD
(1.5)Tj
3 0 TD
(2.1)Tj
2.88889 0 TD
(1.0)Tj
3 0 TD
(6.0)Tj
2.88889 0 TD
(1.9)Tj
3 0 TD
(9.2)Tj
2.88889 0 TD
(2.2)Tj
2.44409 0 TD
-0.0001 Tc
(22.3)Tj
3.4448 0 TD
-0.0002 Tc
(2.9)Tj
3 0 TD
(0.5)Tj
2.88889 0 TD
(0.5)Tj
3.27597 0 TD
-0.0001 Tc
(364,834)Tj
5.72333 0 TD
(903)Tj
-64.33228 -1.2 TD
(13\32015)Tj
4.77707 0 TD
(71.9)Tj
3.4448 0 TD
-0.0002 Tc
(3.7)Tj
3 0 TD
(1.0)Tj
2.88889 0 TD
(0.7)Tj
3 0 TD
(2.6)Tj
2.83333 0 TD
(1.2)Tj
3 0 TD
(5.2)Tj
2.94444 0 TD
(1.6)Tj
3 0 TD
(2.8)Tj
2.88889 0 TD
(1.0)Tj
3 0 TD
(6.7)Tj
2.88889 0 TD
(1.8)Tj
3 0 TD
(9.8)Tj
2.88889 0 TD
(2.1)Tj
2.44409 0 TD
-0.0001 Tc
(20.4)Tj
3.4448 0 TD
-0.0002 Tc
(3.2)Tj
3 0 TD
(1.1)Tj
2.88889 0 TD
(0.9)Tj
3.27597 0 TD
-0.0001 Tc
(359,691)Tj
5.72333 0 TD
(887)Tj
-64.33228 -1.19999 TD
(16+)Tj
4.77707 0 TD
(67.1)Tj
3.4448 0 TD
-0.0002 Tc
(4.8)Tj
3 0 TD
(1.0)Tj
2.88889 0 TD
(0.8)Tj
3 0 TD
(3.4)Tj
2.83333 0 TD
(1.5)Tj
3 0 TD
(4.6)Tj
2.94444 0 TD
(1.6)Tj
3 0 TD
(5.5)Tj
2.88889 0 TD
(2.4)Tj
3 0 TD
(7.7)Tj
2.88889 0 TD
(2.5)Tj
2.51807 0 TD
0 Tc
(1)Tj
0.48193 0 TD
-0.0002 Tc
(1.3)Tj
2.88889 0 TD
(2.7)Tj
2.44409 0 TD
-0.0001 Tc
(26.5)Tj
3.4448 0 TD
-0.0002 Tc
(4.2)Tj
3.55591 0 TD
0 Tc
(.)Tj
2.88889 0 TD
(.)Tj
2.72006 0 TD
-0.0001 Tc
(242,537)Tj
5.72333 0 TD
(578)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 364.5581 50.992 Tm
(Household Income (Dollars))Tj
ET
BT
/F15 1 Tf
0 9 -9 0 375.3582 50.992 Tm
0 Tc
<B2>Tj
/F14 1 Tf
0.47486 0 TD
-0.0001 Tc
(10K)Tj
4.30221 0 TD
(78.2)Tj
3.4448 0 TD
-0.0002 Tc
(5.3)Tj
3 0 TD
(3.0)Tj
2.88889 0 TD
(2.7)Tj
3 0 TD
(1.9)Tj
2.83333 0 TD
(1.5)Tj
3 0 TD
(1.8)Tj
2.94444 0 TD
(1.9)Tj
3 0 TD
(3.2)Tj
2.88889 0 TD
(2.5)Tj
3 0 TD
(8.3)Tj
2.88889 0 TD
(4.0)Tj
3 0 TD
(6.9)Tj
2.88889 0 TD
(3.3)Tj
2.44409 0 TD
-0.0001 Tc
(14.8)Tj
3.4448 0 TD
-0.0002 Tc
(4.7)Tj
3 0 TD
(1.2)Tj
2.88889 0 TD
(1.3)Tj
3.27597 0 TD
-0.0001 Tc
(156,924)Tj
5.72333 0 TD
(264)Tj
-64.33228 -1.19999 TD
(10-20K)Tj
4.77707 0 TD
(76.3)Tj
3.4448 0 TD
-0.0002 Tc
(4.9)Tj
3 0 TD
(2.5)Tj
2.88889 0 TD
(2.1)Tj
3 0 TD
(1.9)Tj
2.83333 0 TD
(1.3)Tj
3 0 TD
(3.7)Tj
2.94444 0 TD
(1.8)Tj
3 0 TD
(2.6)Tj
2.88889 0 TD
(1.8)Tj
3 0 TD
(6.8)Tj
2.88889 0 TD
(3.2)Tj
3 0 TD
(6.4)Tj
2.88889 0 TD
(2.7)Tj
2.44409 0 TD
-0.0001 Tc
(18.2)Tj
3.4448 0 TD
-0.0002 Tc
(4.5)Tj
3 0 TD
(0.7)Tj
2.88889 0 TD
(1.0)Tj
3.27597 0 TD
-0.0001 Tc
(187,040)Tj
5.72333 0 TD
(354)Tj
-64.33228 -1.19999 TD
(20-30K)Tj
4.77707 0 TD
(78.5)Tj
3.4448 0 TD
-0.0002 Tc
(4.4)Tj
3 0 TD
(0.6)Tj
2.88889 0 TD
(0.7)Tj
3 0 TD
(3.1)Tj
2.83333 0 TD
(1.7)Tj
3 0 TD
(3.6)Tj
2.94444 0 TD
(1.8)Tj
3 0 TD
(1.8)Tj
2.88889 0 TD
(1.1)Tj
3 0 TD
(4.5)Tj
2.88889 0 TD
(2.0)Tj
3 0 TD
(9.7)Tj
2.88889 0 TD
(2.9)Tj
2.44409 0 TD
-0.0001 Tc
(14.9)Tj
3.4448 0 TD
-0.0002 Tc
(4.3)Tj
3 0 TD
(0.8)Tj
2.88889 0 TD
(1.1)Tj
3.27597 0 TD
-0.0001 Tc
(190,339)Tj
5.72333 0 TD
(398)Tj
-64.33228 -1.20001 TD
(30-50K)Tj
4.77707 0 TD
(69.7)Tj
3.4448 0 TD
-0.0002 Tc
(4.4)Tj
3 0 TD
(1.5)Tj
2.88889 0 TD
(1.4)Tj
3 0 TD
(2.5)Tj
2.83333 0 TD
(1.3)Tj
3 0 TD
(6.0)Tj
2.94444 0 TD
(2.2)Tj
3 0 TD
(2.9)Tj
2.88889 0 TD
(1.5)Tj
3 0 TD
(7.6)Tj
2.88889 0 TD
(2.6)Tj
2.44409 0 TD
-0.0001 Tc
(10.4)Tj
3.44479 0 TD
-0.0002 Tc
(2.9)Tj
2.44409 0 TD
-0.0001 Tc
(23.8)Tj
3.4448 0 TD
-0.0002 Tc
(4.1)Tj
3 0 TD
(0.6)Tj
2.88889 0 TD
(0.7)Tj
3.27597 0 TD
-0.0001 Tc
(271,517)Tj
5.72333 0 TD
(605)Tj
-64.33228 -1.19999 TD
(50-75K)Tj
4.77707 0.00001 TD
(66.9)Tj
3.4448 0.00001 TD
-0.0002 Tc
(5.7)Tj
3 0 TD
(1.6)Tj
2.88889 0 TD
(1.5)Tj
3 0 TD
(3.6)Tj
2.83333 0 TD
(2.0)Tj
3 0 TD
(5.4)Tj
2.94444 0 TD
(2.1)Tj
3 0 TD
(3.3)Tj
2.88889 0 TD
(1.7)Tj
3 0 TD
(8.6)Tj
2.88889 0 TD
(3.1)Tj
2.44409 0 TD
-0.0001 Tc
(13.5)Tj
3.44479 0 TD
-0.0002 Tc
(4.1)Tj
2.44409 0 TD
-0.0001 Tc
(23.9)Tj
3.4448 0 TD
-0.0002 Tc
(5.0)Tj
3 0 TD
(0.7)Tj
2.88889 0 TD
(0.9)Tj
3.27597 0 TD
-0.0001 Tc
(200,708)Tj
5.72333 0 TD
(452)Tj
-64.33228 -1.20001 TD
(>75K)Tj
4.77707 0 TD
(64.9)Tj
3.4448 0 TD
-0.0002 Tc
(5.6)Tj
3 0 TD
(2.3)Tj
2.88889 0 TD
(2.4)Tj
3 0 TD
(1.2)Tj
2.83333 0 TD
(1.2)Tj
3 0 TD
(6.6)Tj
2.94444 0 TD
(2.5)Tj
3 0 TD
(5.4)Tj
2.88889 0 TD
(3.6)Tj
3 0 TD
(7.7)Tj
2.88889 0 TD
(3.2)Tj
3 0 TD
(6.9)Tj
2.88889 0 TD
(2.8)Tj
2.44409 0 TD
-0.0001 Tc
(29.9)Tj
3.4448 0 TD
-0.0002 Tc
(5.5)Tj
3 0 TD
(0.4)Tj
2.88889 0 TD
(0.7)Tj
3.27597 0 TD
-0.0001 Tc
(148,285)Tj
5.72333 0 TD
(377)Tj
-64.33228 -1.19999 TD
(Unknown)Tj
4.77707 0 TD
(71.9)Tj
3.4448 0 TD
-0.0002 Tc
(6.4)Tj
3 0 TD
(0.4)Tj
2.88889 0 TD
(0.7)Tj
3 0 TD
(3.4)Tj
2.83333 0 TD
(2.3)Tj
3 0 TD
(4.4)Tj
2.94444 0 TD
(2.9)Tj
3 0 TD
(4.8)Tj
2.88889 0 TD
(3.9)Tj
3 0 TD
(5.2)Tj
2.88889 0 TD
(2.5)Tj
3 0 TD
(9.7)Tj
2.88889 0 TD
(4.0)Tj
2.44409 0 TD
-0.0001 Tc
(21.5)Tj
3.4448 0 TD
-0.0002 Tc
(5.7)Tj
3 0 TD
(0.4)Tj
2.88889 0 TD
(0.7)Tj
3.42391 0 TD
0 Tc
(1)Tj
0.48193 0 TD
(1)Tj
0.48193 0 TD
-0.0001 Tc
(1,848)Tj
4.61152 0 TD
(230)Tj
ET
BT
/F16 1 Tf
0 7 -7 0 453.1004 55.2706 Tm
(*Those 25+ years of age who have made a quit attempt in the past year and were daily smokers 1 year ago.)Tj
-0.61123 -1.2 TD
(**Combination includes use of the method alone or with any other method.)Tj
ET
0.125 w 
444.0005 50.0026 m
444.0005 650.0026 l
S
118.9995 650.0025 m
118.9995 50.0025 l
S
1 w 
68.9995 650.0025 m
68.9995 50.0025 l
S
0.125 w 
84.5 562.5 m
84.5 358 l
S
85 348 m
85 91 l
S
/GS0 gs
Q
endstream
endobj
6 0 obj
<<
/Length 6353
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 118 639.6514 Tm
0 0 0 1 k
0.029 Tw
[(The difference in usage rates \(14 per)17(cent in the 1993 CTS versus 21 per-)]TJ
-1.8 -1.20001 TD
[(cent in the 1996 CTS, versus 24 per)18(cent in the 1997 U.S. sales data\) could)]TJ
0 -1.2 TD
(be due to several reasons. There is good evidence that the historical trend is)Tj
0 -1.19999 TD
(due to increased recognition of the efficacy of patch and gum and due to)Tj
0 -1.2 TD
(their increased availability as an OTC item \(Shiffman )Tj
ET
BT
/F1 1 Tf
10 0 0 10 352.2902 591.6516 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 374.2274 591.6516 Tm
-0.0001 Tc
(, 1997a & b\).)Tj
-27.42274 -1.2 TD
0 Tc
0.029 Tw
[(Some smokers may have pur)18(chased gum or patch but never actually made a)]TJ
0 -1.19999 TD
[(quit attempt; however)50(, r)-1(ecent work indicates that 94 per)18(cent of OTC nico-)]TJ
0 -1.2 TD
(tine replacement therapy \(NRT\) use is for cessation purposes \(Pillitteri )Tj
ET
BT
/F1 1 Tf
10 0 0 10 430.5202 555.6517 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 452.4574 555.6517 Tm
0 Tc
(,)Tj
-35.24574 -1.2 TD
-0.0001 Tc
(1998\). )Tj
1.8 -1.92 TD
0 Tc
0.029 Tw
[(In summar)-12(y)74(, it is reasonable to estimate that between one-fifth and)]TJ
-1.8 -1.2 TD
(one-quarter of all quit attempts are accompanied by the use of nicotine)Tj
-0.0002 Tc
0.0287 Tw
(gum or patch.)'
ET
BT
/F2 1 Tf
10 0 0 10 46 481.2517 Tm
0 Tc
0 Tw
(Bupropion)Tj
ET
BT
/F0 1 Tf
10 0 0 10 120.3592 481.2517 Tm
0.029 Tw
(Bupropion was not yet available for smoking cessation when the 1996)Tj
-2.03592 -1.2 TD
-0.0001 Tc
0.0287 Tw
(CTS was conducted. When the phar)Tj
16.87757 0 TD
-0.0002 Tc
(macy sales data wer)Tj
9.23523 0 TD
-0.0001 Tc
(e collected in 1997,)Tj
-26.1128 -1.23606 TD
-0.0002 Tc
(Zyban)Tj
6 0 0 6 129.0234 460.1912 Tm
0 Tc
<A8>Tj
10 0 0 10 136.846 456.8912 Tm
0.029 Tw
((the trade name of bupropion when used for smoking) had only)Tj
-3.6846 -1.2 TD
-0.0001 Tc
0.0287 Tw
(been available for smoking cessation for between 1 and 6 months. Use of)Tj
0 -1.23606 TD
-0.0002 Tc
(Zyban)Tj
6 0 0 6 129.0234 435.8306 Tm
0 Tc
<A8>Tj
10 0 0 10 136.846 432.5306 Tm
0.029 Tw
(appeared to stabilize the last 3 months of these data. Projections for)Tj
-3.6846 -1.2 TD
(a full year based on these last 3 months of pharmacy audits indicate that)Tj
0 -1.23605 TD
-0.0001 Tc
0.0287 Tw
(2.4 million quit attempts/year may involve Zyban)Tj
6 0 0 6 334.585 411.4701 Tm
0 Tc
<A8>Tj
10 0 0 10 339.2521 408.1701 Tm
-0.0001 Tc
(. In addition, it is esti)Tj
10.09193 0 TD
0 Tc
(-)Tj
-34.01714 -1.23606 TD
0.029 Tw
[(mated that 15 per)18(cent of W)75(ellbutrin)]TJ
6 0 0 6 269.8499 399.1095 Tm
<A8>Tj
10 0 0 10 277.6725 395.8095 Tm
(use \(the trade name of bupropion for)Tj
-17.76725 -1.2 TD
[(depression\) is actually for smoking cessation \(Glaxo-W)76(ellcome, personal)]TJ
T*
(communication\). Adding these usage measures together results in an esti-)Tj
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(mate of 3.7 million quits/year with bupr)Tj
18.9817 0 TD
(opion. Using the same value of 1.5)Tj
-18.9817 -1.2 TD
(for the ratio between quit attempts and number of individuals who have)Tj
T*
0 Tc
0.029 Tw
(attempted to quit in the last 12 months would yield an estimate of 14 per-)Tj
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(cent of all quit attempts that involve bupr)Tj
19.82899 0 TD
-0.0002 Tc
(opion.)Tj
ET
BT
/F2 1 Tf
10 0 0 10 46 304.6097 Tm
-0.0001 Tc
0.0315 Tw
(Any medication)Tj
ET
BT
/F0 1 Tf
10 0 0 10 148.6185 304.6097 Tm
0 Tc
0.029 Tw
(Although no data are available, it is thought that in 1997 there)Tj
-4.86185 -1.2 TD
(was little concomitant use of gum with patch or of bupropion with gum or)Tj
T*
(patch. Recent publications suggest that combined use may improve quit)Tj
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(rates \(Hughes )Tj
ET
BT
/F1 1 Tf
10 0 0 10 166.5259 268.6098 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 188.4632 268.6098 Tm
0 Tc
0.029 Tw
(, 1999; Jorenby )Tj
ET
BT
/F1 1 Tf
10 0 0 10 262.837 268.6098 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 284.7743 268.6098 Tm
0 Tc
0.029 Tw
(, 1999\). But if we assume that com-)Tj
-18.47743 -1.2 TD
-0.0001 Tc
0.0287 Tw
(bined use is minimal, then based on phar)Tj
19.55653 0 TD
(macy sales data, the use of any)Tj
-19.55653 -1.2 TD
-0.0002 Tc
(medication would be pr)Tj
11.20862 0.00001 TD
-0.0001 Tc
(ojected to occur in 35-38 per)Tj
13.51673 0 TD
-0.0002 Tc
(cent of all quit)Tj
-24.72535 -1.2 TD
-0.0001 Tc
(attempts in 1998, based on assumptions about the number of quit attempts)Tj
-0.0002 Tc
(stated above.)'
6 -1.92 TD
0 Tc
0.029 Tw
(The 1996 CTS asked those who were daily smokers 1 year prior)Tj
0 -1.2 TD
[(to the sur)-12(vey whether they had made a quit attempt lasting)]TJ
0 -1.19999 TD
(more than 24 hours. Those who had made a quit attempt were)Tj
0 -1.2 TD
[(asked what method or methods they had used \(T)72(able 5-1\).)]TJ
T*
[(T)72(able 5-2 presents the current smoking status of those who had)]TJ
-6 -1.19999 TD
(made a quit attempt in the last 12 months by the method of cessation assis-)Tj
0 -1.2 TD
[(tance they reported using. Of those who repor)-1(ted using no cessation assis-)]TJ
T*
[(tance, 17 \261)-316(2 per)18(cent were former smokers at the time of the sur)-12(vey)73(. Of)]TJ
T*
(those who reported using patch or gum, either alone or in combination)Tj
-0.0001 Tc
0.0287 Tw
(with other methods, 32 )'
11.39991 -0.00001 TD
0 Tc
0.029 Tw
[<B1>-316(5 per)18(cent were former smokers at the time of the)]TJ
-11.3999 -1.2 TD
[(sur)-12(vey)74(. When the data were analyzed for those who had been quit for 3+)]TJ
-0.0001 Tc
0.0287 Tw
(months at the time of the sur)'
13.9214 0.00001 TD
-0.0002 Tc
(vey)Tj
1.53369 0.00001 TD
-0.0003 Tc
(, r)Tj
0.98718 0.00001 TD
-0.0001 Tc
(esults wer)Tj
4.58948 0.00001 TD
(e less impr)Tj
4.99195 0.00001 TD
0 Tc
0.029 Tw
[(essive \(11.2 \261)-316(2.6)]TJ
ET
BT
/F2 1 Tf
10 0 0 10 48 200.41 Tm
-0.0002 Tc
(EFFICACY/)Tj
0 -1.2 TD
(EFFECTIVENESS)Tj
0 -1.91999 TD
-0.0001 Tc
0.0315 Tw
(Nicotine Gum )Tj
0 -1.2 TD
(and Patch:)Tj
ET
0 0 0 0 k
45 32 48 13 re
f
BT
/F0 1 Tf
10 0 0 10 46 36.6514 Tm
0 0 0 1 k
0 Tc
(158)Tj
ET
0 0 0 0 k
45 677 233 12.5 re
f
BT
/F1 1 Tf
10 0 0 10 46 681.151 Tm
0 0 0 1 k
0.029 Tw
[(Smoking and T)72(obacco Contr)7(ol Monograph No. 12)]TJ
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
/GS0 gs
Q
endstream
endobj
7 0 obj
<<
/Length 5652
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
0 0 0 0 k
404 30 55 15 re
f
q
BT
/F0 1 Tf
10 0 0 10 440.7808 36.6514 Tm
0 0 0 1 k
(159)Tj
ET
0 0 0 0 k
367 678 92 12.249 re
f
BT
/F1 1 Tf
10 0 0 10 414.6955 681.9003 Tm
0 0 0 1 k
-0.0002 Tc
0.0287 Tw
(Chapter 5)Tj
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
0 0 0 0 k
45 393 414 255 re
f
BT
/F11 1 Tf
10 0 0 10 46 640.0664 Tm
0 0 0 1 k
0 Tc
0.025 Tw
[(T)70(able 5-2)]TJ
ET
BT
/F12 1 Tf
10 0 0 10 46 628.0664 Tm
[(Curr)18(ent Smoking and Cessation Status by Method of Cessation Repor)-2(ted by )18(Those who wer)18(e)]TJ
0 -1.19999 TD
[(Daily Smokers 1 )37(Y)111(ear)-257(prior)-256(to the Survey and who Made a Quit )54(Attempt in the Last 12)]TJ
0 -1.20001 TD
(Months: 1996 CTS*)Tj
ET
BT
/F13 1 Tf
9 0 0 9 146.5523 585.2413 Tm
0.028 Tw
[(Current Smoker w/Quit )37(Attempt)-1506(Former Smoker of)-2778(Pop)-1611(Samp)]TJ
1.63282 -1.28 TD
[(Daily)-5138(Occasional)-2417(Any Quit Length)-3084(Size)-2333(Size)]TJ
-1.02752 -1.2 TD
0 Tw
[(%)-3222(CI)-4001(%)-3111(CI)-3889(%)-3222(CI)-4724((N))-3057((n))]TJ
-11.77778 -1.59999 TD
[(T)74(otal)]TJ
ET
BT
/F14 1 Tf
9 0 0 9 143.9936 548.5214 Tm
[(71.79)-2055(2.09)-3054(7.56)-2055(1.21)-2498(20.65)-2055(1.90)-1164(1,266,663)-1831(2,680)]TJ
ET
BT
/F13 1 Tf
9 0 0 9 46 534.1214 Tm
-0.009 Tw
[(Single Aid )-37(Only)]TJ
ET
BT
/F14 1 Tf
9 0 0 9 55 523.3214 Tm
0 Tw
[(None)-7499(74.59)-2054(2.30)-3055(8.35)-2054(1.60)-2499(17.06)-2055(2.20)-1997(915,186)-1832(1,886)]TJ
0 -1.2 TD
0.028 Tw
[(Counseling Only)-3638(.)-3722(.)-4166(3.79)-2054(5.39)-3611(.)-3722(.)-3664(21,538)-3222(38)]TJ
0 -1.19999 TD
[(Self-Help Only)-3416(73.04)-2054(9.63)-3055(6.48)-2055(5.66)-2498(20.48)-2055(8.88)-2553(32,124)-3222(74)]TJ
0 -1.2 TD
[(Patch Only)-4970(67.1)73(1)-2128(8.17)-3054(6.49)-2055(4.06)-2499(26.40)-2054(8.04)-2553(58,422)-2666(142)]TJ
T*
[(Gum Only)-5361(57.49)-1498(14.99)-3055(8.00)-2054(6.32)-2499(34.52)-1499(14.16)-2553(41,251)-3221(92)]TJ
ET
BT
/F13 1 Tf
9 0 0 9 46 465.7215 Tm
-0.0002 Tc
0.0278 Tw
(Aids in Combination)Tj
ET
BT
/F14 1 Tf
9 0 0 9 55 454.9216 Tm
0 Tc
0 Tw
[(Counseling**)-4109(71.81)-2055(7.1)74(1)-3128(3.32)-2055(2.55)-2499(24.87)-2054(7.16)-2553(89,356)-2666(189)]TJ
0 -1.2 TD
[(Self-Help**)-4999(69.06)-2055(6.22)-3055(4.34)-2054(3.07)-2499(26.60)-2054(6.08)-2072(1)74(17,871)-2665(260)]TJ
T*
[(Patch/Gum**)-4109(62.62)-2055(4.87)-3055(5.68)-2054(1.76)-2499(31.71)-2055(4.51)-1997(266,595)-2665(612)]TJ
0 -1.19999 TD
[(Unknown)-6833(.)-3722(.)-4722(.)-3722(.)-4722(.)-3722(.)-4220(8,549)-3222(16)]TJ
ET
BT
/F16 1 Tf
7 0 0 7 50.2786 409.5792 Tm
-0.0001 Tc
0.0278 Tw
(*Those 25+ years of age who have made a quit attempt in the past year and were daily smokers 1 year ago.)Tj
-0.61123 -1.2 TD
(**Combination includes use of the method alone or with any other method.)Tj
ET
1 w 
45 600 m
459 600 l
S
0.125 w 
45 560 m
459 560 l
S
45 420 m
459 420 l
S
142 583 m
282 583 l
S
0 0 0 0 k
45 54 414 324 re
f
BT
/F0 1 Tf
10 0 0 10 100 369.6514 Tm
0 0 0 1 k
-0.0002 Tc
(per)Tj
1.46875 0 TD
0 Tc
0.029 Tw
[(cent for any use of patch or gum versus 9.7 \261)-316(0.7 per)18(cent for no meth-)]TJ
-1.46875 -1.20001 TD
[(ods used\). The results for 3+ month cessation were not statistically differ)-1(-)]TJ
0 -1.2 TD
-0.0001 Tc
0.0287 Tw
(ent, possibly due to the small number of obser)Tj
21.88136 0 TD
(vations. )Tj
-20.08136 -1.91999 TD
(In inter)Tj
3.55164 0 TD
(vention studies, the one community practice Rx study found a)Tj
-5.35164 -1.2 TD
-0.0002 Tc
(long-ter)Tj
3.67871 0 TD
-0.0001 Tc
(m (6-12 months) quit rate with nicotine gum of 18 per)Tj
25.80519 0 TD
(cent \(Smith)Tj
-29.4839 -1.20001 TD
(Kline Beecham, 1995\). Acr)Tj
12.36609 0 TD
(oss five studies of Rx nicotine patch \(T)Tj
18.06508 0 TD
-0.0002 Tc
(able 5-3\),)Tj
-30.43117 -1.20001 TD
(quit rates ranged fr)Tj
8.92908 0 TD
0 Tc
0.029 Tw
[(om 5 per)18(cent to 11 per)17(cent. In OTC settings, two gum)]TJ
-8.92908 -1.19999 TD
-0.0002 Tc
0.0287 Tw
(studies r)Tj
3.90344 0 TD
(epor)Tj
2.07837 0 TD
(ted long-ter)Tj
5.46277 0 TD
-0.0001 Tc
(m quit rates of 13 per)Tj
10.14271 0 TD
(cent and 15 per)Tj
7.34144 0 TD
0 Tc
0.029 Tw
(cent. Six stud-)Tj
-28.92873 -1.20001 TD
-0.0001 Tc
0.0287 Tw
(ies of OTC patch r)Tj
8.59253 0 TD
0 Tc
0.029 Tw
[(eported quit rates from 5 per)17(cent to 17 per)18(cent with a)]TJ
-8.59253 -1.2 TD
[(median of 10 per)18(cent. Most studies that directly compar)-1(ed patch in Rx and)]TJ
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(OTC settings found similar quit rates \(Hughes )Tj
ET
BT
/F1 1 Tf
10 0 0 10 318.3583 242.4517 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 340.2955 242.4517 Tm
-0.0001 Tc
(, 1999\). )Tj
-22.22955 -1.92 TD
0 Tc
0.029 Tw
[(In summar)-12(y)74(, a reasonable estimate for a real-world quit rate for OTC)]TJ
-1.8 -1.2 TD
[(and Rx gum and patch is 10 per)18(cent. Thus, with 6.3 million uses, 630,000)]TJ
T*
(successful quits/year are estimated to be associated with gum or patch use)Tj
0 -1.19999 TD
[(\(see T)72(able 5-4\). Given that those who choose to use gum or patch are mor)-1(e)]TJ
0 -1.2 TD
-0.0001 Tc
0.0287 Tw
(heavily dependent than those who choose to quit on their own \(Hughes )Tj
ET
BT
/F1 1 Tf
10 0 0 10 443.8259 175.2518 Tm
-0.0004 Tc
(et)Tj
-34.38259 -1.2 TD
-0.0002 Tc
(al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 111.2061 163.2518 Tm
-0.0001 Tc
(, 1997\), this estimate may be biased to show smaller gum/patch ef)Tj
31.06825 0.00001 TD
(fects.)Tj
-32.18886 -1.19999 TD
0 Tc
0.029 Tw
[(The difference in per)17(centage of quit rates in which patch or gum are used)]TJ
0 -1.2 TD
(between 1993 and 1996 could be because of the Rx barrier to obtaining)Tj
-0.0001 Tc
0.0287 Tw
(patch or gum that existed in 1993 but did not exist in 1996.)'
ET
Q
endstream
endobj
8 0 obj
<<
/Length 6459
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
q
BT
/F2 1 Tf
10 0 0 10 46 428.1514 Tm
0 0 0 1 k
-0.0001 Tc
(Bupr)Tj
2.72559 0 TD
(opion)Tj
ET
BT
/F0 1 Tf
10 0 0 10 120.3592 428.1514 Tm
-0.0002 Tc
(Ther)Tj
2.14844 0 TD
0.0287 Tw
(e ar)Tj
1.70398 0 TD
0 Tc
0.029 Tw
(e no community practice Rx studies with bupropion. There is)Tj
-5.88834 -1.20001 TD
(one head-to-head comparison of nicotine therapy versus bupropion)Tj
0 -1.2 TD
-0.0003 Tc
(\(Jor)Tj
1.67725 0 TD
-0.0001 Tc
0.0287 Tw
(enby )Tj
ET
BT
/F1 1 Tf
10 0 0 10 142.8845 404.1514 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 164.8218 404.1514 Tm
-0.0001 Tc
(, 1999\). In this study)Tj
9.7085 0 TD
-0.0002 Tc
(, bupr)Tj
2.79187 0 TD
-0.0001 Tc
(opion had higher quit rates than a)Tj
-18.98255 -1.2 TD
0 Tc
0.029 Tw
[(nicotine patch \(30 per)18(cent versus 16 per)17(cent\). On the other hand, long-)]TJ
T*
[(term quit rates for bupropion in other studies wer)-1(e similar to those found)]TJ
-0.0001 Tc
0.0287 Tw
(with gum and patch studies. In summar)'
18.83009 0 TD
0 Tc
(y)Tj
0.48193 0 TD
0.029 Tw
[(, because there is but one study)74(,)]TJ
-19.31202 -1.19999 TD
[(this paper will assume that the quit rates for real-world bupropion are simi)-1(-)]TJ
0 -1.2 TD
-0.0002 Tc
0.0287 Tw
(lar to that for r)Tj
7.042 0 TD
(eal-world gum and patch\321)Tj
ET
BT
/F1 1 Tf
10 0 0 10 298.1239 344.1516 Tm
(i.e.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 311.0682 344.1516 Tm
-0.0001 Tc
(, 10 per)Tj
3.53467 0 TD
(cent. Thus with 3.7)Tj
-24.64149 -1.2 TD
0 Tc
0.029 Tw
(million users, 370,000 quits/year are estimated to be associated with bupro-)Tj
-0.0002 Tc
(pion.)'
ET
BT
/F2 1 Tf
10 0 0 10 46 300.9517 Tm
-0.0001 Tc
0.0315 Tw
(Any medication)Tj
ET
BT
/F0 1 Tf
10 0 0 10 148.6185 300.9517 Tm
0.0287 Tw
(As discussed above, bupr)Tj
11.58191 0 TD
-0.0002 Tc
(opion and NR)Tj
6.58668 0 TD
(T ar)Tj
1.81994 0 TD
0 Tc
0.029 Tw
(e probably rarely used)Tj
-24.85038 -1.20001 TD
[(together)74(. Thus, the total number of medication-associated quits projected is)]TJ
0 -1.2 TD
-0.0001 Tc
0.0287 Tw
(630,000 + 370,000 = 1.0 million quits for 1998.)Tj
9.7 -1.92 TD
0 Tc
(T)Tj
0.53906 0 TD
-0.0002 Tc
(o calculate the pr)Tj
8.13538 0 TD
(opor)Tj
2.1753 0 TD
-0.0001 Tc
(tion of additional successful)Tj
-10.84974 -1.2 TD
(quits (not quit attempts) associated with medication,)Tj
-9.7 -1.2 TD
(one has to make assumptions about the quit rate in those who do not use)Tj
-0.0002 Tc
(medications to quit. W)'
10.75794 0.00001 TD
-0.0001 Tc
(e assume that the 1-year quit rate for those who do)Tj
-10.75794 -1.19999 TD
0 Tc
0.029 Tw
(not use medication is similar to the self-quit rate. This rate has been esti-)Tj
0 -1.2 TD
[(mated at 5 per)18(cent \(Hughes )]TJ
ET
BT
/F1 1 Tf
10 0 0 10 232.8602 197.7519 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 254.7975 197.7519 Tm
-0.0001 Tc
(, 1992\), and the 1996 CTS data \(See)Tj
-15.47975 -1.2 TD
(Chapter 2\) r)Tj
5.70581 0.00001 TD
-0.0002 Tc
(epor)Tj
2.07837 0.00001 TD
0 Tc
0.029 Tw
[(ts an 11.5 per)18(cent quit rate for 3+ months among those)]TJ
-7.78418 -1.2 TD
[(who were daily smokers one year prior to the sur)-12(vey)74(, which, if conver)-1(ted to)]TJ
T*
[(a 1-year quit rate, would approximate the 5 per)18(cent estimated rate. W)29(ith)]TJ
T*
(this assumption of a doubling of the success rate with medication, 50 per-)Tj
T*
(cent of all quits in which medications are used during 1998 are projected to)Tj
-0.0001 Tc
0.0287 Tw
(be additional quits associated with medication use.)'
ET
BT
/F2 1 Tf
10 0 0 10 48 256.7517 Tm
0.0315 Tw
(Quits with medications)Tj
0 -1.19999 TD
-0.0004 Tc
(fr)Tj
1.01562 0 TD
-0.0001 Tc
(om the CTS)Tj
ET
0 0 0 0 k
45 32 48 13 re
f
BT
/F0 1 Tf
10 0 0 10 46 36.6514 Tm
0 0 0 1 k
0 Tc
(160)Tj
ET
0 0 0 0 k
45 677 233 12.5 re
f
BT
/F1 1 Tf
10 0 0 10 46 681.151 Tm
0 0 0 1 k
0.029 Tw
[(Smoking and T)72(obacco Contr)7(ol Monograph No. 12)]TJ
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
0 0 0 0 k
45 460 414 188 re
f
BT
/F11 1 Tf
10 0 0 10 46 640.0664 Tm
0 0 0 1 k
0.025 Tw
[(T)70(able 5-3)]TJ
ET
BT
/F12 1 Tf
10 0 0 10 46 627.5399 Tm
(Six-Month Quit Rates in Minimal-Contact Studies of Nicotine Gum and Patches)Tj
6 0 0 6 390.1701 630.8398 Tm
(a)Tj
ET
BT
/F13 1 Tf
9 0 0 9 225.5023 608.7146 Tm
0.028 Tw
[(OTC)-8306(Rx)-5056(Risk Ratio of)]TJ
-2.97204 -1.2 TD
-0.0002 Tc
(NRT)Tj
4.99912 0.00001 TD
0 Tc
[(Placebo)-4167(NRT)-1931(OTC NRT vs. Placebo)]TJ
-21.97178 -1.19999 TD
-0.0002 Tc
0.0278 Tw
(Nicotine Gum)Tj
ET
BT
/F14 1 Tf
9 0 0 9 55 575.9683 Tm
0 Tc
0.028 Tw
[(Smith Kline Beecham, 1995)-4024(15)-4945<D1>-5777(18)]TJ
5.4 0 0 5.4 328.5022 578.9383 Tm
(b)Tj
9 0 0 9 393.5 575.9683 Tm
<D1>Tj
-37.61111 -1.20001 TD
-0.0001 Tc
0.0278 Tw
(Schneider )Tj
ET
BT
/F16 1 Tf
9 0 0 9 98.2615 565.1682 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F14 1 Tf
9 0 0 9 118.0167 565.1682 Tm
0 Tc
0.028 Tw
[(, 1983)-6635(13)-5167(8)-6166(30)-6860(1.6)]TJ
ET
BT
/F13 1 Tf
9 0 0 9 46 550.7682 Tm
-0.0001 Tc
0.0278 Tw
(Nicotine Patch)Tj
ET
BT
/F14 1 Tf
9 0 0 9 55 539.9683 Tm
(Hays )Tj
ET
BT
/F16 1 Tf
9 0 0 9 78.251 539.9683 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F14 1 Tf
9 0 0 9 98.0062 539.9683 Tm
0 Tc
0.028 Tw
[(, 1997)-9137(9)-5444(4)-6222<D1>-6916(2.5)]TJ
-4.77847 -1.2385 TD
[(Alza Corporation, 1996)-6442(9)-5222<D1>-6055(7)]TJ
5.4 0 0 5.4 326.0006 531.7919 Tm
(b)Tj
9 0 0 9 393.5 528.8217 Tm
<D1>Tj
-37.61111 -1.19999 TD
[(McNeil Pharmaceuticals, 1996)-2924(1)74(1)-4981<D1>-5944(12)-7056<D1>]TJ
0 -1.2 TD
-0.0001 Tc
0.0278 Tw
(Leischow )Tj
ET
BT
/F16 1 Tf
9 0 0 9 95.2579 507.2219 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F14 1 Tf
9 0 0 9 115.0131 507.2219 Tm
0 Tc
0.028 Tw
[(, 1997)-7247(5)-5222<D1>-6222(5)-7333<D1>]TJ
-6.66812 -1.2 TD
-0.0001 Tc
0.0278 Tw
(Sonderskov )Tj
ET
BT
/F16 1 Tf
9 0 0 9 105.2642 496.4218 Tm
-0.0002 Tc
(et al.)Tj
ET
BT
/F14 1 Tf
9 0 0 9 125.0194 496.4218 Tm
0 Tc
0.028 Tw
[(, 1997)-5894(1)74(1)-5203(4)-6222<D1>-6916(2.8)]TJ
ET
BT
/F16 1 Tf
4.2 0 0 4.2 46 485.5199 Tm
(a)Tj
7 0 0 7 48.3348 483.2098 Tm
[(Due to dif)18(ferences in study design and in data collection, quit rates can be compared within rows but not across rows)]TJ
4.2 0 0 4.2 46 476.8504 Tm
(b)Tj
7 0 0 7 48.3348 474.5403 Tm
(Surveys, not experimental trials. Because so few returned for CO verification, these are self-reported quit rates. With CO verifica-)Tj
-0.33354 -1.19998 TD
-0.0001 Tc
0.0278 Tw
(tion they are likely to be somewhat lower)Tj
18.142 0 TD
0 Tc
(.)Tj
ET
196 608 m
279 608 l
S
1 w 
45 625.5 m
459 625.5 l
S
0.125 w 
45 597 m
459 597 l
S
45 493 m
459 493 l
S
/GS0 gs
Q
endstream
endobj
9 0 obj
<<
/Length 3241
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
0 0 0 0 k
404 30 55 15 re
f
q
BT
/F0 1 Tf
10 0 0 10 440.7808 36.6514 Tm
0 0 0 1 k
(161)Tj
ET
0 0 0 0 k
367 678 92 12.249 re
f
BT
/F1 1 Tf
10 0 0 10 414.6955 681.9003 Tm
0 0 0 1 k
-0.0002 Tc
0.0287 Tw
(Chapter 5)Tj
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
0 0 0 0 k
45 54 414 573 re
f
BT
/F11 1 Tf
0 10 -10 0 52.9336 55 Tm
0 0 0 1 k
0 Tc
(T)Tj
0.541 0 TD
0.025 Tw
(able 5-4)Tj
ET
BT
/F12 1 Tf
0 10 -10 0 64.9336 55 Tm
(Use of, and Cessation with, Most Commonly Used Smoking Cessation Medications*)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 83.7588 205.6283 Tm
-0.0002 Tc
0.0278 Tw
(Nicotine Gum )Tj
-16.7365 -1.2 TD
-0.0001 Tc
(Basis)Tj
17.59719 0 TD
(and Patch)Tj
6.87596 0 TD
-0.0002 Tc
(Bupropion)Tj
7.36976 0 TD
0 Tc
(T)Tj
0.53685 0 TD
-0.0002 Tc
(otal)Tj
5.62025 0 TD
-0.0001 Tc
(National Estimates)Tj
-38 -1.6 TD
(Use from Sales Data)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 108.9587 228.7466 Tm
-0.0002 Tc
(6.3)Tj
7 0 TD
(3.7)Tj
5.72204 0 TD
-0.0001 Tc
(10.0)Tj
5.97278 0 TD
(Number of smokers over age 18)Tj
21.02722 0 TD
(44.1)Tj
-58.0272 -1.2 TD
((millions))Tj
37 0 TD
((1996 CPS Data))Tj
ET
BT
/F13 1 Tf
0 9 -9 0 134.1587 55 Tm
(Use)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 134.1587 218.4919 Tm
(21\32024%)Tj
7.83387 0 TD
(14%)Tj
5.16613 0 TD
(34\32038%)Tj
6.83424 0 TD
(Quit attempts in the last year that are )Tj
20.61976 0 TD
0 Tc
(1)Tj
0.48193 0 TD
-0.0001 Tc
(1.5%)Tj
-58.10169 -1.19999 TD
((% of all quit attempts))Tj
37 0 TD
(currently successful for 3 or more months )Tj
0 -1.20001 TD
((% of all daily smokers age 25+))Tj
0 -1.2 TD
(\(See )Tj
2.39937 0 TD
0 Tc
(T)Tj
0.5 0 TD
-0.0001 Tc
(able 2-2\))Tj
ET
BT
/F13 1 Tf
0 9 -9 0 180.9586 55 Tm
(Successful Quits )Tj
8.40835 0 TD
(Associated)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 180.9586 226.245 Tm
(0.63)Tj
7 0 TD
(0.37)Tj
6 0 TD
(1.00)Tj
5.97278 0 TD
(Quit attempts successful for 3+ months)Tj
21.30518 0 TD
-0.0002 Tc
(2.0)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 191.7585 64 Tm
(with Use)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 191.7585 106.7487 Tm
-0.0001 Tc
((millions))Tj
32.25014 0 TD
((millions))Tj
ET
BT
/F13 1 Tf
0 9 -9 0 206.1585 55 Tm
(Excess Quits )Tj
6.57608 0 TD
-0.0002 Tc
(Attributable)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 206.1585 218.4919 Tm
-0.0001 Tc
(15\32050%)Tj
7 0 TD
(15\32050%)Tj
6 0 TD
(15\32050%)Tj
6.83424 0 TD
(Number of quit attempts attributable to)Tj
19.77649 0 TD
(0.15\3200.50)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 216.9585 64 Tm
-0.0002 Tc
(to Medication)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 216.9585 127.737 Tm
-0.0001 Tc
(\(% of successful )Tj
29.91811 0 TD
(medication)Tj
-37 -1.20001 TD
(quits where medication is used\))Tj
ET
BT
/F13 1 Tf
0 9 -9 0 242.1584 55 Tm
(Excess Quits )Tj
6.57608 0 TD
-0.0002 Tc
(Attributable to)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 242.1584 214.9884 Tm
-0.0001 Tc
(0.10\3200.32)Tj
7 0 TD
(0.06\3200.18)Tj
6 0 TD
(0.15\3200.50)Tj
7.22351 0 TD
(Fraction of all successful quit attempts)Tj
19.5824 0 TD
(7.5%\32025%)Tj
ET
BT
/F13 1 Tf
0 9 -9 0 252.9584 64 Tm
-0.0002 Tc
(Medication)Tj
ET
BT
/F14 1 Tf
0 9 -9 0 252.9584 113.7435 Tm
-0.0001 Tc
((millions))Tj
31.47294 0 TD
(attributable to medication)Tj
ET
BT
/F16 1 Tf
0 7 -7 0 267.3584 55 Tm
(* See text for basis of calculations.)Tj
ET
1 w 
68.5 625.5 m
68.5 54 l
S
0.125 w 
96.5 625 m
96.5 54 l
S
256.5 627 m
256.5 54 l
S
/GS0 gs
Q
endstream
endobj
10 0 obj
<<
/Length 5867
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 165 639.6514 Tm
0 0 0 1 k
0.029 Tw
[(A recent meta-analysis of treatment patch or gum per)-1(formed)]TJ
-6.5 -1.20001 TD
[(as part of the U.S. Public Health Ser)-12(vice Agency for Healthcare Resear)17(ch and)]TJ
0 -1.2 TD
-0.0002 Tc
0.0287 Tw
(Quality (AHRQ) )Tj
ET
BT
/F1 1 Tf
10 0 0 10 177.4121 615.6514 Tm
-0.0001 Tc
(Clinical Practice Guideline)Tj
ET
BT
/F0 1 Tf
10 0 0 10 296.0291 615.6514 Tm
0 Tc
0.029 Tw
(suggested that there was a dou-)Tj
-19.60291 -1.19999 TD
[(bling of the cessation rate for nicotine patch therapy and a 30 to 80 per)18(cent)]TJ
0 -1.2 TD
(increase in cessation with nicotine gum (Fiore, 2000). Data from the 1996)Tj
0 -1.20001 TD
(CTS suggest that patch or gum use was associated with an increased likeli-)Tj
0 -1.19999 TD
[(hood of being quit at the time of the sur)-12(vey\321approximately twice that of)]TJ
0 -1.2 TD
[(no therapy \(31.7 per)18(cent compared to 17.1 per)17(cent; T)72(able 5-2\)\321but the)]TJ
T*
(likelihood of being quit for 3 or more months was increased by only 15 per-)Tj
T*
[(cent. This population estimate of a 15 per)18(cent increase is based on a small)]TJ
0 -1.19999 TD
[(number of obser)-12(vations and is substantially lower than estimates of larger)]TJ
0 -1.2 TD
(populations studied as part of cessation evaluations. In addition, it is based)Tj
T*
[(on self-selected groups and, for the reasons discussed above, it probably r)-1(ep-)]TJ
0 -1.19999 TD
(resents an underestimate of the effect of those medications and is included)Tj
0 -1.2 TD
(as a lower bound of the likely magnitude of the effect.)Tj
6.85 -1.92 TD
(Before discussing the significance of the above projections,)Tj
-6.85 -1.2 TD
-0.0002 Tc
0.0287 Tw
(some cautions ar)Tj
7.90503 0 TD
-0.0001 Tc
(e needed. First, the pr)Tj
10.18653 0 TD
0 Tc
0.029 Tw
(ojections may actually be underesti-)Tj
-18.09156 -1.2 TD
(mates, as they do not include quits from medications other than nicotine)Tj
-0.0001 Tc
0.0287 Tw
(patch, nicotine gum, and bupr)'
14.39478 0 TD
(opion. On the other hand, the numbers may)Tj
-14.39478 -1.2 TD
0 Tc
0.029 Tw
(be overestimates, as they assume smokers do not use more than one med-)Tj
0 -1.19999 TD
[(ication at a time and do not use more than one medication per year)74(. As)]TJ
0 -1.2 TD
(stated above, we do not have any actual data on these two issues. Third, the)Tj
T*
[(calculations assume that all medication use is for cessation. A recent sur)-12(vey)]TJ
0 -1.19999 TD
[(found that 94 per)18(cent of OTC gum use is, in fact, for cessation \(Pillitteri )]TJ
ET
BT
/F1 1 Tf
10 0 0 10 440.9084 356.4521 Tm
-0.0004 Tc
(et)Tj
-34.09084 -1.2 TD
-0.0002 Tc
(al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 111.2061 344.4521 Tm
0 Tc
(, 1998\). Fourth, these estimates assume that utilization will continue at)Tj
-1.12061 -1.2 TD
(the same rate. Often, medications have an initial period of popularity fol-)Tj
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(lowed by a decline in use. OTC gum and patch have been available for a)Tj
0 -1.2 TD
(suf)Tj
1.36475 0 TD
(ficient period to indicate that sales ar)Tj
17.48829 0 TD
0 Tc
0.029 Tw
(e now stable. Bupropion has been)Tj
-18.85304 -1.20001 TD
-0.0001 Tc
0.0287 Tw
(available for less than a year; thus, whether its sales will decline \(or alter)Tj
33.95205 0 TD
0 Tc
(-)Tj
-33.95205 -1.2 TD
-0.0002 Tc
(nately)Tj
2.82324 0 TD
-0.0001 Tc
(, they might still incr)Tj
9.99171 0 TD
-0.0002 Tc
(ease\) is dif)Tj
4.86572 0 TD
(ficult to know)Tj
6.54639 0 TD
0 Tc
(.)Tj
-22.42706 -1.92001 TD
0.029 Tw
(The term \322quits )Tj
ET
BT
/F1 1 Tf
10 0 0 10 195.1106 265.2523 Tm
-0.0001 Tc
0.0287 Tw
(associated with)Tj
ET
BT
/F0 1 Tf
10 0 0 10 264.8543 265.2523 Tm
(medication\323 has been used to avoid the)Tj
-16.48543 -1.2 TD
0 Tc
0.029 Tw
(often implicit assumption that the effects of medication are entirely due to)Tj
T*
(traditional pharmacological effects.)Tj
1.8 -1.92 TD
(Of course, some of these effects are due to placebo effects and other)Tj
-1.8 -1.19999 TD
[(non-pharmacological effects, including telephone-based counseling offer)-1(ed)]TJ
0 -1.2 TD
[(to smokers tr)-12(ying to quit. The one randomized study of such counseling)]TJ
T*
(showed that it improved quit rates on its own by a factor of 1.7 \(Shiffman)Tj
ET
BT
/F1 1 Tf
10 0 0 10 100 174.0525 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 121.9373 174.0525 Tm
0 Tc
0.029 Tw
[(, 1997a & b\). However)50(, probably less than 5 per)17(cent of medication)]TJ
-2.19373 -1.2 TD
(users take advantage of such a program \(Smith Kline Beecham, personal)Tj
T*
(communication\). Thus the contribution of telephone counseling to medica-)Tj
0 -1.19999 TD
(tion-associated quits is probably small. Another non-pharmacological effect)Tj
0 -1.2 TD
(is that medication availability may prompt quit attempts. OTC availability)Tj
-0.0001 Tc
0.0287 Tw
(has made it easier to access medications among smokers who do not have)'
T*
0 Tc
0.029 Tw
[(to see a physician for such medication. Finally)74(, the pharmaceutical compa-)]TJ
T*
(nies have engaged in a large amount of direct-to-consumer advertising, the)Tj
T*
(majority of which includes a stop-smoking message and encourages cessa-)Tj
T*
(tion, and the impact of this advertising on cessation activity has not yet)Tj
T*
(been examined \(Shiffman )Tj
ET
BT
/F1 1 Tf
10 0 0 10 223.9612 54.0528 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
10 0 0 10 245.8985 54.0528 Tm
-0.0001 Tc
(, 1997a & b\).)Tj
ET
BT
/F2 1 Tf
10 0 0 10 48 451.4518 Tm
0 Tc
0 Tw
[(INTERPRET)80(A)76(TION)]TJ
0 18.71996 TD
-0.0001 Tc
0.0315 Tw
(AHRQ Analyses)Tj
ET
0 0 0 0 k
45 32 48 13 re
f
BT
/F0 1 Tf
10 0 0 10 46 36.6514 Tm
0 0 0 1 k
0 Tc
(162)Tj
ET
0 0 0 0 k
45 677 233 12.5 re
f
BT
/F1 1 Tf
10 0 0 10 46 681.151 Tm
0 0 0 1 k
0.029 Tw
[(Smoking and T)72(obacco Contr)7(ol Monograph No. 12)]TJ
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
/GS0 gs
Q
endstream
endobj
11 0 obj
<<
/Length 7593
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
0 0 0 0 k
378 676 81 12 re
f
q
BT
/F1 1 Tf
10 0 0 10 414.6955 679.6509 Tm
0 0 0 1 k
-0.0002 Tc
0.0287 Tw
(Chapter 5)Tj
ET
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
0 0 0 0 k
421 30 38 15 re
f
BT
/F0 1 Tf
10 0 0 10 440.7808 36.6514 Tm
0 0 0 1 k
0 Tc
(163)Tj
ET
0 0 0 0 k
45 45.003 201.6 134.9991 re
f
BT
/F0 1 Tf
8 0 0 8 46 173.1233 Tm
0 0 0 1 k
-0.0002 Tc
(Alza Corporation.  )Tj
ET
BT
/F1 1 Tf
8 0 0 8 117.5616 173.1233 Tm
0 Tc
0.029 Tw
[(Nicoder)-10(m data summar)-12(y)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 203.8135 173.1233 Tm
-0.0002 Tc
0.0287 Tw
(. Paper)Tj
-17.92669 -1.2 TD
0 Tc
0.029 Tw
(presented at: meeting of the Nonprescription)Tj
-0.0003 Tc
(Dr)'
1.17065 0.00001 TD
-0.0002 Tc
0.0287 Tw
(ug Advisor)Tj
5.01306 0.00001 TD
-0.0001 Tc
(y Committee of the FDA, Bethesda,)Tj
-6.18371 -1.2 TD
(MD, 1996.)Tj
-1.8 -1.2 TD
-0.0003 Tc
(Fior)Tj
1.80615 0.00001 TD
-0.0001 Tc
(e, M.C., Bailey)Tj
6.69946 0.00001 TD
-0.0002 Tc
(, W)Tj
1.55847 0.00001 TD
-0.0001 Tc
(.C., Cohen, S.J., et al. )Tj
ET
BT
/F1 1 Tf
8 0 0 8 208.8282 134.7234 Tm
0 Tc
(T)Tj
0.58619 0.00001 TD
(r)Tj
0.34106 0.00001 TD
-0.0002 Tc
(eating)Tj
-19.48077 -1.20001 TD
0 Tc
0.029 Tw
[(T)72(obacco Use and Dependence: Clinical Practice)]TJ
-0.0001 Tc
(Guideline.)'
ET
BT
/F0 1 Tf
8 0 0 8 98.3795 115.5234 Tm
0 Tc
[(Rockville, MD:)-287(U.S. Department of)]TJ
-4.7474 -1.2 TD
-0.0001 Tc
0.0287 Tw
(Health and Human Ser)Tj
10.76721 0.00001 TD
(vices, Public Health)Tj
-10.7672 -1.2 TD
0 Tc
0.029 Tw
[(Ser)-12(vice, Agency for Healthcare Resear)17(ch and)]TJ
-0.0002 Tc
(Quality)'
3.406 0 TD
-0.0001 Tc
0.0287 Tw
(, 2000.)Tj
-5.206 -1.2 TD
0 Tc
0.029 Tw
[(Gilpin, E., Pier)18(ce, J.P)128(.  Measuring Smoking Cessation:)]TJ
1.8 -1.2 TD
[(problems with recall in the 1990 Califor)-1(nia)]TJ
(T)'
0.5391 0 TD
-0.0002 Tc
0.0287 Tw
(obacco Sur)Tj
5.0722 0 TD
(vey)Tj
1.5337 0 TD
-0.0003 Tc
(. )Tj
ET
BT
/F1 1 Tf
8 0 0 8 122.3785 57.9236 Tm
-0.0001 Tc
(Cancer Epidemiology)Tj
8.99134 0.00001 TD
(, Biomarkers)Tj
-16.7386 -1.2 TD
0 Tc
0.029 Tw
[(& Pr)8(evention)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 105.1139 48.3236 Tm
-0.0001 Tc
0.0287 Tw
(.  3(7):613-617, 1994.)Tj
ET
0 0 0 0 k
256.4 45 201.6 135 re
f
BT
/F0 1 Tf
8 0 0 8 257.4 173.1211 Tm
0 0 0 1 k
0 Tc
0.029 Tw
[(Hays, J.T)92(., Cr)-1(oghan, I.T)92(., Offord, K.P)128(., )]TJ
ET
BT
/F1 1 Tf
8 0 0 8 398.3786 173.1211 Tm
-0.0002 Tc
0.0287 Tw
(et al.)Tj
ET
BT
/F0 1 Tf
8 0 0 8 418.4528 173.1211 Tm
0 Tc
0 Tw
(Over-the-)Tj
-18.3316 -1.19999 TD
0.029 Tw
(counter (OTC) transdermal nicotine patch thera-)Tj
0 -1.20001 TD
0 Tw
[(py)74(.)]TJ
ET
BT
/F1 1 Tf
8 0 0 8 285.3303 153.9211 Tm
0.029 Tw
[(Jour)-10(nal of Addictive Diseases)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 391.3313 153.9211 Tm
-0.0001 Tc
0.0287 Tw
(16:136, 1997.)Tj
-16.74142 -1.19998 TD
(Hughes, J.R.  Phar)Tj
8.41785 0.00001 TD
(macotherapy of nicotine depend)Tj
15.33485 0.00001 TD
0 Tc
(-)Tj
-21.9527 -1.20002 TD
-0.0001 Tc
(ence.  In: )Tj
ET
BT
/F1 1 Tf
8 0 0 8 309.0783 134.7212 Tm
0 Tc
0.029 Tw
[(Phar)-10(macological Aspects of Dr)-10(ug)]TJ
-4.65979 -1.2 TD
-0.0001 Tc
0.0287 Tw
(Dependence: T)Tj
6.2782 -0.00001 TD
-0.0002 Tc
(owar)Tj
2.11865 -0.00001 TD
0 Tc
0.029 Tw
[(d an Integrative Neur)8(obehavioral)]TJ
-8.39685 -1.19999 TD
-0.0002 Tc
(Appr)Tj
2.06348 0.00001 TD
-0.0001 Tc
0.0287 Tw
(oach, Handbook of Experimental Phar)Tj
16.59376 0.00001 TD
(macology)Tj
-18.65724 -1.2 TD
(Series)Tj
ET
BT
/F0 1 Tf
8 0 0 8 290.8586 105.9213 Tm
(.  Schuster C.R., Kuhar M.J. (editors) New)Tj
-2.38233 -1.2 TD
0 Tc
(Y)Tj
0.55518 0.00001 TD
-0.0002 Tc
(ork: Springer)Tj
6.00574 0.00001 TD
-0.0003 Tc
(-V)Tj
0.99877 0.00001 TD
-0.0001 Tc
(erlag, 599-626, 1996.)Tj
-9.35969 -1.20002 TD
0 Tc
0.029 Tw
(Hughes, J.R., Giovino, G.A., Klevens, R.M., Fiore,)Tj
1.8 -1.2 TD
-0.0001 Tc
0.0287 Tw
(M.C.  Assessing the generalizability of smoking)Tj
0 -1.19999 TD
(studies.  )Tj
ET
BT
/F1 1 Tf
8 0 0 8 304.7688 67.5214 Tm
-0.0002 Tc
(Addiction)Tj
ET
BT
/F0 1 Tf
8 0 0 8 343.2317 67.5214 Tm
-0.0001 Tc
(92:469-472, 1997.)Tj
10 0 0 10 118 640.1514 Tm
0 Tc
0.029 Tw
(Neither did the analyses address whether any medication-associated)Tj
-1.8 -1.2 TD
(quits are from \322stealing\323 quitters who would have quit via behavior thera-)Tj
T*
[(py)74(. There ar)-1(e no data on whether this is the case; however)50(, even if it were,)]TJ
0 -1.19999 TD
[(the effect would be ver)-12(y small given the miniscule utilization of behavior)]TJ
0 -1.2 TD
[(therapy \(<2 per)18(cent of all quits; Smith Kline Beecham, 1995\). )]TJ
1.8 -1.92 TD
[(W)30(ith these caveats in mind, T)72(able 5-4 pr)-1(esents a number of summar)-12(y)]TJ
-1.8 -1.20001 TD
[(estimates for the effects of medication. W)30(ith 44 million smokers and 17)]TJ
0 -1.19999 TD
[(million making quit attempts each year)50(, and with 11.5 per)17(cent of those quit)]TJ
0 -1.2 TD
(attempts lasting at least 3 months, approximately 2 million successful quits)Tj
T*
[((for at least a 3-month period) would occur)74(. Drug-use data would suggest)]TJ
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(that 6.3 million uses of patch and gum would occur \(some individuals)Tj
0 -1.2 TD
0 Tc
0.029 Tw
(would use medications in more than one cessation attempt per year\), and)Tj
T*
[(3.7 million uses of bupropion would occur)74(. Of the total population of daily)]TJ
0 -1.19999 TD
-0.0001 Tc
0.0287 Tw
(smokers, 21-24 per)Tj
8.79737 0 TD
0 Tc
0.029 Tw
(cent of those who make a quit attempt are estimated to)Tj
-8.79737 -1.2 TD
[(use patch and gum, and an additional 14 per)18(cent are estimated to use)]TJ
-0.0002 Tc
(bupr)'
2.18945 0 TD
-0.0001 Tc
0.0287 Tw
(opion. If 10-per)Tj
7.32154 0 TD
(cent success rates ar)Tj
9.30945 0 TD
-0.0002 Tc
(e estimated for use of either med)Tj
15.42433 0 TD
0 Tc
(-)Tj
-34.24477 -1.20001 TD
-0.0001 Tc
(ication, then appr)Tj
8.43897 0 TD
(oximately 1 million successful quits would be associated)Tj
-8.43897 -1.19999 TD
(with medication. If the attributable fraction for medication use is between)Tj
0 -1.2 TD
(0.15 and 0.5, then the number of excess quits pr)Tj
22.82289 0 TD
-0.0002 Tc
(oduced by medication)Tj
-22.82289 -1.2 TD
0 Tc
0.029 Tw
[(would be 150,000 to 500,000, or 7.5 to 25 per)18(cent of all successful quits.)]TJ
3.85 -1.91999 TD
-0.0001 Tc
0.0287 Tw
(The major conclusions of these analyses ar)Tj
20.02369 0 TD
-0.0002 Tc
(e that medications ar)Tj
9.92591 0 TD
0 Tc
(e)Tj
-33.7996 -1.20001 TD
-0.0001 Tc
(widely utilized for smoking cessation and make a substantial contribution)Tj
0 -1.2 TD
(to cessation success in the smoking population. Up to 1 million successful)Tj
(quits/year may be accompanied by medication use, and ther)'
28.35133 0 TD
(e may be an)Tj
-28.35133 -1.19999 TD
(additional 150,000 to 500,000 successful quitters associated with medica)Tj
34.00758 0 TD
0 Tc
(-)Tj
-34.00758 -1.2 TD
0.029 Tw
[(tion use in the United States each year)74(.)]TJ
1.8 -1.92 TD
[(The development of truly effective medications, the decreased pr)-1(ofes-)]TJ
-1.8 -1.19999 TD
[(sional time necessar)-12(y with OTC medications, the large increase in availabili)-1(-)]TJ
0 -1.2 TD
(ty with OTC access, and the direct-to-consumer advertising for both Rx and)Tj
-0.0002 Tc
0.0287 Tw
(OTC dr)'
3.47083 0 TD
-0.0001 Tc
(ugs by the phar)Tj
7.32532 0 TD
(maceutical companies have led to a situation in)Tj
-10.79615 -1.19999 TD
-0.0002 Tc
(which medications make an impor)Tj
16.35816 0 TD
-0.0001 Tc
(tant contribution to smoking cessation)Tj
-16.35816 -1.2 TD
(in the United States.)Tj
ET
BT
/F2 1 Tf
10 0 0 10 48 384.752 Tm
(CONCLUSION)Tj
ET
0 0 0 0 k
45 182.503 119 18 re
f
BT
/F2 1 Tf
10 0 0 10 46 192.1548 Tm
0 0 0 1 k
-0.0002 Tc
(REFERENCES)Tj
ET
Q
endstream
endobj
12 0 obj
<<
/Length 6398
>>
stream
/GS0 gs
1 g
0 720 0 0 re
f
/GS2 gs
q
0.125 w 
0 0 0 1 K
45 675 m
459 675 l
S
0 0 0 0 k
44.995 676 229.505 12 re
f
BT
/F1 1 Tf
10 0 0 10 45.9947 679.6512 Tm
0 0 0 1 k
-0.0001 Tc
0.0287 Tw
(Smoking and T)Tj
6.52442 0.00001 TD
0 Tc
0.029 Tw
[(obacco Contr)8(ol Monograph No. 12)]TJ
ET
0 0 0 0 k
45 30 39 15 re
f
BT
/F0 1 Tf
10 0 0 10 46 36.6514 Tm
0 0 0 1 k
(164)Tj
ET
0 0 0 0 k
46 53 201.6 595 re
f
BT
/F0 1 Tf
8 0 0 8 47 641.1211 Tm
0 0 0 1 k
(Hughes, J.R., Goldstein, M.G., Hurt, R.D., Shiffman,)Tj
1.8 -1.2 TD
(S.  Recent advances in the pharmacotherapy of)Tj
-0.0002 Tc
0.0287 Tw
(smoking. )'
ET
BT
/F1 1 Tf
8 0 0 8 100.7438 621.9211 Tm
0 Tc
0.029 Tw
[(Jour)-10(nal of  the American Medical)]TJ
-4.91797 -1.19999 TD
-0.0001 Tc
(Association)Tj
ET
BT
/F0 1 Tf
8 0 0 8 106.0778 612.3212 Tm
0.0287 Tw
(281:72-76, 1999.)Tj
-7.38473 -1.2 TD
0 Tc
0.029 Tw
[(Hughes, J.R., Gulliver)50(, S.B., Fenwick, J.W)99(., Cruser)50(, K.,)]TJ
1.8 -1.2 TD
[(V)55(alliere, W)99(.A., Pepper)50(, S.L., Shea, P)129(., Solomon,)]TJ
-0.0001 Tc
0.0287 Tw
(L.J., Flynn, B.S. Smoking cessation among self-)'
0 -1.19999 TD
(quitters.  )Tj
ET
BT
/F1 1 Tf
8 0 0 8 97.1832 573.9213 Tm
(Health Psychology)Tj
ET
BT
/F0 1 Tf
8 0 0 8 165.6452 573.9213 Tm
(11:331-334, 1992.)Tj
-14.83065 -1.2 TD
0 Tc
0.029 Tw
[(Jorenby)74(, D.E., Leischow)73(, S.J., Nides, M.A., Rennard,)]TJ
1.8 -1.2 TD
-0.0001 Tc
0.0287 Tw
(S.I., Johnston,J.A., Hughes, A.R., Smith, .S.,)Tj
(Muramoto, M.L., Daughton, D.M, Doan, K.,)'
0 -1.19999 TD
0 Tc
0.029 Tw
[(Fiore, M.C., Baker)49(, T)92(.B.  A controlled trial of sus-)]TJ
T*
(tained-release bupropion, a nicotine patch, or)Tj
0 -1.20001 TD
-0.0001 Tc
0.0287 Tw
(both for smoking cessation.  )Tj
ET
BT
/F1 1 Tf
8 0 0 8 170.4128 516.3214 Tm
(The New England)Tj
-13.6266 -1.19999 TD
0 Tc
0.029 Tw
[(Jour)-10(nal of Medicine)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 134.2536 506.7215 Tm
-0.0001 Tc
0.0287 Tw
(340: 685-691, 1999.)Tj
-10.9067 -1.19999 TD
0 Tc
0.029 Tw
[(Leischow)74(, S.J., Castellini, S., Merikle, E.  The efficacy)]TJ
1.8 -1.2 TD
(of nicotine patch as an over-the-counter medica-)Tj
-0.0002 Tc
0.0287 Tw
(tion. )'
ET
BT
/F1 1 Tf
8 0 0 8 81.6549 477.9215 Tm
0 Tc
0.029 Tw
[(Jour)-10(nal of  Addictive  Disor)8(ders)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 195.5525 477.9215 Tm
-0.0001 Tc
0.0287 Tw
(16:140, 1997.)Tj
-18.56906 -1.2 TD
(McNeil Consumer Pr)Tj
9.78296 0 TD
(oducts Company)Tj
7.91785 0 TD
-0.0002 Tc
(.  )Tj
ET
BT
/F1 1 Tf
8 0 0 8 195.9503 468.3215 Tm
(Nicotr)Tj
2.64819 0 TD
(ol data)Tj
-19.46698 -1.19999 TD
0 Tc
0 Tw
[(summar)-12(y)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 93.8355 458.7216 Tm
0.029 Tw
(. Paper presented at: meeting of the)Tj
-4.05444 -1.2 TD
[(Nonprescription Drug Advisor)-12(y Committee of)]TJ
-0.0001 Tc
0.0287 Tw
(the FDA, Bethesda, MD, 1996.)'
-1.8 -1.2 TD
0 Tc
0.029 Tw
[(Pier)18(ce, J.P)128(., Gilpin, E., Farkas, A.J.  Nicotine patch use)]TJ
1.8 -1.19999 TD
(in the general population:  Results from the)Tj
0 -1.2 TD
[(1993 California T)71(obacco Sur)-12(vey)74(.  )]TJ
ET
BT
/F1 1 Tf
8 0 0 8 186.6745 410.7217 Tm
[(Jour)-10(nal of the)]TJ
-15.65931 -1.2 TD
-0.0001 Tc
0.0287 Tw
(National Cancer Institute)Tj
ET
BT
/F0 1 Tf
8 0 0 8 154.9196 401.1217 Tm
(87:87-93, 1995.)Tj
-13.48995 -1.2 TD
0 Tc
0.029 Tw
[(Pillitteri, J.L., Hughes, J.R., Callas, P)129(.W)99(.  )]TJ
ET
BT
/F1 1 Tf
8 0 0 8 196.6163 391.5217 Tm
(Use of nico-)Tj
-16.90204 -1.19999 TD
[(tine gum for smoking r)8(eduction vs. smoking)]TJ
0 -1.2 TD
-0.0001 Tc
(cessation)Tj
ET
BT
/F0 1 Tf
8 0 0 8 92.5914 372.3218 Tm
-0.0002 Tc
0.0287 Tw
(.  Pr)Tj
1.87769 0 TD
-0.0001 Tc
(esented at Society for Resear)Tj
13.19801 0 TD
(ch on)Tj
-18.97462 -1.20001 TD
(Nicotine & T)Tj
6 0 TD
(obacco: New Orleans, 1998.)Tj
ET
0 0 0 0 k
257.4 53 201.6 595 re
f
BT
/F0 1 Tf
8 0 0 8 258.4 641.1211 Tm
0 0 0 1 k
0 Tc
0.029 Tw
[(Prochazka, A.V)119(., W)76(eaver)50(, M.J., Keller)49(, R.T)92(., Fr)-12(yer)49(, G.E.,)]TJ
1.8 -1.2 TD
[(Licari, P)129(.A., Lofaso, D.  A randomized trial of nor-)]TJ
-0.0001 Tc
0.0287 Tw
(triptyline for smoking cessation.  )'
ET
BT
/F1 1 Tf
8 0 0 8 399.1174 621.9211 Tm
0 Tc
0.029 Tw
[(Ar)18(chives of)]TJ
-15.78968 -1.19999 TD
[(Inter)-10(nal  Medicine )]TJ
ET
BT
/F0 1 Tf
8 0 0 8 341.2161 612.3212 Tm
-0.0001 Tc
0.0287 Tw
(158:2035-2039, 1998.)Tj
-10.35201 -1.2 TD
0 Tc
0.029 Tw
[(Schneider)50(, N.G., Jar)-12(vik, M.E., Forsythe, A.B., Read,)]TJ
1.8 -1.2 TD
[(L.L., Elliott, M.L., Schweiger)50(, A.  Nicotine gum in)]TJ
-0.0001 Tc
0.0287 Tw
(smoking cessation. )'
ET
BT
/F1 1 Tf
8 0 0 8 345.9992 583.5212 Tm
(Addictive Behavior )Tj
ET
BT
/F0 1 Tf
8 0 0 8 415.8342 583.5212 Tm
(8:253-261,)Tj
-17.87928 -1.19999 TD
(1983.)Tj
-1.8 -1.2 TD
0 Tc
0.029 Tw
[(Shiffman, S., Gitchell, J., Strecher)49(, V)120(.J., )]TJ
ET
BT
/F1 1 Tf
8 0 0 8 404.7204 564.3214 Tm
[(et al.)-631(Real-)]TJ
-16.49005 -1.2 TD
[(world efficacy of computer-tailor)7(ed smoking cessation)]TJ
T*
[(material as a supplement to nicotine r)8(eplacement)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 443.3177 545.1213 Tm
(.)Tj
-21.31471 -1.19999 TD
[(Presented at 10th W)76(orld Confer)-1(ence on T)72(obacco)]TJ
-0.0001 Tc
0.0287 Tw
(or Health, Beijing, China, 1997a.)'
-1.8 -1.20001 TD
0 Tc
0.029 Tw
[(Shiffman, S., Pinney)74(, J.M., Gitchell, J., Burton, S.L.,)]TJ
1.8 -1.19999 TD
(Lara, E.A.  Public health benefit of over-the-)Tj
-0.0001 Tc
0.0287 Tw
(counter nicotine medications.  )'
ET
BT
/F1 1 Tf
8 0 0 8 390.4426 497.1215 Tm
0 Tc
0.029 Tw
[(T)72(obacco Contr)7(ol)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 272.8 487.5215 Tm
-0.0001 Tc
0.0287 Tw
(6(4):306-310, 1997b.)Tj
-1.8 -1.2 TD
0 Tc
0.029 Tw
[(Sonderskov)74(, J., Olsen, J., Sabroe, S., Meillier)49(, L.,)]TJ
1.8 -1.2 TD
-0.0002 Tc
(Over)Tj
2.26343 0 TD
-0.0001 Tc
0.0287 Tw
(vad, K. Nicotine patches in smoking cessa)Tj
19.61988 0 TD
0 Tc
(-)Tj
-21.88331 -1.2 TD
-0.0002 Tc
(tion. )Tj
ET
BT
/F1 1 Tf
8 0 0 8 293.0549 458.7216 Tm
0 Tc
0.029 Tw
[(American Jour)-10(nal of  Epidemiology )]TJ
ET
BT
/F0 1 Tf
8 0 0 8 419.1214 458.7216 Tm
-0.0001 Tc
(145:309-)Tj
-18.29017 -1.2 TD
0.0287 Tw
(318, 1997.)Tj
-1.8 -1.2 TD
(Smith Kline Beecham. )Tj
ET
BT
/F1 1 Tf
8 0 0 8 343.692 439.5216 Tm
(OTC)Tj
2.37964 0 TD
-0.0002 Tc
(Nicor)Tj
2.31543 0 TD
0 Tc
0.029 Tw
[(ette data summar)-12(y)]TJ
ET
BT
/F0 1 Tf
8 0 0 8 446.4206 439.5216 Tm
(.)Tj
-21.70257 -1.2 TD
(Paper presented at meeting of the)Tj
0 -1.19999 TD
[(Nonprescription Drug Advisor)-12(y Committee of)]TJ
0 -1.2 TD
-0.0001 Tc
0.0287 Tw
(the FDA, Bethesda, MD, 1995.)Tj
ET
Q
endstream
endobj
13 0 obj
<<
/Nums[0<</S/D>>]
>>
endobj
14 0 obj
<<
/Differences[32/space 38/ampersand 40/parenleft/parenright 43/plus/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon/less/equal 65/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W 89/Y/Z 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 168/registered 177/plusminus 209/emdash/quotedblleft/quotedblright]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
15 0 obj
<<
/Length1 8000
/Length 8000
/Subtype/Type1C
>>
stream
  MDYGLS+StoneSerif   E¯ ¯¯¯¯˚˚]˚éˇ˙U
 ãã
 ãã      ¥≠   ñ• Copyright (c) 1987, 1990 Adobe Systems Incorporated.  All rights reserved.ITC Stone is a registered trademark of International Typeface Corporation.ITC Stone Serif  N  5 I F  Q S P W O B N D U J T G L H V  M Z E 	 )     
  C 1 [   " X R # K / 6 4 3 Y    * 0 $ .   +  % 8 ' ( â  ; •  ú  ,  2 i w  & : 7  - P   G ∫ó\°ô:îŸ3ó	ÑB∂›Äˇ	9	ß	Ë
H
™
Ó(?≤T‹˘Zº'§ÖÔj‚TÆîÀ"Ö6ñÒ;ülÁ˛ßÍø‹2≥÷[´˚4°\Ä∆˚ˇdã•˘´˜ïÏ˜ˆ˘0Â‚üTI¨§p˜-¸Ωp˚-§Õ¨ü¬‚Â¸≥.èê1Äq˜°•1ñèÜËìã•¯Fø˜;•©w˜Â˜ñÂÏ˜Z˘s_{KOâqµ•ózp¸í1êé6q˜é•6óêàÂ˜Úü˜˜ıè3L˚L1êé6q˜é•6óêàÂ˜fÛs‘˚4CeY`˜…˚/ƒ˜{Æ˜:Æ±Í˜Å‚¯]˜®ß˜B›˚˚>L˚#˚	@∞<©i2‹ﬂò§™˜…{™sjsTã˚#V˜	˜Æ˜Ã≥Œ√º_K_o}u`˚é•˜hÆ¯9•Ü∫ÒÂ˜™Ó‹˜T˜àæéƒô±πõµ®ø◊÷W˚.1y˚&˚%`dö™jPyπ™á∂˜Aﬂ˜0˜˜S(»˚LLlXcâ€âç®]oHTâqº™è]¸£1êé6q˜©•Lêgçá†á£ãôã¨˚ùã•¯v°ÊG•˜ÂH˜’¯#êàèâëè(®ûëèêèàënæ{®åÇãz}~rsWUÂâçò]oHUâqª™è]˚©1êé6q˜†•Uêgçá†á£ãôã¨˜0(”íœ¥öóåÜïQÆ¯ZÆ±Ó˜“Ó˜≥˜4ˆ˜˜%˜A˚‡˚˚:&˚˚˚?˜4˜õÆ˚RÓ˜˜.œ‘·˜	∫˚	˚˚/FD8.†v¯n•¯G˜˜I¯2¡u≈ë∑•˚òqΩüZnò˜?¸ ¨˜I¯û¥üªªã•˚cqø¬ÑCn˚˚´ìã•¯6•Åø˜Â˜ñÂ∏˜\˜ãÚü˜˜ıè3L˚L1êé6q˜é•6óêàÂ˜fÛs‘˚4CeY`·âç–]oHTâqº™è]˚©1êé6q˜é•6óêàÂ˚!…éw¯PÆ≥Â˜SÂ∏˜’˜l˚MiW]l±∫ÒÚ£„¨x˜:˚ôÖßHqà∂ãæ˜r˜Xø˚	_iÑy]áÄÉÖx|VäÑéáëâ≠Éëäèãéê£Ø†¬»ã…ã¢Qã4˚ a˚	]Sm,òB¬QÕ™ßóö¢Ÿøãmìlöy˜ºã•¯6•Åø˜Â˜xÂ˜xÂº˜\˜Ö˜D∫∂›Èê>@˚K1êé6q˜é•6óêàÂ˜˜<∂æ·Èê>@˚K1êé6q˜é•6óêàÂ˜eÛn’˚;NeYbªtv≥3;HeYkâ·âç‹]oHTâqº™è]˚©1êé6q˜é•6óêàÂ˚9ƒ¯DÆ±Ó¯M›~rksT˚$[˜ı˜%‰∫∆±¶{{ôæPèàëåêéÆ°éçãèàèhŒjûVífã˚(˚%˚2AÆ=´h2⁄˜ó§˜ ˚¨«¯π˜ Â˜Ú¯p˚,˜5prxwyyx";]€˚∞˚√v—˜πÑ•sÅqâpãIâ€≤˜õ˜¥ü˚Ëã•¯6•µw‡˜	·˜	.Âƒ˜Z¯î]oHTâqº™è]˚©1êé6q˜é•6óêàÂ$¯˚˜j¶q´™¶ß™™p¶klpqk˚áÆ¯ZÆø•r‡˜!‰L•‰øöy∞∂Ç¬ÿ‚ÈπÛπ∞-ÕBøX•ª≤Æ§µTƒ©[ié•Ôö]cçk9=\7I¨{‹P®«`øtJai_QQW≠—åq˚√ã•¯(π˜b¿˜Â˜Á¯p˚˜∂å¨∞õüÇÇ¢Ø|ëâìâêêõ£ééêíÖë\≥îzâ~âoáXjw|gqggãK:F]–˚≈1êé6q˜¢•Sêgçá†á£ãôã¨˜≈Ì¥ü(ãò~•˜å¢˜E•˜G•©w˜Â˜[Ù∑¯ºòU∂˚˜(6È˜˜™®Æüûó•˚CqØ É_^`_C9H¯Hâçj_{KOâqµ•ózp¸í1êé6q˜é•6óêàÂ˜)ç˜u˚¶˜˚˚éÆ¯®˜î¥ß©›]Í˜SÍq⁄Ÿ˜∂é»Ä—Å7TRQ/$R√’ø¥®≥£!˜Œ¯G¶∑Åò\QÖJçórlèg-%R!;∞[◊e,=Ç^ßr∏Öâ…"S|Ççvã|˚ˆI˜˜‡Ò‘WºDô/ùOñbêã£úöôòïäìôäûb˜‘‚◊æwΩt†V˚-®ÃçØA/]|CHà6àsÓŒº†—–éd∆ëw¯/•µwÁÂ˜ÅÂT¯›¨ÖßHqà∂ãæ¯âç¨]oHTâqº™è]˚1˚(_Y.3—÷˜“âç¨\oHUâqº™è]˚o˚™8˜®°ç£µ„æãnìlöz˚5v˜ŒwÌÒœ˚J∞¡Í˜&´®o¿{ÑO\|çê^£D6#˚Ëã•˘!•©w˜Â–˜Z˘s_{KOâqµ•ózp¸í1êé6q˜é•6óêàÂ0¯Ù-˚é√˘0•¯F˜˜¡˜˚˜ºq—¿É¿ã•˚ôq∑òzN¶˜<¸W˚{jotd|PváãÉãÉzÇéÅì’≤ô§≤û˜û¯Œû¥ûººã•˚cqø¬ÉCm]ƒìw¯PÆ˜;•©w±Í˜ØÂ∂¯4˜ZM_V˚]˜ÛŸ∑˜˜…¥z`•J˜:¸ÖßHqà∂ãæ¯âç∂_{KOâq¥¶ózp˚ ög^çk˚˚0˚E˚—˚"˜9£òì°≤Œ≥åmëuöy˚æ†v˘sw÷‰˜·˚O˚+˜y˜5˜I˜?Æ˜2˜ÒÇù˚4 2˚4ã˚S˚~˜˚,˜*˜'ã•˜„¥˜§•˜Ï˜ÛÏ˜s˜˝˜Û˚Ä.èê1Äq˜°•1ñèÜË¯VËáÜÂñ•˚°qÂÄáê.˚A˚Û˜AËáÜÂñ•˚°qÂÄáê.¸V.èê1Äq˜°•1ñèÜË?ã•˘Bw˜íÎ˜Ú˘\˚ã)ói∏ù¥ö¿°ãB¸=fã|ápátcâ@Ñq˜Î•>íeçá¢Ü¶ãöã∞?Ω˜{∫˜¸Ø¥Ô˜•Ô‰˜åö˜B˜oé˜né˜M ‚˚ã˚%ã+#ä˚ä˚)ÎGÙã÷ãπ©Ø∞çâo˚3*˚˚Nç˜Ÿ¯74NUB-^‚Úÿ≤ËÎÿŒ7˚Ö?Ø˜¸∫˜{Ω«Ô˜•Ô¯y˘\˚áz˚G˚kà˚lâ˚BÙ%˜!ã˜ãÍÛå˜å˜),œ!ã@ã^mefâç®˜3Ï˜!˜Ná˚Ÿ¸7‚«¡’Ëπ5#?c-4/N‡˜í†v˜Ù˜‡˜˚	Ò–Õ˚A∞¬Í˜%´®n¿|ÑO\|çê^¢D6$‡¿¯¿i©m≠≠©©≠≠m©iimmi˚æ†v˘sw˜P‰™˚b˜Ï˜˜,˜~˜S2˜4˚4ˆÇy˜%Æ˚2ã˚?˚Iy˚5˚+˚˚—†v˜Y›µ˜ç˜∑˜Y›˚ç9LÆ¯N∫˜;•©w‹Â˜´ÓÏ˜?˜Üæéƒô±≠óª∂¡’’U˚$˚J5M:faëù}{ûà∫®‹1˚"õ ¬o‰˜˜˜˜0˜I/»˚KLlX`˜√âç(_{KPâq¥¶ñzp@ã•˜ªw¯´q•˜Ï˜wÔÏ˜s˘0»˜¡W˚˚Q@˚çw˜-Ç˜Ÿ˜$˜9Õ˚:˚öòqÂÄáê.¸V.èê1Äq˜°•1ñèÜË˚Hã≥¯/ºc≥ÿ•˜Õ•∏¯>¯à˚Ò˚•æå†≥Õ˜'˚–¸9úd¯'˜qYäzb=˚YH˜√¯/?©˘,©º‰AÔ˜Ñ€PÔX˜8¯» ∂¬ÿÿ∂RADeY_v3∞E∏‘§˜
¸∂6Pﬁ‚›≠∑∆¨ﬁa˜d&7WL0Xå˘J˚˚C$EæOﬂb§Mr3^˚˚Ï9˜˜ÙŸ˜˜-ø9±Hºõ·ΩXÛ0Ω˚˜⁄˜⁄øi©m≠≠©©≠≠m©iimmi≠ã•˜b±¯Nwô˘$¯S˜|∂˚õ_ÖjLãq˜}•`{´√ui‰%˜»G˜]S8˚q˚	˚€`3{jnzpãq˜J•_x¨≤òπ˜ö±˜˜Ÿçı˚Ÿ˜%†v¯n•˘.˜ê¯n∑¢jVö˜¸¥˜+¯˜$¸¥˜¯†…ú¶∑ã•˚^qµƒÑ*n>˚àâ˚¯
^˚'¸âI˜ës„ØèÕã•˚ía˚é•˜hƒ¯D§±Í˜ØÂ¯4˚jã}ásávgâKÜq˜™•6óêàÂ˘YÅ0ôNç˚ã˚0ã˚Dã˚—˚"˜9ã£ãòì≤°Œ∞ﬂYM_V˚]˜Ûÿ∂˜˜…¥|`•jã•q´˜“´˜≤´q•˜Ï˜]ÔH˜v˜s˘0ƒÎªe(˚GjR?kÀuÈ◊`˚(`T18y§„å˚K¯øqÂÄáê.¸V.èê1Äaq˜©˜'ˆ«˜ Ù6–!éç⁄¢Ã…ﬂ˜7±˚-˚„˚yv˘J•µw·˜	ı˜	%Âƒ˜R`ÜWÖvÅhrzuáv⁄⁄ª˜>$¯≤âçD]oHUâqª™è]|˜j¶q´™¶ß™™p¶klpqk˜&ã•˘•˜µ¯sµ˘F¯…†èúçõêØ≠ô∫ê•˚âqÕÜ≠}êgç{èzãv¸/â˚)˜I˚/˜L˚)˜I˚Jqƒ™kgß¸kvázâ{Ügj}[Üq˜â•IêiôÜØâõáúã†¯N˜7˚T˜9˚Y˜3˚P˜∫˘•˜Ï¯ ø˜g¯”ËáÜÂñ•˚°qÂÄáê.˚æ˚IÕ˚ ˜i˜˜€˜k˜Æ†èúçõêØ¨ôªê•˚Äq∫Ü≠}êgç{èzãv˚™˚4C/˚˚)eˆ˜ ˚*Æ˘"Æ≥•{Ô˜bÛA•‰¯0¯ª˜êäèÖçôcRê`ÿ˚'D1˚Œd¡g˜*(ÆVJBQUD®>B∑˜Äq˚$Ééáèâwø¬À˜˜Õ˜ﬁiæ!⁄T'÷Eµ—’ø©≈€±SEìxãò~•˜∞´˜⁄´q•˜Ï˜fÔv˜s˘0ÿ‘«e˚˚cI48l˚K˜‡ÂÄáê.¸V.èê1Äq˜°•1ñèÜË˜MÈñ˚]˜´˚∆Úòh†S—Y‘)˜)ÿ© “Ú˜	&¿&˚∑>ã•¯T•ò˜˜å˜˜ã¯)∫nç°æ•˚}q≥®wc•ı˚4˚
˚.dXqt`ãq˜J•VÇ•ÕæÿÓ÷˚ÆWàqbãq˜}•^pò¨u˚%˜fÎ˜º«üóµã•˚9q∑éz`j<(?ã•˜F–¯?w˜ﬂÁ¯;˘PQ˚˚)˚;˚Ç]<ñm˜∞Cgã}áqáueâFÖq˜¡•Zëfçá°á•ãôãØ”Û–#˚œ∫›˜˜C»…˚”?ã’¯Õ–ﬁ•˜•˜¯ï˜HQts[I˚¨ø¡ŒÃ¬¡ÃÀ˜˜ã˜ã˜.¬˚ã<ãAiSE˚•ˆô ∑’ÿ∏QH˚˚˚@?]\^\YRY¯O…˜H?~©˜ﬂ∂˜∑©˜˚˜?˜Ë˜D˜∫˜>†˚I*VA=[cï∂n[“áëÉâÇÇtyÉÑãàéÑÆ?û~ﬂtÃâ˜
â˜“â˜â˜-Œ$ïçp‰£ÿ…äÓÖ˜7¨˚	ã]ã=z_n>™|ßŸµ©…ã¡ª[:(LP˚á˚¡ã•˘•˜Ï˜s¯”ËáÜÂñ•˚°qÂÄáê.¸V.èê1Äq˜°•1ñèÜË˜9Æ˘"Æª˜¯˜¯˜q˜2˜@˜g˜.˚˜O˚m˚d˚<˚3˚l˚V˜)˚/˜S¶Æ˚˚˜˜Ü˜—˜,˜>˜˜*˚É˚W˚L˚NÊÆ˘"Æª˜¯•˘?˜F<kM?˚˚`0˜ ˜[å˜HåÂ˜˜O˜3æ4;é•˜õÄôoîõZ]ù*˚°˚˚`˚.˚†˜M)˜a‚—úò±ßîùè°©˜˜Õövë•˘•˜µ¯∆Ïà¯TÖõ˜§¯ªçx¸8.èê1Äq˜°•1ñèÜË¯R ¶≥‘•˚6˚¥¸√˚´¯√˚Qqªºd\ü¸Yvázâ{Ügi}\Üq˜u•\êiôÜØâõàúã†¯)ç?†v˘÷•¯H˘B˚O˚6˚¥1˚*Í˜/˜Ù„˜H—˜∑¸6˚•∆èŒÖ§?≠¯%v˜s÷¯*‚˜R˘P3˚æ˜d{Î'ã˚;PG=Oi≠°yM÷ÑìÑÖÖÜvxÖÜéÉéÖµ;üy…qŸã˜˜’˜˜ ˚˜˚hü∏˜'˜o§÷˚¡˚FΩ˘∂•˜Ï˜s¯”ËáÜÂñ•˚°qÂÄáê.¸]˚DtE_tyóôtiùÖéÉéááxvààÉÑíÑ≥]ïúãóãßäƒ•ûï£óÎ¡ã˜e?´˘(´©ı˜¬ı˜≥˜*ˆ˜'˜Å˜*=˜R˚G˚G=˚R˚*˚Åˆ˚'˜*´s˚É˜Ú˜⁄˜É£§˜ì˚⁄˚Ú˚ìr˜ã•q´˘´q•˜Ï¯%˜l˜s˘0ˆ˜TÒ˚˚R˚ê˚7˚2,rå˜ò˚K¯®ÂÄáê.¸V.èê1Älqå˜¬˜å˜'˜>˜\˜b˚˜˚Ü˚‡¯*†v˘6•ô˙ò˜®˘P˚öq¿¨b)ß˜+¸´∂˜\¯≥˜]¸≥π˜N¯Ëú¬≥¢©ã•˚pq‹äúmxM_˚"a˚"^˚ â˚Z¯™e˚]¸±â˚¯Bwœ¢• ã˚ã•˜ƒ´˜∆´q•˜Ï˜O•§•Ï˜s˘0˜*”úTAò•˜5¸S‹qÂÄáê.¸V.èê1Äq˜°•1ñèÜË˜aÍŒ°gPé•˜jqMâprL,˜&Æ˜∞•˜ÏÆª˜¯6Ïs•¯¯JÊﬂ†§À˜BËáÜÂñ•˚µq˜Äáê.N=Ä]˚˚_;˜I˜2å˜?åœ˜$˜e4˜3æ4;é•˜õÄôoîõZ]ù*˚¢˚˚`˚.¯˚†˜M)˜a˜Ú†v˜c…ã˙|˙|˜c…˛|M˜9¥nû¯/π˜dß¡ˆjﬂ˜_•˜#≥∑¯ò˜aiOV-© OﬁÊ∑ô›ﬂ™¯£˜˚ªXqw˜
∞Yá˚iD˚Å˜t2ﬂx∑∑Àº™≥»¨iEü•Á°u[ùO˚ND4>¬a≈Sà˚|O=/&ÿ"˜C˜ŸΩ…ªa≠h´o≥f˜	ûe§,›[ππ›á˜	á∆˜ª•Rã∂¯˙∂q•›•¯D•ÿ¯º˘P¸j˚0•—å£∂⁄˜u¸6˝°h¯°˜Dq0äda;˚Æ(¯2˘˜ø˜ô˜1•˜DôÚø¶ø˜Jÿ˜
÷˜<ø¯˜P˜B˜7˜[˜[˚B˜7˚P˚_˚3˚7˚[˚[˜3˚7˜_ø˚>˚ ˜#˜;˜:˜˜$˜?˜0˜.˚#˚;˚;˚/˚#˚/˚C¯ã¢àüäçÄç}ãÉãx˚ãxãÉâ}âÄwätà}˜?ôtéwåâñâôãìãûø˚—öT¨◊ïxóm≤o≥U›¥ú∞≤≈À=•R˚J˜˚R˜ôà¢ü†æ®sUE`}S˚ô†v˘sw´˜ŸÎ˚ ˜ô˘ﬂL˚ö˝ﬂ?ãÕ˜ïÕ˜íÕ˜í¯˚oI˜o˚nÕ˜n˜oÕ˚o˜nI˚o¸Û¯åÕ¸å?†v˜pÕ˜pw˜íÕ˜í˜≤˚oI˜o˚pÕ˜p˜oÕ˚o˜pIùãö|•˜⁄§˜Ω•˜Ï˜∫˜x˜˜.èê1Äq˜°•1ñèÜË˜w°º˜k˚û¥X°h≤ãÙö+ƒ˚(˜U#˜˜b˜b¥¥±≤®ó•˚MqØå…É_^˚`˚arrxlà˜ZËáÜÂñ•˚°qÂÄáê.?†v˜Õ˜ÕÆ¯å¯Ø¯¸åI¯å˚¸åI¯å˜9˚?œnúÚÆ˘"Æª˜¯˜|˙˚Ñúºqäkëníjì^òH´˚∆˜≥˜˜
˜`˜-˚˜P˚n˚a˚?˚0˚o˚S˜&˚2˜Vπ˜o˚”dÆÜ†ì¸˘·˜˜)˚Ç˚Z˚S˚Q˚˚˜˜á˜Œ˜1˜A˚*†v¯Nv˜Œw“˜:§˜:˜_˘sfT,˚%km®Wöí«πöâÜπt—‡ÛË˜1¨fT,˚%km®Wöí«πöâÜπt—‡Û˚*†v¯Nv˜Œw“˜:¶˜:Ë˜æ¯9∞¬Í˜%´©nø|ÑO]|çê]¢E6#˚3j∞¬Í˜%´©nø|ÑO]|çê]¢E6#˜˜Ä˜⁄˜†⁄øi©m≠≠©©≠≠m©iimmi`¯ i©m≠≠©©≠≠m©iimmi@ã•q´˜“´˜≤´q•˜Ï˜D•Ø•w≥¯Ä©˜Hq ]íb˚%1dí‡˜vﬂŒ¢hPç•˜iqMâprL7˜≤˜”üTAï•˜5¸RäåqÂÄáê.¸V.èê1Äàã•˘•˜ßÏ˜Q˜°•1ñèÜË˜§çßïü˜;˜√¶ª¶òßã•˚bq∆´nNi˚˚è˚˜èrøÑ±◊ã•˚ìqπßrJ¨˜.˚≈˚..èê1Ä“†v˘6•ô˘I˜≤˘P˚§qª™l ∞»˚>œ˚U»˚Aæﬂ˜a‡˜`ﬂ˜a†Ω¨ï®ã•˚lqœ•lLrM˚-N˚.K˚-W˜,Q˜@d˜
jÎ≥õ¬ã?òv•¯ë¯´√¸<˜Y¯<˜YÀ¸ë˚~U¯ë˚~?ã•q´˘•˜Ïp≥¯©˜Hr ]ëb˚%2dí—¯fËáÜÂñ•˚°qÂÄáê.ê¸V.èê1Äó˘Pó˚hó±î˜Dó˜™í˜í˝/óÆ
Â˜≥˘endstream
endobj
16 0 obj
<<
/FontFile3 15 0 R
/Ascent 735
/Descent -250
/Flags 34
/ItalicAngle 0
/StemH 0
/FontName/MDYGLS+StoneSerif
/CapHeight 700
/XHeight 747
/Type/FontDescriptor
/FontBBox[-201 -250 1279 961]
/StemV 90
>>
endobj
17 0 obj
<<
/FontDescriptor 16 0 R
/Widths[287 0 0 0 0 0 815 0 352 352 0 574 287 333 287 389 574 574 574 574 574 574 574 574 574 574 287 287 574 574 0 0 0 684 617 741 786 575 520 796 797 349 349 668 574 963 796 815 575 815 631 500 611 779 721 1056 0 647 593 0 0 0 0 0 0 509 587 485 604 495 347 537 658 310 315 551 310 946 658 592 607 608 385 407 370 611 557 795 573 556 470 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 778 0 0 0 0 0 0 0 0 574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1000 500 500]
/Name/F0
/LastChar 211
/BaseFont/MDYGLS+StoneSerif
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 14 0 R
>>
endobj
18 0 obj
<<
/Differences[32/space 38/ampersand 44/comma/hyphen/period 49/one/two 53/five 58/colon 65/A/B/C/D/E 71/G/H/I/J 77/M/N/O/P 82/R/S/T/U 97/a/b/c/d/e/f/g/h/i 107/k/l/m/n/o/p 114/r/s/t/u/v/w/x/y]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
19 0 obj
<<
/Length1 5656
/Length 5656
/Subtype/Type1C
>>
stream
  XVTXSU+StoneSerif-Italic   H¯ ¯¯¯¯˚˚f˚î˙I
 ãã
 ãã  5  1  ò≠  ˆ ï´∫Copyright (c) 1987, 1990 Adobe Systems Incorporated.  All Rights Reserved.ITC Stone is a registered trademark of International Typeface Corporation.ITC Stone Serif ItalicITC Stone Serif  0  F U  B M  4 N P L J O H E 5 C D $ S . Q I /    1 ( V T X Z 6 %  &  #  W + G " * ) Y  3 0 2   b ≤ ≥fÉ˚ÆıiËn0¬É‘+Åá		Ç	∆
'
É
·q¯_Ág”2oÒò=ùŸ8ú‹_*ßˆ˚ˇ˚u ˜`ß˜a£¨‡˜{”˜ˇ˜gZSk_3t˜Û£˜9c˜ÔÌ«s©U˚8˚&˚D˚8A°˚Ï¨±ò®∫ıÃ˚Ö˜U‘ô‰˜ŸöùxoPe˚˚D¨˚—Ã¯)µÕÏ¯¯tèü˚'±˜0mwtpuqÄw'2Ça„<˚˙~J©\∞ã˜V«Ñ®rÅ\}nãmoô·úÕ˜≈˜	˚ÿ¯µ¨Á˜PÓ¯ã¯à'˚Ñ˚˚Q˚[^î<≈Õ˜˜˜÷çâl˚\ázè|çí}úÖ˜<ÂÇ°\tizññ∫Ñ˜Ï˚ê\˚"˚!\\ã»Æäâ€¥˜i˜1è˚ˆîv˘iw¡˜∂˘s˚LuÜu≤èõçõãìÇñÑtáw˚¸™Å\ázé|éí}úÖ˜;ÂÉ°\tÉáÄáÑã}äû´ë˜–˜–∑uòi∂∫¶™∂ß{•h]jp^˚=Æ˘$¨˜Ê˜ÏÉ•¯n˘<åêâíÖçZôVè]ã%ã 6ã"ãR≠Q€E“N≤Gã[ã3?ZKã@ãL∂ñ˜qo˚$âÉéáéâwª¿~÷˜0›˜ ⁄ Éƒ7ﬁ5‚W≤ ◊∆Ø»H ∂e1á•˜bîv¨v¯W»˜Ò˜\ËÙ|Îz∞‰õ‘∆˜ü˜,˜æã≠ä]hÇ)¸„û‘œ˜ù˜˜∑ã≠ä]hÅÑG˚£Ä\ázé|éí}úÖ˜;ÂÉ°\tÉáÄáÑã}äû©ë:œ˜¢£Èx©Uã8˚˚/Xâç≤ˆ∏˜-ã/˚˚1Yàçµ˜Fê¢éùwç˚HEëx∑ôîéìéîã¢ÖszÜ˚+©¯j£¨Á˜ñÁ˜X˜S„˜~˜ÂnÂ˚˚;˚˚X˚-Æ$˜ó©AÇÈø˜“˜V˜ õ á#˚BN˚P˚˚*Öúïv¯îwˇ …Ä ˇ Ä °wPÂ˘]Üuøêñç¢äãoÄâÇá{˚˝‰«˜ú®˜˚R¨Wöo•ã÷ïús•jº\À˚˜+˜.˜úôüñùì•ïóµCgg%.@JwÂ¯5˚ˆîv¯†w˜ÀÔyÒ3˜Ë∆¯;∑ôîéìéîã¢ÖszÜêH˚√Å\ázè|çí}ùÖ˜;ÂÇ°]tÇáÄáÑã}äû´íHÿ˜Òê¢éùwç˚HE$˜0˜+≤§¨¨ê´ê|¨dbtjkájáõjØ?îv¨v¯W»˜Ú˜ÔÄÈd∞‰õ’∂˜m˜ ˜4·ã¥{S_ÄàK˚ê\àzé|éë}ùÖ˜;ÂÉ°\tÉáÄáÑã}âû©í4—˜™¢Êt§Xã.˚˚.Tâç¥˜Fê¢éùxç˚IEëx∑ôîéîéìã¢Öszá˚O˚u©¯8w˜ò´¶Vÿ¬ÿp‚Ÿ‰V›› ˜I≥∞o◊O]K@fPGGØŒŸÍ¨…†! ˜ƒ¯=®¨{ôkÅQÉTéT ïxsês˚ (*#I∑a∆åÀ ïäñéñämkTjãfãwû{õÅCp˚%Vã+ã8˜t’ã˜ã˜«ã˜ã‚˚;¬ã ãØ≈ûµ•dÄ±§≈ €úàüz¢TÄ˚Ä˚! ´Ì€æñR`Mc)IdÄZx¡∏˚ÿ¯µˇ ºÄ ˇ Ä ¢w¨Á˜QÓÏ¯/¯^˚êf˚.˚!\]ä»Æäâ€µ˜i˜0èæ˜íÖq¿êñç¢äãoÄâÇá{m˚˚óã˚˚Qã˚[^ï<ƒÕ˜˜˜÷éâl˚\àzé|éë}ùÖ˜;ÂÉ°\thzññ∫˜ ˘âã•˘±˘)•˘d˘P¸˘f˚7•Ë´ú´Á˜˚¸√z<Üò9ÄÖq˜•ë•;îÇÑõ÷˜¯√˜ËêY@â•˚ãØ¯1 ˇ ∞Ä ˇ Ä ¢w¯@ÁË¯¯UæêFj˚s˚/34uuèïy˜©Ø˜-˜∆˚®˜õÖqøêñç¢äãoÄâÇá{˚ ˝˜˜2˜W˜5˜p≈u‘K"˚
˚!btâçÈ¯'˚y ¯8¥¨ﬁ¯5¯=ôÃwöaíjãk\{r^˚C)Ü˚Må{Ü8™&Ùã†ã±ò∫®ÙÃ£ZgRk_ã?v÷À˜
‘˜7˜Øßloù¡´˘*©¬ı¯y•˘M˘,≠ë˚ôC˚L˚ñ˚˚ª˚-˜˚'˜W˜Ôß¢î¬˜#tìU<_0˚,ã˚)V˜#˜
˜k˜˜N˜l˜!úS˚ä•˚¡†v¯>·˜Ò˜≥˜Mù›≥Û¥∞óòûëõîòÉÇñ•ôõ‰HãQ\F˚â∞˜ê¢éùwç˚HEëx∑ôîéìéîã¢ÖszÜ4¸&˜Éã•˘•˜(‚˘6ö¶ÆuF£,¸r}Lz}Câáq˜zë•Dçsòó–“¯.ç¿˚Aº˚Bª˚A§˜Î¯¬ç7¸[{<Üò8ÄÖq˜•ë•;îÇÑõ÷ﬁ¯hò€∑¢™ã≠ë•˚K˚Ù¸ Y˜QT˜PS˜Q˚:˚˚é£˜v≠¯<¡ï›˜…ÁΩ˜ﬂ◊∂˚¸≥ÑmÖ~}ÉÖ{zãtÜs˜èë£>ãàìàëÖñçôèùÆ˜=˜FÅ˜L˜.˜Ç®å8xfásZ<g©˜-cn˚;e˜;∏£µΩü≠Æû][˚@˚ ˚2%v{çè~?îv¨v¯W»ˇ µÄ ˇ Ä °w˜ÒÔÄËj∞‰õ’∂˜m˜ ˜4·ã¥{S_ÄÑK˚ê\ázè|çí}ùÖ˜;ÂÇ°]tÇáÄáÑã}äû©ë*“˜™°Êt§Yã-˚˚.TâçÓ¯P˚LuÜuæêñç¢äãoÄâÇá{˜ã•˘•å˘∑›˘6◊ö^_¶'¸lz<ká_áÖq˜}ë•Aèrñò◊’¯?˜˚M˜˚oŒ˚ «˜¯·ú‹Øè∞ãë•˚äÖqÁã¶~~>A¸Tâ˚˜Q˚˜P(˜O˚C?ã•˘Bw·¯¯X˘\˚û)êiºù∑öƒ°|B2¸=Ñfá|ÇpÇtcâ>ÑÜq˜Íê•@íeçå¢¶èöí∞?ã’¯œŒ¯M˜˜A¯Ä˜ £…∏÷ÿ©MX˚˚B˚6<QY_^QUÅZ¯4‡˜IhQhyZH˚ç ¿‹«ø∫‘Ã˜G˜ã˜ã‡H’˚ã=ã9lNBn˚?≥¯Í’¯Ô˜Ø˘P˚)˚∫˜<wÊ˚ã4"CVJ^iõ™hM√ÖêÜåáÑq_ÜÉêàèÖ¥Oª~æÉµã˜˜Û˜'∆g˜˚|¡œ˜ ˜r≤’9ã•˜™•˜Ë©q•¯{h˜∫˘2√Ù´9V˚$"P$âÜq˜!}˜Aˆã˜ ò‘\Â˚K˚ÑÖq›Çîì{?(¸Çz<Üò9Äáq˜£ë•;îÇÑõ÷Ê©ˇ!Ä ˇ Ä ˜Ô©¬ı¯v•¯W˜…µà§àòáåzå{ázq˚OVa?ã˚&ãT˜ã˜ã˜k˜˜P˜lã˜ã±[Ñ˚••˜)çôÇêÄêöhPò5˚K˚ó˚˚ª˚-˜˚%˜N·Ê°£¬Æ˜Yèüéúíöìöóèßè¥éë•˚£-‘¯Kw´w√ÎwÚÙÔ–¯§¯à2z=b˚â˚!˚Uãq{õæñ(ÿ˜Èê¢éùwç˚HEëx∑ôîéìéîã¢ÑszáîL˚©r˚¨v∞ã‹˜$˜)¿≠çâx2\ázè|çí}úÖ˜<ÂÇ°\tÉáÄáÑã}äû©ë˚áß¯i¶Îÿ€‰£¯
¯Çõ_]çgL=\EÄÄH≤_¿[ƒXûrãTãlhRLäTäU¥ô—su˚¨y∂ÅƒãÒË’◊Õ^πeØY∫g™∂¬ø¢•H¿£^_ç£Êîv¯†w˘%»˜N˜j˜Ïç¥˚ÏÆ˜V˜’¶∏ΩÀÉüt≈àëÜïãwÜàÄáãzçOãyäYmY˚˚Sâ]¯"*aêyç{å{åVn[q`-˚6ân˜Ùáõç©yãÑÅáàÇ˚Vìvòëôèôå¡èéBèe≠˚Ô˚=˚v˘îw¯1«â˚ÄåÖçÄóàüòäóåèúó∂î™§∑≠π˜∫¯&üßº Éüs≈ëàÜïxÜàÇáãzOyé^cT˚%˚^l¯ âöç©yã˚2Sîuóéîéôå¡èädíDß˚‰gaqghdkhinçsæ ˘•˜‚˜¢¯Èú⁄è~ﬁñë•˚•Öq⁄Çïì{?J˚›Éaàeéh%îÀL˜'˜	˜‹˜KØŒ˜Íù›ê~›ñë•˚xÖq⁄Çîí{=J˚⁄l˚1PO˚ã˚qÁÛü˜ã•q¨˘ß˘˜ p¯=˘4˜5«˚˚$˚:*˚o˚˚á´‹úˆ¯¢˚’˝4˜ÿ˜Ω˜-˜n˜V˜K!Ù˚[˚€Öq⁄Çîì{?ê(¸Çz<áò9Ä˜˜Ä˜∏˜V˜†∏∑uòi∂∫¶™∂ß{•h]jp^Pÿ¯ uòi∂∫¶™∂ß{•h]jp^?ã•q±˜∆±˜¨±q•¯•Ê•v˜º˘*˜“íY@â•¨˜7¸SåÜq€Öîì{<(¸Çz9Üò:ÉdÖq¯ÅŒ˜JqyiU$\Ñ-ã1eé⁄õ∑˜tﬂÃëcçåc•∂˜lqz_~lxÄNã7˚5v˜Õw}˜bò˚Jπ¿˜˜&í´ë®y¿|ãÑãE\ä|á^ìE#$eã®˜Ÿ¨˜Æ™q•¯WÛ=Ûÿ˜˜ˆÃ‰…W8˚
MC˚
,å®‚ù÷˚%˜˜(‘˜$—L’4óç‘◊¢Ôƒ˜ŸQƒ˚˚≠Öq€Çîì{?*¸Ç{<Üò8ÄÖqd˜œ˘1–ÍùVZ˚:V?=˜∂lû¯/∏˜c©•ı∂Á˜a•‹“ø¯h˜onTY/!U„Ã”≤ŸÂØ˜∫¸˜èû\®_∫]ƒ’ıû˜î∆‡¿§èü˚üTráwÓ•YÅ˚	T:˚K˜ÅH·Ç≥ùÂ—®∫µ¥kEê•ûÁl°[ùUã˚:O˚	]ÆV´b'{˚E˚àL»˚˜C˜ƒ≈≠∑˚=îv¯†w¯1«˜O˜ç˜Áüßº Éüs≈àëÜïãxÜàÇáãzOyç_dS˚#˚_j¯âöç©yã˚2Sîuóéîéôå¡èädíDñ˚è˚ô˚˚‘†v˘6•f¯Bf˚R˜ ≈ ˜%ú‡Ô¯áú⁄è~ﬁñë•˚•Öq€Çîì{?(¸Çw(a,L?˚—†v¯^µãv˜n±ñ¯êÿ¯%¯à˚'ñª£˜ ∏¥«ãµ´lpô§óóÕ|ô[ètãa˚Du˚iV-ÇaÍ˚#˝W∏ƒ˜,€˜—º˜Ç˜†£†Æã•˜^±¯Fwc˘,c˜Së•cãw§¨»…˜˜èô˚èbyrZáÖq˜{ê•TìÅïÄ‡B¯œO˚˚y˚,˚ßL0l_whTã˜ä˜Ñ˜T˜Ìç≠˚Ì˚‘ã•˘•w¯1˜Ø¯Èú⁄è~ﬁñë•˚•Öq€Çîì{?(¸Çz<Üò9Äáq˜£ë•;îÇÑõ÷˜ ã•˜„¥˜§•w˘›˘[¯Èú⁄è~ﬁñë•˚§Öq⁄Çîì|?c˚W˚‡≤˜Wú⁄è~ﬁñë•˚•Öq€Çîì{?(¸Çz<Üò9Äáq˜£ë•;îÇÑõ÷ø˜ñ˜‡W˚ñ{<Üò8ÄÖq˜•ë•;îÇÑõ÷˚îvóÃ¯∆ñwã¯zX¨ÃzáÇâäÑÖdÑäèÖëºüüôüú˜˜4êº˚7ëxësòãïóééî˜ΩÑ¢~Ü}á}äVáz±xÃlˆ˜˜£¶ØßÅ§ßàëÖñãzÖ~àÄáãzÉSÉyÉypj]Sc˜1ÑßÖ•Çã`ÉzÉàÉ˚^ësúêôèôå¡èíM∫˚+8,mi`wrÇ˚—†v˜Y›Ø˜û˜±˜Yú›˚çz9cãõ{•˜æØ˜ ©q•¯kÎl„Úz<Üò9Äáq˜£ë•;îÇÑõ÷∑˜q⁄åı˚íôiûgæã÷éõjßn∑]Á:˜5”ö˜”ã˜”R◊˚!˚èÖq›Çîì{?4˜‘ ·•G[<Y˚˚
GÊ©˘,©¬ı¯Xı¯X˘\˚k˚J˚=˚í˚ª˜jÖ‰÷˜≤’¯˜T˚‚˚({m˜±˚˚˚N?˚w˚W˚R˜˜˜[˜[˜Bó˘Pó˚hó±î˜Dó˜™í˜í˝/ó£
Á˜≥˘endstream
endobj
20 0 obj
<<
/FontFile3 19 0 R
/Ascent 735
/Descent -250
/Flags 98
/ItalicAngle -12
/StemH 0
/FontName/XVTXSU+StoneSerif-Italic
/CapHeight 700
/XHeight 747
/Type/FontDescriptor
/FontBBox[-210 -256 1299 949]
/StemV 92
>>
endobj
21 0 obj
<<
/FontDescriptor 20 0 R
/Widths[287 0 0 0 0 0 759 0 0 0 0 0 287 333 287 0 0 574 574 0 0 574 0 0 0 0 287 0 0 0 0 0 0 685 612 704 776 574 0 741 758 330 330 0 0 889 759 741 568 0 610 481 648 701 0 0 0 0 0 0 0 0 0 0 0 538 537 421 537 425 333 463 574 296 0 500 296 856 574 499 519 0 349 407 333 556 481 741 519 481]
/Name/F1
/LastChar 121
/BaseFont/XVTXSU+StoneSerif-Italic
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 18 0 R
>>
endobj
22 0 obj
<<
/Differences[32/space 47/slash 58/colon 65/A/B/C/D/E/F/G/H/I 76/L/M/N/O/P/Q/R/S/T/U/V/W 89/Y 97/a 99/c/d/e/f/g/h/i 107/k/l/m/n/o/p 114/r/s/t/u 119/w 121/y]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
23 0 obj
<<
/Length1 5475
/Length 5475
/Subtype/Type1C
>>
stream
  GLRGDP+StoneSerif-Bold   E¯ ¯¯¯¯˚˚*˚è∏˙t
 ãã
 ãã  /  +  ä±  = ñ™π Copyright (c) 1987, 1990 Adobe Systems Incorporated.  All rights reserved.ITC Stone is a registered trademark of International Typeface Corporation.ITC Stone Serif BoldITC Stone Serif  ,  0 7 & 3 * 8 N Q B D U  P G . F E J O T 4 L H $ 6 ' % " 5 / ( V 1 I # S Z :   2 X ) M - .   R Ø'∞r=«I¢ËÈ3Æ5ç	q˙d„	d
(
â
¯nŒ+}˝ÖÓ_Ów¯[–Ì&û´¯S˚„˜;∂˘∂±˜m˜«˜m¯˜9˜u˜˜ô˜g˚;˜˚N˚x˚4˚@˚J˚Ω˜}B˜
§∂3D˜˜w˜oœÀŒﬁ‰$˚u˚°5bM˜%†v˘*±˘˜5¯˘P¸e∆ø5búû_˜¸≠'˜'—˜Z”˜X”˜Zö≤≤™πã±˚}e√Ø~5l]˚^˚]˚U˜&[˜ Y˜-áù°†∑ãÆã±eΩ˜µΩ˜ôΩe±˜˜g˜;™≠™w´¯È©˜JlNiOD'GiéŒ˜o€ŒüP[™˜õlYépSL;˜ô˜Œ´]J†™˜5¸«åeºâ´Çè}èÄãzã{¸z{ãzáÄá}kÇZâ˜&ã±˜üº˜Ωºe±˜˜g˜-˜xÏ˜·˘≈À™g L}00[‹˚¡˜»Ωâ´Çè}èÄãzã{¸z{ãzáÄá}kÇYâe¯±Zçkîáôáñãúãõ˜Zµ ÷—˚YÃ˜h•:Í5Û>ÙÙ¶√›ã‘,˜(ƒ˚¸U˚Xã±˘±˜˜g˜·¯Âõãúèñèô´îºç±¸eΩâ´Çè}èÄãzã{¸z{ãzáÄá}kÇYâe¯±Zçkîáôáñãúãõ¯ò†v˘*±˙|˜.¯#˘O¸e¿É¨wß)˜#¸´˜D˜¯dç˜¸d˜R˜8¯Ëú¬≥ó©ä±˚äe‹°Ç|Hj˚&e˚&l#â˚9¯ï˚ ˚*¸äâ%¯wœ¢ì ê¯8ã±¯ﬁ;±Ì˜\˜˜\˜˜\‹˜æ˜å˜;√ô¶ºê^@˚^{ãzáÄá}kÇxâe˜—±yçkîáôáñãúãõ˜!˜=ƒó§Ωê^@˚^{ãzáÄá}jÇyâe˜·±içkîáôáñãúãõ˜xÌg⁄(9AeW^ÿYfòY9BeW]„âçºmI˚	2e√ùsR˚à{ãzáÄá}jÇjâe˜‡±yçkîáôáñãúãõ¿˚é±˜\¨¯/±gŸ·˜\˜:˜o‹˜≤˜—üîßõ§£õüü®∆ú'5˚:QNgpoú∞zC~¥ªâßﬁ˜MÀ˜k˜K˜˚
5AcZ`‚âç®mI˚	2e√ùsR¸Ç{ãzáÄá}jÇjâe˜Í±oçkîáôáñãúãõwÓ¯∑ù˜Y˜˜\˘ «kâgö˜˜F·˚JGJ~uQyÖÜ~cÅdÜvïáîÜ¡zóàñçèò¢Ÿ≥ππãøã®ZãA˚6]Fw&i˚	8√R’¿¨óú¶ÊÃãräqö`˜ë®˚ü˜;knJVa~Æ¥»æΩ·§,„¯∑´˜Y¯ê˜!kcZjK0hÁıÔ†ÈŸ¶£a©πHèÖíêôì™ùóëåëàîu‹röU¢,ã˚@˚%˚-;©=¿]I÷”å˜˜5˜˚=Ê˜Î»Ù˜\¯X¯w˚'˜ETc|SwYv˚6N·˚®˚¬aË˜dæ~¡uÇzÜsã+õ˜ﬁ˜%Íø£à¨¯^¨´˜e˜9˜e˜…˜8˜"˜ ˜9˜#˚˜ ˚)˚ùa˚jP˚Ê˚˜N™¨PcÂ˜@˜™ÕΩz˚Él˚7TrÄ˚?ã±¯»˜Q ˜˜\¯n¯w˚5˜©û¢ü´©{}¶∏ríâîâêí¶ÆêìâêâéRæ{ôläsãxràÉc1w˚L!W2N‰˚œ{ãzáÄá}kÇiâe¯±Jçjîáôáñãúãõ˜œ˜ø£˜Úã±˘±˜∆¯á˜gÅ˘Pe¡∂iO¶¸&lãnàrán{Kâe˜~±Lçzóá®á§ã®ã™˜ ç˜t¸o¶˜à¯oç¸{ãzáÄá}jÇZâe¯±Zçjîáôáñãúãõ¯dœû¢◊±˚ä˚É¸[˚q¯[,„˜\±˜4±´˜_˜˜:¯¶˜®ß˜S‰˚,˚lA˚˚&¿4∂mMÂ´ñÁµ˜&ÓmµrwZjJã˚)¢˜gÄ±˜Ø∑∞∞û[Qb}~¿Ò¯π˜/±©w´˜u˜8˜\Ï¯9˜^9gmcQmÃÍ˜F≠±Ã°§ÄZù˜\˜€âçÏ_{K˚8âeñ—Ñ@oFög^ç^˚<,˚˚'˚◊˚˜+∂úï¶≤ ∆ãräoö`˜ù®Ü∂eâgöã˚ìã±¯±µwø˜SÌ˜T˚T˜\‘Ìˆ{ãzáÄá}jÇjâe˜Ô±jçkîáôáñãúãõ$¯'âçDmI˚	2e√ùsR˜µU¥a¿…Ø∑ø¡g¥NUbaVÊã±¯ﬁ;±Ì˜\˜%˜\ÿ˜æ˜ã˜L»â£¥ûa=˚^{ãzáÄá}kÇyâe˜‡±içkîáôáñãúãõ˜xÛ_‘#9CeY`·âç∞mI˚	2e√ùsR˚à{ãzáÄá}jÇjâe˜‡±yçkîáôáñãúãõ˚P±¯T±©™{˜DÆ˜D\™‰©öz√»Å∆ÿ˜˜	£˜∑s∑J√6“fß©≤°®±Tµ≤UV¢™˜ïOUíS˚?\.líjÎI®ˆBåfimyaWR[—∆wlQ∂˘∂ß˜v˚n™˜†˜y1™‘¯ç¯´˜(êàëÑéò\MçAË˚Z5F˚S¬:ˆI˜>ûhIBQ]Qò*k˜ ∆tl˚8Ééáèâwø¬˜˜>˜Õ˜Ãn…)÷d˚ÍN¢“’øü¢ŸØ:V™Êã±¯Fß˜;±©wÌ˜\ËÌˆ{ãzáÄá}jÇjâe˜Ô±jçkîáôáñãúãõ˜;ç˜<˚¶˜öòd∂˚˜(#˜Êÿ±¨±™∂èß˚ôo çπyqi`VHN,Ä¯Hâç(_{K˚8âeï—Ö@oâ˚éø¯¨˜Ä‘j¨§˜!(˜<˜3˜<˚˜<©˜÷a¿}»}RVGyYM1¢ ¥£Øô†¯D¯Y°æ~°˚VybôaèWã˚.,G,;ƒHÁw…˚9Ä^ñeæ|â'nwÇçvã|˚˜2Iˆ˜6˜,¡˜«kŒ'¢˚©Fúããùïééççì£àã©f˜˜ª˜Ωz•v©˚[˚ÄJÜr€€ºù”ƒ¡©O(fa~ESÜÀ≥˘≥±˜m¯™˘0˜_$W8C4˚V˜+˜Kå˜Hå÷˜˜Óø2BØ™˜õÄôoîõZ]ù2˚⁄9˚`˚.˚~˜#˚˜å‹€ßîß¨óùêê†§˜ ˜&·¯‡±˜	˜g˜¿∆˜‹¯Âõãúèñèô´îºç±¸eΩâ´Çè}èÄãzã{˚€˚>—˚ ˜á˜˜€˜E˜µÏÄßÎé±˚{eÀâõènérãnãl˚¢˚1Lj(%g–ÏQã±˜≠Ω˜≠Ωe±˜˜g˜I™ü™‹´˘*Ωâ´Çè}èÄãzã{¸z{ãzáÄá}kÇYâe¯±Yçkîáôáñãúãõ˜hÈŒûP[å™˜õlYépSL-*˜≠˜œ´]J†™˜5¸»˜]ã≥˘ ≥˜˜g˜°˜g´˘Peºâ¨Çè}èÄãzã{¸z{ãzáÄá}jÇZâe¯˜V˜r—˜¿˜b˚5˜˚_˚cù˜:‡'˚R˚ê!=˚	Zéú‚˜&ã±˜?√¯Swí˜<¯L˜e±'õ_}p_ãe˜ı±`Wºªybˆ˚*˜˝\˜:7˚p˚˚÷qWlL[zlãe˜l±ZÉ©πõ´Í†√È˜Ö„˚ÖÊã±¯¯Ω˜ù˜g¯p˘’ﬂ£]R∂™o˜-˝/o˚-™ƒ∂¢π‡’¸≥{ãzáÄá}kÇYâe¯±Zçkîáôáñãúãõ˜&ã±˘±˜∆¯\∆˘I¯™™ä®è§è®úó ç±˚ûeÏâöènérånãl˚øâ˚ ˜˚0˜`9˜˚Àe øeM®¸ länàrán|Kâe˜ù±,çzóá®á§å®ã™˜‚ç˜˚4˜D˚Ñ«'˜B≥˜¶±˜‡≥±˜m˜ô˜NK™¯¯˜¬‹ä¨Çè}èã{ã{F˚KäYV/˜˜râ˜Jå€˜˜¥Ôø2BØ™˜õÄôoîõZ]ù2˚⁄9˚`˚.˚~˜#˚˜å»˜ ˜©õø˜\õãõèóèô¨îºå±¸"”‹˜ˇŸÊ˜\˜˜\˘H«qâgö˜‰âçJm˚	1ãeƒúsR+˚?c|kMÜ∫÷˜”âçJm˚	1ãeƒúsR˚j=†D˜øøúï†Ÿ∂ãwâqös˜ë®”ã±˜ö´˜”ºe±˜˜g˜&˜|Ï˜·˘π‹û-V˚]WRÅk˜qÇ˜·˜·TÔ˚:¸^òeΩâ´Çè}èÄãzã{¸z{ãzáÄá}kÇYâe¯±YçkîáôáñãúãõÊã±¯ﬁ˜/±©wÌ˜\˜%˜\˜æ˘qâçÏ_{K˚8âeï—Ö@o¸]{ãzáÄá}jÇjâe˜„±vçkîáôáñãúãõ˜ ˜L»â£¥ûa=˚^{ãzáÄá}kÇyâe˜‡±içkîáôáñãúãõ˜xÛ_‘#9CeY`˜ã≥˜Õ≥˜ü≥˜˜g˜%˜`˚G˜vÙ˜·˜ıπ«Àa˚
*\ST\vè˜ ˜˚,˜7ˆ—˜Ù6–˚îç¯˜öÕøÎˆ&∏˚	¸Deºâ¨Çè}èÄãzã{¸z{ãzáÄá}jÇZâe˜¡˘(ΩÕ®h.&ae\S˚ã±˜©˜Y;±Ì˜\–¯õ¯íòêûÅúf≈†}xòrjnokuaKâ˜âç∞mI˚	2e√ùsR˚à{ãzáÄá}kÇiâe˜Ï±mçkîáôáñãúãõ˜P˜.¨}ìò†áÖôŒpûÉó~õßw˚yv˘\±¯q˜)¯˜V;˜U©s∏ºã±˚∆eΩù`uï˜Y¸=w\uZ^ÄgwkyÉÑãÖãÉeÉçÅòﬂ°õõüî˜ú¯›ü∑ê∫œã±˚{e»∞uYt˜ã±˘±˜µ˜g˜˜+¯‚±Yçkîáôáñãúãõ˜	Øô´õ©˜4˜∑¢π§éßã±˚xe∆≥uLi˚˚ì˚˜ör¿Ñ§◊ã±¸eπ∂|L®˜3˚‹˚){ãzáÄá}kÇZâe¯?†v˘swØ¯ä˜˚ ¯-˘ﬂ-¸,˝ﬂ˜N˜,˜NÀ˜N†À›X∑`æª∂∏ºª`∑ZY_bX`˜ÊX∑`æª∂∏ºª`∑ZY_bX˜:˚:Ê ∂˘∂±˜m˜«˜m¯˘1ﬁﬂ˚˚j˚1p˚/˚
9;˜˜}˜§˜)˜¯Ö˝òÄßeájìpíjìR£aû0±◊∞˜#È˜b˜V˚'˜0˚a˚G˚f˚˚}˚}˜>˚˜R≤˜X ËYïÇ≈¶˜ﬂ†v¯b±˘¡˜/ò¯b∑¢vVö˜(¸˜˜˜€ç˜˚€˜˜$¯©⁄¢Ö∑ã±˚zeµ…å,_B˚Xâ˚˜‹˚˚˚”:˜\jÿØèÕã±˚Ì˜Éã±˜À…˜è±˜˜g˜s˜g˜·˜Ò˜s˚Ü{ãzáÄá}jÇZâe¯±Zçjîáôáñãúãõ¯zõãúèñèô¨îºç±¸eºâ¨Çè}èÄãzã{˚J˚s˜Jõãúèñèô´îΩç±¸eΩâ´Çè}èÄãzã{¸z{ãzáÄá}kÇYâe¯±Yçkîáôáñãúãõ˚ìã±˘	±©wÌ˜\–Ìˆ{ãzáÄá}jÇjâe˜Ô±jçkîáôáñãúãõ0˘âçP_{K˚8âeï—Ö@oúã±eΩ¯¯±˜˜gp´¯È©˜JlNiOD'Gié“¯iõãúèñèô´îΩç±¸eºâ´Çè}èÄãzã{ê¸z{ãzáÄá}kÇZâó˘Pó˚hó±î˜Dó˜™í˜í˝/ó±
˜\å˜œ˘endstream
endobj
24 0 obj
<<
/FontFile3 23 0 R
/Ascent 735
/Descent -250
/Flags 262178
/ItalicAngle 0
/StemH 0
/FontName/GLRGDP+StoneSerif-Bold
/CapHeight 700
/XHeight 747
/Type/FontDescriptor
/FontBBox[-150 -251 1464 992]
/StemV 200
>>
endobj
25 0 obj
<<
/FontDescriptor 24 0 R
/Widths[315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 574 0 0 0 0 0 0 0 0 0 0 315 0 0 0 0 0 0 796 764 714 851 685 592 824 889 454 0 0 667 1000 796 817 722 816 796 592 741 796 795 1166 0 778 0 0 0 0 0 0 0 630 0 555 703 555 479 648 741 395 0 741 395 1070 741 647 703 0 537 462 481 722 0 981 0 630]
/Name/F2
/LastChar 121
/BaseFont/GLRGDP+StoneSerif-Bold
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 22 0 R
>>
endobj
26 0 obj
<<
/Differences[32/space 45/hyphen 49/one/two/three/four/five 84/T 97/a/b 101/e 108/l]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
27 0 obj
<<
/Length1 1552
/Length 1552
/Subtype/Type1C
>>
stream
  JDVODB+TimesNewRomanPSMT   7˚È¸NM
 à?ãã
 à?ãã   f   b   ë  
      5 B C M F          $ ätmÙıÇëÌx=m˙C  ˛î˚ ˙î˛t‡˙T˚@˛T¿¯ÌŸL{˚“±è»öº§Ø£Ø©£Æò•î∏êÀã˜7˛†?ÉZ}vhsbzR[f¯”∞\VdôßryüÇøﬂ˙†˜S√∏Åy≠≠yßn†eósïcìS±|˜“˛Á˜ó¯˘õuû•¨œ“ΩÔ÷√ccpr}ÉÉÜÅâÅãÅãÇéÉíÉëÜòàüáüä¿ã„˜À„Ö∆®x∑n´d†W¶Hô:ã!ã8sQ[P[nVãRãmísõzõyüÉ§ã§ãüìõúõõì£ã™â≈ã®ó••¢°£≠óµ¬µzi®®iöL0g˚2Q˚[GcGc\`p^wjÅdã_ãDüR¥`¥_øvÀã≥ã≤îØõ£ñ∆µÈ‘ãTïdüu˚z‹ejö´on´}≥ª±ñÆ¢´°´±©¿©®õÃ®≥˚ÒH8HjY¯
˜œé^˚ß˚ôhßï¢ëûãõòÜÉñïÇì{êsêséKã#˛Iƒd√n¬x¬x¡Å¡ã˜ãÚµË·˜ Ó¡˜ã˜7ã˜h˜E€E€9¥-ã$ã+M3˚˘,Ò˝ùÆÆîØÕ«kLøøL¶1˚	˚p*WIHWRjOeeìúggúh§i≠¯∏¥≥≠•¶ô:˜‚é˚•˚úh•ï°ëùãõòÜÉïïÇì{êsèséLã$˝‘RÜeÉwÇw||É{Çoáaãg¯UØ[kèïzyï~ôÉûÉùá±ã≈ø^˜ó˘Á¯œ˜jÂIœœI6≠%˚&_3;;3c˚˚0˚%≤˚Ÿ55ŸÍa˜ﬂ∞÷œŒ÷¥ﬁôÁlüm;eR_j_jW{Oã1ã<±IŸHÿjˆå˜˘¸¡˜Å∂∑º°√Ø≠Äv¨¨u§núfïsíaèQ¸<í◊§«∑∂¯
¯'L˚ò¸£˜ÜÓz‘mÁd‘T¿DøD¶?ã9ã6mCPPPPGn=ãWãYúYÆk°uò~ë~ê|ézãsãxÉ|}{}Ñzyiùm∞op∞∆}›€⁄ûØÿ¡•º≠∑∂∑µØø®»®«öÕã”ã˜^ˆ3Ê#Ù˚ Õ˚D•‰˜J¯,Ÿ˜>¸z´ﬁ¯¯ô˜+¸ô˚+¯
˜ì®ü∑≠ñ§úöÜÅóóÅî{êvëoèKã)˝p9áZÑ{É{~~yÅxÅbÜKäf¯í∞Måcëwïwï}ôÖûÖùàªã◊yj˚ﬁ˚5öl¯
˙˜ôymwst{s{qÄnÜnÖYâCã˚ˆ¥∞Û˜˜:˜J˜˜€˜Ω˜ ´œõ–ã–ãÎfﬁA“A—0Ø˚ã#ã5jFIFI`,{˚∞§÷≤ƒ¿≤¿≤«üŒã‘ã o¿TøS¶Eã5ã˚[˚+˚+˚˚:˚D˚˚jf˘¥Í˜ôf¯
˜˙Œ˜–·√ÛÀ¿ua∂∂a°SGV[s_s_deVlVkVxWÖm´øæÄuΩΩu≤s®qüwûoùf¢YóWãWãCqLYWYVPqGãoãpésì{èpóc†c†qóÄèêyzé{uxÉ}{{|Ñzxqõr¨uu¨…Á˜L˜!√˜Ì’·±˜
›u“a»`«L∫8¨˜Ù…ÒãÓã«u√_¿Q—7Ø˚ ã3ãArPYPYZEe0¨{¯
˘ó¯à˙˚˝	˛˚¯“˚˙˜9˜˙˜J˜"˚J˝¯p˘5˝5¸p¯î˘endstream
endobj
28 0 obj
<<
/FontFile3 27 0 R
/Ascent 1869
/Descent -442
/Flags 34
/ItalicAngle 0
/StemH 0
/FontName/JDVODB+TimesNewRomanPSMT
/CapHeight 1869
/XHeight 0
/Type/FontDescriptor
/FontBBox[-167 -216 1009 913]
/StemV 0
>>
endobj
29 0 obj
<<
/FontDescriptor 28 0 R
/Widths[250 0 0 0 0 0 0 0 0 0 0 0 0 333 0 0 0 500 500 500 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 611 0 0 0 0 0 0 0 0 0 0 0 0 444 500 0 0 444 0 0 0 0 0 0 278]
/Name/F11
/LastChar 108
/BaseFont/JDVODB+TimesNewRomanPSMT
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 26 0 R
>>
endobj
30 0 obj
<<
/Differences[32/space 42/asterisk 44/comma/hyphen/period 49/one/two 54/six 57/nine/colon 65/A 67/C/D 71/G 76/L/M/N 80/P/Q/R/S/T/U 87/W 89/Y 97/a/b/c/d/e/f/g/h/i 107/k/l/m/n/o/p 114/r/s/t/u/v/w/x/y]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
31 0 obj
<<
/Length1 7863
/Length 7863
/Subtype/Type1C
>>
stream
  KLNSJO+TimesNewRomanPS-BoldMT   7¸¸bM
 à?ãã
 à?ãã   k   g   Ãë  ±    /  $ F T B U J P O  . I E 3 Q S C Z % M 4 N L  : V W 8 2 " -     5  H G X  Y  D / ( 1 6  1  $ ‘]!n·~Ÿ}3Áò	0	”
Ö6t`ee áÎ™mÏpÓ$€ë˘0e†”„vÏ»b ˙C  ˛î˚ ˙î˛t‡˙T˚@˛T¿˘—0kÜiÅr{{{{yÑvãzãdóN£!¥&†,ã˚ã˚k˚K˚K01G˚G˚j˚ã˚ã˚©˚»˚ »˚‚8˜Q˜Q˜n˜%ã˜ãÎù›Æ›Ø€ƒ◊€˜	</@KDfDe=y6ã#ã6§JæIæ[÷mÔlÔ|˜ã˜ã˜†˜µ´ŸøÀ“º—ªŸ§‡ãÊjJ€€I¡-©˚≤¯jd˜ó˘Ä˘‚ŸE9≤-˚(\/77/a˚˚0˚ß!≈5 “ÙV˜€“°µ…»∂√‘æÛi°eQhbkujugÄcãJãT¶]√O”jÌÖ˜¯ïÖ˜,f˜EŸ¸)˚™ÆÚû‹≥«≠°ßúÆ¢ûÖô£vùmócócëAã ˚§˜'˘˙U{s}ÑÜÉÜÇâãã}êyï[£ZòYã-ãCmYQYQsJãCãI°N∑U©eÕUÒE–[∏hütüsïpãkãoÄswwwwqÇkã\ãY°W∑W∑bÕm„iõ˚‰¨¨ôûú°íôáÑüo’«}∏ƒøô•ª∫•∞≤•Ω•Ωòæãøãƒ{ølπlπKƒ)Õ)ÕO∫vß}õÖùãùã£î†üùûù¢ïßã∂∂yi∑∑hµJ¥-≠|˜”i¯
˘£s©¥~¡∏≥ó†ØØ°≠Ø≠Ωm£ryyzÇÉçëÖÑêÜìàñáñä¶ã∂˜ˇÔÜÃÇß{∑j≥W±W±Eû3ãAãEGtGsVje_e_x^ã[ãiômßrßqØµã≤ã´ñ£¢£¢òß¨•~ßr®xüÇùôõìôùóûßÆï∑•£Ñ}°†}ô{ìyìyè^ãE-˚b,˚?NRMRmKãDãVú_ØhÆh∑z¡ãÂãÚΩ˜ëXûe©r˚?˜msîù{u¢Ä¶™Øò∞•Ø≤¡«Ω‹ª˚Õe_dyj´¯+˝_:WBPJPIDM7Ph˜¸ç'éMíuñb•f¥j¥jΩ{«ã˜ã„À¡˜m°Idbj`Äèï~ïÇóÜõÜõâÆã¡¯’˜rÓ˚r˜Íj:˜M>mm|fa`ög©mm©Ø|∂µ∞ö©©©©õØ∂µ|∞m©©mfõ``g{mm˚#¸+f∑à®ÄõyöyìaãI¸∂IÑb~|wtlbäg¯çØ^çmñ|ù{ùÑ∂ãÕ˘y¸¯
˜R˘¡='e˚˚˚±˚◊)(◊˜ Z˜!˜#˜¡˜ ›Œ‰≠˜˜ÁxﬂgŸgÿV«EµEµ?†:ã˚ã!Y='¯≈£wûlòaóaí=ã˚ã˚UÑ˚~LÇbzkquwzrÉmãlãpós§s£{ØÑªÅ…áÕã”˜éÙì◊ì◊õΩ£•£•©ò≠ãßã°Ñù}¯}—˙;f¥Ö¶Äòzòyí_ãE¸§CÖ_Ä}zuodág¯mØgèsó~û~ùÖ∏ã—¯â›º¿¥≈úõÖÄôôÄñ|ëwëwéZã?¸4IÖaÅ{{rr|hág¯mØaèpñ~ù~ùÖ∏ã”¯ ˜ Ö‘Å±}Ωq¥c≠c≠XúOãXã\_s_s]f[W˜¸¯ÁL¸æf∂±©Ñ~¢°~ö|ìzízè`ãG˝ÓNäiäÑÉkÅs~z}yx}qÅqÅoÜmå}f¯d∞M]ï†nn†x¶É≠áöä¥ãŒ˙O¯§˚4£¯ú’˛ÅGáaÑ{Åt}{{Çs}kÑcã_f˘X∞_elëòutò|öÑùÉúà∂ã—˙Œéµìõï°òöúï£ô´í≥ã∑∞¸º¸˛¸˙¯}—Lf¥Ö¶Äòzòyí_ãE˛JCÖ`Ä}zuodág¯nØcêqô¢ÅõÜµãŒ¯â®π¶´•ù§ù•ï¶ãùãõÖôÄôÄñ|ëwëwé[ã>¸5GÖazzur}jág¯nØbèpñ~ù}ùÖ∑ã”¯ıÑ◊}∏}∏p≤a≠a¨YúQã]ã^au`u\eXU¯±¸¯}¯«La∑©ÜÇõõÅó}ìxë|é`ãD˚Æc∂f©iùhúcî_ãEãJvOcOb[Oi;h;z1ã'ã˚ß √5– ÈV˜ãπãµñ∞ü∞üµ≤ª≈˚(¯ÿ¨eçqí|ñ|ïÅúÜ°áòâ∂ã‘˙»¸3˜˛˙/WS]Qpvëò|m§s¥zƒy√É„ã˜
ãˆí€õøõøüØ§†õòüí§ã“ã«[Ω-¸Ä˘—˘¯˛¯I¸˛¯?∞gçkñp†yôl∞a«˚⁄¯_›üÃ™πµ”ÃØﬁãÔã›s“[»[»Mµ?¢?°˚ó˚8ã˝
f…µÖÄ¢°õ|îxîxê]ãB˛AÜ]ÇyÇx{|uu`ÜMãf˘J∞M`êóutñ{öÇûÇûáπã’¯‰ù˘-ˆŸrZªªY§?$C}Qq_q_gl]z]zEÉ/ãR¯Êˆ¯}¯¨ëu∑ªø—À†≥≈≈¥∑«©Ÿ©Ÿõ‚ãÍã„|›n◊m◊`«S∑S∂L°GãQãV{[liuiik[˜¸f∑à®ÄõyöyìaãI˛oKÑd~{wulÄbâf¯©∞\lèì{{ìòÉúÉùà´ãª˜ØaÆm≠z"˘EÏ∂¬ºœµ≠wd•±Oû˚˚5˚2y!iSesnxgIN≥›R¯á˜ó÷˙;f´á°ÖòÉóÇï}íyê|éiãV¸ô9ÉY}x}xoÄcàg¯çØeçqê{ì{ìÄôÉùÜïâ§ã±ä√˜kŸï“°Ãôµü´ß¢úôùìüãìãìâíáèàõ~•u•t©ÄØã©ã•ó°§°£ñÆã∏ãµ´u¢¢umóf_^{k]\kUKM+˜h¸¯}∂Lf≠â£ÜôÇôÇñ}íyè~éjãU˚[≠˜/±g±q≥{{≤∏Éæ‚Ÿ°∂œœ∑¡ ¥ﬂ≥ﬁ†ËãÒãÂ{€k—k–^¿S±R±OûKã-ã5b=:¯ó¸¯Ω¸è∑Æwe•ØUù)˚#˚*Ç${R{QvesxswnÇiãcãkór£q£{´Ö≥á¢â¡ã‡¯4Àø¬¨≈¯
¯i˚g'kKqoyxzÅ{ãÅãÉèÜíÖìàõã§ä∏Ä¨w†w°pïjãhãnsqsrÄkãd_úe≠jl≠∏{√–≈ß√π´≥Ωˆœ˜A˜ü˘I∏˜
´–üüûü§ó™è∞˚Õf¥â®Éõ}õ|îwãsãcwEd'˚˚Ø˚4¯i’{Ωã•õëòôóòñ¢ë¨ç∞¸Öf©Å•{°s°s¨Jπ#˜¬˝In=˘—˘‚Àèì¥Áúÿ£À´À´√µºøªø≥Œ™€©€õ„ãÎã˜k˜M˜M˜/›˚¡(∑˚°˚6ã¸Ûf∏±©Ñ~°°~ö|ìzíyè`ãF˛EàaÖ}Åu{zvvmÖdã^f¯Û˜)·œm¬T∑:¡#ß˚ã˚Bã˚lc˚4;%P?6e˚ãiãqêyï~ëÇïÜòÖóâÆã√˙∂˜€Åwª:∂Lf∑à®ÄõyöyìaãJ˛\IÑb~|wtlbäg¯çØ^çmñ|ù{ùÑ∂ãÕä¸¯}˙8kÇbÇqÅÅÅÄ}Üzãyãkï^°^°eölìaïaë_ã˚ã'e<?;?d/ã˚ ãKôQ®W®Vµ[¡a¡`„W˜O„_»hÆp≠p•oúmúmîlãkãUt[_c_bOwAã*ã1∞7◊7◊S˜n˜$f¸î∞óßöûüôûòùíùãüã¶Ñ´~ƒsª{±Ç±É≥Ü∂ã˜ã˜≥„›„›∏Ïã˜ã‰o⁄U—S– ’˚2Ÿ˚√C≤l°`©l™x´}¢Ñ¶ã©ã∫ûµ≥Ø≥Ø¡ûœã„ã‹h◊F◊F∫0ü˚¥Ä¯Xm˙¥◊˙;f¥Ö¶Äòzòyí_ãE¸§CÖ_Ä}zuodág¯vØaèpó~†~†Ö∑ãÕ¯äÆΩ¨Æ´†°ô£í¶ãùãõÖõõñzívëuèVã7¸&TàgÜ{Ü{Å}||wÖqäg¯xØ_çnô|§úÜµãœ¯ä©µ®™©†®†®ñ®ãûãúÖôÄôÄñzíuëtèVã8¸&JÖbyyqo|eàg¯wØaêpñ~ù~úÖ∏ã”¯ÔÉ”|π|πp∞e©e©WöKãUãX}ZqZpX`VOuƒk∂cßbßYôOãWã[_u_u\dXS˜¸¯}œLf¥Ö¶Äòzòyí_ãE˛JCÖ`Ä}zuodág¯wØaèpñ~ù}ùÖ∑ã”˜<«∆˜M˚£ßaôoã|ÅÜÉÅÉÉÅ|ávg¯wØhçnòu¢zõV‘3˜˚p˜÷ÒÔ‚‡∆æ©ú©úÆï≥ç∞¸7fµÖ®Éöôì|ãyãyÖxÄxÄwol_`˚m˚i˙¸¯
˘h¸á˚xùgª†µñ≠ã†ûÖÄõõÄó~ë{ë{édãM˝S5ÜUÉtÇszys~r}bÖQãgf˘^∞lWfíötsô|ûÑ¢É¢à¿ãﬂ˙Èj˘—˙¶Lf«áµÅ¢{úî|ãyãjlIO'˚à¸-˚â¯UUÎq»ã£óíóõóñõ¶ë≥®∞˝f∂äÆÄ•w•w∑GÀ˚˜”¸Ÿ˚§GáaÑ{Åt}{zÇs}lÑcãDf˘ç∞?gnëòuuò}öÑúÉúà∑ã—˜‹˜∫¯”˜øÿ≠ß£ü≠ò∏ë∞¸2¯}¯„˙;f¥Ö¶Äòzòyí_ãE¸àeVkhqzw~vÖsãyã{ê}ï}ïÅôÖüÖûà∂ãŒ˘¸f¥Ö¶Äòzòyí_ãE¸˚ í?ô`ô_¶e¥k¥l∫z¿ã¬ãΩò∏¢∑£∏≤∏¡˚¯Øbèpñ~ù}ùÖ∑ã”˘p¸¯
¯Æo˜Ã˘r∞„ß¿ûùùù£ñ©è∞˚∆f±â•Ñö~ö~ìzãwãgyMh5˚˚√˚.˜Ûmœ}πã§üìúõöññ†ë´∞¸Öf©Ö°õz†s©T±4˜œ˝i∫véLføâØÉû{ù{ïvãpãxàwÜuÖu}btO˚q¸Ÿ˚ã˘mŸ|∫ãõôèóìñìññìôêüë¨èπå∞˝%fµ™ÖÄ°°ûxúqõq£V™=√˚$˚i¸ñ˚û˘&j›{¿ã•ûíõõòõò™íªç∞¸‡fµá™}ùtùs™Hπ˚¯R˛Á∞¯˘˛˜‰˝˛≤¯=˙Û±Í†øèìò£öûùóúó†í•ç∞˚Ù˙CR˜qı˜¿˜-˜D˜^G˜<˚˜˜˚˚@œ˚d˚f˚@G˚˚˚˚G˚=˚^˚CΩ˚*Ô˚Ô˚˜:˜8iº˚	‘2ÌNÌO˜l˜ã⁄ãÂò§»Ümnàq):¢∑KJ∏[Œm„˜)§˜Ÿı˜˚™˙æ)•˚1˚m˚qb˚99˚>R<e&&<≤ŸR9˜b˜@˜|˜U¶˜)¬Ù˜ÃË ˜˜ÍM˚À˘—˙0˜mù_ïrçÖè~çããwÉ{}Åu|fÑWãpf˘$∞aékóu†m¶dÕ]ı¸}˙Ïx¸y˛Œ]#dGljkjcw[Ñf¯W∞Dê_ìyñlù|ßã±ãßî∞û∑ƒ˜¯s”˚=¸ò˜á˜d¯g˜^¸g¸.˘`‰¯pk j:hUhTbc[r[qOCã˚Kbéë{sî|ôÉûÉûá∑ã—˘Ùœéµìõï°òõùï£ô™í≥ã∆∞˝gf∏±©Ñ~°°~ö|ìzíyè`ãF˛GáaÑ{Åt~{zÇs}kÑdã^f¥æ¯pb¯
˙0¯gt]yl}}}}yÅuÖuÖ]àCã˚π˜v˜p˜'˜@œ˜ºÊ§Âã‰ãª{øk√k√^∑S´R´LõGã+ã6lBNAMU-g˚∞~Ò√€øÚ…¿s]∑∂]°QE+p(W'W&˚)˚X˚à˚∑u˘≤◊¯˜˜ókj{d]]õc´kl´≥zππ≤ú™¨´´ú≥ππz≤k¨´kcú]]czkk¯
¯≥Ô˜⁄ÒÙœ˜œ˜Æ˜ã˜#ã˜vÌa·a·RÃEπD∏@¢<ãAãCvGbFbVQfAfAy9ã2˚≠&œAAœ·fÚ´©èì®®ìÆöµ°y,k7^C^BNN>Z>Y-f˚ro˜Lí˜4µ˜⁄Ç¯ÜZd°πo_—u˜˜M˜ò÷•≥ßù•ö≠•°É}ú™o£aõQß"ô˚ã˚ãRáIÖA`uiÅqã¯
¯ÑÒ˚=##B˚B˚g˚!ã˚,ã#û,≥3≥3¬H“]—^ÿtﬂã◊ã”†œ≥Œ≥ø≈∞÷Ø’û›ãÂ˜iÔG’’G7∞&__Ñ~`wÖs~nw¢Ò¨‡µ–µ–≈∆‘ª‘ªÏ≥˜™ß˚Dâ˚0d˚=Ü¸êª≤t^®∑E¢˚˚L˚Csggsozmmqó§ul≠s»y·y·É‰ãÁãµçœëÁµ°Æñ¶ã˘`’L¸±öÔ∞ÿ≈¡¥±ÕüÁãÌ˛™GáaÑ{Åt}{zÇs}kÑdã^f˘Z∞^dlëòuuò|öÉùÉúà∂ã—˙™ ∑Ö•∏uØm•f•f¢N°7Ø¯˚>¯
¯2˙ùìr§e≥d≥cüaãmãrÅwwwwÇtãpãmór£v£u™Å±ãôã¶å≥éõãùåûãˆámmuw|Ä{ozcucuou|v|vÑsãqãqîtüyüx¢Çßã®ã•ñ°¢°°öµî»êØë¶ìüíûö¶°ØühôqëyëyënëdìNõa¢s¢s•Ä®ã¶ã¢îüüûüï£ã®ã•Ñ†úy°o°dücüpõ{ó{ót¢o¨Ωç∞ç§ãùãùäõã≠â¢äôã≤ã´ñ§°£°ò§ã®•Å¢wüûwrïndct_akitu{Ä{p~f|é≥è©ëüëüò©†≤ü±ñ¨ãßã≠Äßv°v°rñoãqãsutusÅpmsïk°a°aòlëwëwèmçefõqò{ó¯
¯q˙W˚
+iHA@Hf<0EüM≥V≥UÀ`Âk>kSeh`g_z_ã]ã?∂P‚`L{`vtrttÄoãlãköm©m©oºt—z|–ÿÇﬂ˜Óú´·√°πÆÆ∏≠∫ùøã√ã‰eÃ@∂V©+õ˚ ã˚AâamíõyyöÇü£¶ï¢üüüü•ï©á◊≥äèº√òßÀÀßΩ±∞º∞ºû≈ãŒã≤É±{Ø~•t©k¨˜G˜˚œ•IKòM˜˚©_ö:˚!}Cqgfpjycgkù∞qq∞~œÔ˜ò‹¶≤≤•¨ü≤±©{k°˜!˛~ØÑß}ùwïÄê}ãzã_phVrVsB~/ã˚ãAôd¶c®x©ã≠ãØûß±ü°ó∏êœã˜1ÏàÉØ´¯˝˘ŸÌ˚˜â˜CãÆë•òõõòõìüöòÜÅñìÑèÅ}ÅâÄâÄáxâÖuïwüyyüßÇÆ≥¨ñ°§£°ò•©∞w≠c™©cOõ9˚+kKEEKh;+å\F˚)˜˝XájÖ{Ñ{~yÇyÇnÜaãg¯ªØQâdñv§}õÖ≤ã ˘˜˘—˙±o˜ö˘{ß›£Ωùùùù£ñ™è∞˚©fØà§ÑòóíxãqãyÇkz[˚˚‰˚¯wΩÇ´ãööêóïìïì¢ë±ç∞¸sf™Ö¢Çö}ö}ùlüYïs˚¸˚¯u√Å≠ãóóëïóïîó°ê´∞¸lf≠Å§|úv•k™H±$˜ç˝:ø˜è˘B˜î˝Bƒ´˜t˙%kk{d]]õc´kk´≥{ππ≤õ´´´´ú≥ππz≤k´´kdú]]czkkä˝"kj{d]]õc´kl´≥zππ≤ú™¨´´ú≥ππz≤k¨´kcú]]czkk¯
˘d˘g∑œ≤∏Ø£Æ£±ó¥ç∞˚ﬂf©áüÖóÅóÅëÄã}ãmpXVBeUB˜z™Çùâêáïäñïïçìëêøù¶å∞¸öf´à®•u•u≤O¿*˜5˚æ>˚C!TIerreb^g¯ØmwçêÄÄêÇìÖïÖïàòãõãïçñëòèìúß´π–‹˚,†cñmãy~ÜÅÅÑÅÉrÜcàg¯ùØkåsìyõjß_œS˜ ˚6˜»Ì˜*´˘¯“¸€˚c¯€˜c˜ó˘l˜.{mlÑkY_ô®gZ≤e«o€o€}‡ã„ãıúŸÆø°≠ßú´ãüãùÇõ{özïnèaëHö]•q•q´~≥ã∞©ñ¢¢¢°ó™±«n¡RºªR>§+˚$˚P˚9G*i˚˚˚∞˚÷--’Ô\˜’–†≤ÕÕ≥¬…∑ﬁl£c`hnn|˘—®Lf¥â´Ö°Ä°§t®g®g˛QC|XnmmmW{Af¯u∞k]bòßgg¶z¿Ÿ˘Ú˙)˛˝≠˙˝Àê∏ñ•ñ•öûüóüó±î≈ì∞¸Tf÷å¡x´e¢nóTã:¸€˝1˘›¸u˙C`k}e}q{}{}yÖyããdóI§I§\önëUïNëHã˚nã˚HD˚#˚ ˚$˚!D˚@ã˚`ã˚¢$∫/ØCæKÃRÃR÷]‡h‡iˆy˜ãÔãÏïÈûÈüÂ®‚≤˜Æºé™ëòï£öúüïüïÆíΩè∞˝'fÆ´ßÑ¢¢~ö}ì{í{èiãV˚Æg}gÅiÑiÑiàkã-ã9¢GπGπY”mÌlÌ|˜ã˜ãˆôÙßÒßÒ∫⁄œƒŒƒﬂ®ÒãıÏiGÂ‰GŒ'∏˚∞¯rf¯Ì˙˘Î°÷∂¬ ¡…ß◊ã„ãÛ`·7—6–˚ Æ˚Vã¸„f…µÖÄ¢°õ|îxîxê]ãB˛AÜ]ÇyÇx{|uu`ÜMãf˘E∞Maêóttñ{öÇûÇûáπã’¯˜.˜ìõÃ˚≥˘‚Õs]∑∑\°A'%u@_[[_Ls:{ãçu¯ﬁ¥˘—ª'ƒ≤ÜÄ°†ö|îxìxê[ã=˝,˚ù1ØIØH»T„aÀlÂ{˜
ã˜ ã˜©›∆‹∆æÃ†“†—ñ˜ã˜4¯ó¬è±î°ñ©ù¢•õ§ö´ì±ãß∞¸if¡∂É|©ûÅõyòqóqí_ãO¸Ω˚$~&qQqQe]WjWjM{BãKãVòa•a•l´y≥y≤Ç€ã˜˘,ÿèªìüìûôöüñüñØë¿ãÆ∞˝Pf˜˙˚X≈’®‡Íÿv»c∑∑bZ¢R[czjjii{e_aôg®ml®≠|≥ß£ëñüèìëéèèêàÜêèÖéÉTyUhUhWS`>i_˜Æ‡¡≈’¯î˘endstream
endobj
32 0 obj
<<
/FontFile3 31 0 R
/Ascent 1869
/Descent -462
/Flags 262178
/ItalicAngle 0
/StemH 0
/FontName/KLNSJO+TimesNewRomanPS-BoldMT
/CapHeight 1869
/XHeight 0
/Type/FontDescriptor
/FontBBox[-184 -226 1009 913]
/StemV 0
>>
endobj
33 0 obj
<<
/FontDescriptor 32 0 R
/Widths[250 0 0 0 0 0 0 0 0 0 500 0 250 333 250 0 0 500 500 0 0 0 500 0 0 500 333 0 0 0 0 0 0 722 0 722 722 0 0 778 0 0 0 0 667 944 722 0 611 778 722 556 667 722 0 1000 0 722 0 0 0 0 0 0 0 500 556 444 556 444 333 500 556 278 0 556 278 833 556 500 556 0 444 389 333 556 500 722 500 500]
/Name/F12
/LastChar 121
/BaseFont/KLNSJO+TimesNewRomanPS-BoldMT
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 30 0 R
>>
endobj
34 0 obj
<<
/Differences[32/space 37/percent 40/parenleft/parenright/asterisk 45/hyphen/period/slash 65/A/B/C/D/E/F/G/H/I 76/L/M/N/O/P/Q/R/S/T/U 89/Y 97/a/b/c/d/e/f/g/h/i 107/k/l/m/n/o/p 114/r/s/t/u/v/w/x/y/z 177/plusminus]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
35 0 obj
<<
/Length1 4140
/Length 4140
/Subtype/Type1C
>>
stream
  MCZIHF+Helvetica-Bold   @¯ ¯¯¯¯˚>˚w˙}˙W
 ãã
 ãã      q≤   Äçï002.001Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Helsinki is a trademark of Stream Technologies Inc.Helsinki BoldHelsinki  4  4 J O H M F  " E 0 Z $ P N C B U G T   ) Q / D 1 I V . S ( 6 L X [  ú * 	 
 : 3  & % 2 ' - 5 Y W  # 6   è µ ˝vãÌÓ)ã›$vΩ.éJÇÏ6`À˙Hç‘[†		<	q	µ	‚
o
¶
ª HtŸÙ gŒ˜4ló™$úw˜˜I˜$˜'˜6˜≤˜"˚˜˜•˜#˚˜%’˘	˜lÚS√˚¨ˆ˚C∑Sôv†ã¥¿º¨◊Ê∫hBï˜#˜$Ñ ‚˚;˚A&8˚"˚*ıo˜nŸÿyÓt™vã^NYl&,Z∞ŸÉ˚"çCôd±aøSÂk˜ã˜@ã˜Áã˜$†v¯ßwﬁ˜–˜ ˜e¯Ê˜˚ ˚˜ ¸Ê¯ß˚ ¸ßd†v¯?˜|wÃ˜˚˜ ˜]˜Ù¯¥¯˜Dœ˚C_rH`âÙÿ˚¸ßÏ˜ ˜ƒÿµπ—«®iE˚◊d˚mı˜ ˜
˜…˜|w≥˜#˜z˜˚˜⁄¯º®¯ä˚<â¸ÀmX©D˚4!˚<˚?‚#˜!–¥£ƒ´éáL4hh>Ktò¥Å˚,#óﬁS˜'˜èí˜.Á˚˜Ñ*eR:G`«ÈÍ∂«Œ◊∑J1†v˘aw–˜ ˜e˘a˚ ˝a-}˜˜Ê˜˜¢˜#˚#˜ ˜p˜#Ù¯¢˜x§˜P2Ù˚5˚4.%˚D˚IÁ&˜9˜⁄¬˜Ø˚#cyny\ÏAdµ‰ÑÙ˜pÊ˚m⁄ò´¨  Øf@ï”†v˜'˜¯Qwü˘;˘O˚ë˘a˚A˚ë˝a˜1Ω˜'˜ùπ˚'3˜§˚LÁ˜∞çd}˜;v¯<˜˜?w≠˜$˜|˜˚˜z¯∏˘a¸˚˚ìâ ^d†D˚5˚ ˚;˚@‰˚˜œæ¶¡ÆçzH˙é˜ò&^Q=E^ ÏÛµ∆÷⁄µR ˜x˜¯ä˜∑˘F˘r˜˙˜m˚˜6˚v˚u˚˚4˚o˚n˜	˚3˜x˜t˜˜4˜m˚*å˚0A,˚˚AÍ˜0˜/÷Î˜˜÷+˚/-˚i˜˘wï¯£¯≠¯ß˚'˚ ¸â˚¯˚/˜X¸æ{K{|UãÖàãçs˚äßûäõ˜	ûû˜_—”x˜¯É˜∑˘˘?˜â˚)*n_f6˚HÁ˜,˜4ÕÊ˜
ﬁµi1ß˜(˜-~˚˚A˚]˚˚'˚|˚|˜˚$˜^˜;ˆÊ˜A∞d}˜	˜Ÿ˜
≠˜#˜ï˜#¯’˜û˜?!˜˚9˚:!˚˚?˚AÛ ˜<˜;Û˜ ˜@˚# _S76_√ˆÙ∏ƒﬂﬁ∏R"˜É†v¯?˜
˚	˜
|wÀ˜ ˚ ˜˜E˜˜>˜ Î˘Ã¯˜C–˚O`qPfÁŒ_jûCF^pJgâ˜ÿ˚¸ßÎ˜ ˜◊–®Øƒ…¢n:˚“˜˜“Î”´∞…Ω•m@˚÷d}˜;v¯=˜˜>w»˜ ˚ ˜˜É˜#z¯’˜•˜72˜˚E]rQeâ˜ë˚ ˝a˜ŒéˆSÆªr–˜·˜˜D˚#Å*]JE@[…ÏÙ∑«◊÷∑O%-}ÔJv˜z‹˜˜®˜˜Q˜|¯°†uíÇ£ø˜¥Î;≈˚˚0FU˚Ä˜Ωèß£¿ ®x`t|}iÜ˚x${XRã*¸.ÀMÎ”≤ù∆…|åqçÅîp¸z˜SRS[K`q§≤ª°û“ò–òàä©ú˚—Öı˜ﬂÔ›˜ ˜»àıâ|Ñä^Ñë±˜≥·Ô5˜%˚ ˚%C'”˚’7≥kÚùûôåç´˚—†v¯EÌ‹˜·˜ ˜—¯EÌ0†øëìµ≤˜çhÄãq#XZ%_?)◊¸E˜ ¯E-}ı˜ı©˜#˚˜˚˜˜a˜ ‘¯ö˜9˜d˚·?ãÍ©´ù¿«®uZë˜˜Ñ;≈˚-˚;D ˚X˜› ã3ggxVÃ=h¢¬à‰˚#˚çÎE˜0˜#Ê–˜˚ô†v˘aw˜,ﬁ˜¸¯ƒs‘&i˜
8˚
&≠sBÛkG)…_–Áœ/…∑GÌ˚—†v˜k˜¶˜™˜≈˜k˜˚™˚”†v˜’˜˜§w“¯◊˘˘a˚*˚§˚´˜§˚*˝a˜*˜’˜´˚’d˚Nv˜U˜˜Ÿ˜{w…˜˚˜!˜{˜#Í¯’˜§˜82˜˚AcsF^â˙ÿ˚˝vÊ˜!˜¶çå≠Rπr–ã˜·˜˜D˚#Ç)^KEÍ?\∆È˜¥∆Ÿ÷∑O$”†v˘aw–˜ ˜ƒ˜ ˘!˘a˚ ¸àâ˚±¯à˚1˝a˜ ¯îç˜∏¸î-}˜˜€˜
≠˜$˜`˜!¯ü˜V˚!KjnSHg¡˜ı≥≈’∫©pPò˜!˜É+‘˚˚71$˚O˚?Â(˜/˜Âÿ˜ùú†v˜ó˜˜h˜¯q˜)˘¯Ä˜4·˚˚‹˝a˜*˜ó˜@˜ÁÈ˜˚)âCfg@˚˜h˜
ÌÆo?d†v¯@˜˜>wÃ˜˚˜ ˜]˜Ù¯µ¯˜C—˚CVnUoà˜ë˚˝aÏ˜ ˜≈ﬂ≥≤’∆ßjC˚◊d}˜
8v¯ßwÕ˜ ˜[˜˚˜Ù¯≥¯ß¯˚˚«B`\IOm¨Ã˜›˚ ˚Ò˚ÕC˜÷æß»ØÙç@˜K†v˘aw–˜ ¯4˜˘ê˘a˚l˚¸…à˚¯…˚o˝a˜ ¯Ïç˜¸Ï˜(˜¯Ïç¸Ï˚ô†v¯(˜"|wÀ˜˚˜ ¯¯%˜"éÜãÅJgp<_âÊ˚¸ßË˜ ˜®ﬂ∑∑ﬂñîäâü˜x˜4v˜û˜˜u˜¯◊˜x˘[¯˚Ω˚˜9¯˚ oQY*˚AÁ˜0˜4ŸÏ˜◊∆_B°˜(˜)x˚Ê˚C˚i˚˚(˚z˚v˜˚+˜YÌÃ´Ÿ»xô0”x˜¯ˆw”¯÷˘˜é¯g˚,¸m/[^*;[¬Â¯e˚-¸p˚7ı*˜F˜TÒË˜D-†v¯ßw˜bw–˜ ¯∆˚T˜Ÿ˜N˜b˚?˚D˚]¯˚ ˝a˜ ˜<∆«˜˚x˜†v¯ßwï˘à˘í¯ß˚#9¸à<¯˚!@¸â8¯˚(˜)¸ß˜%›¯éﬁ¸˜"˚*ã˜˜ƒ˜ü¯^¯r˜˚™˜†˜¡˜¸B˚˜ë˚£˚ ˚˜ÉçvìÚ˜1ÚÜÚ˜1ÚßÚ˜1ÚÛÚ˜1ÚoÄ˘Ó˜?Ô:‹'&::'&‹:Ô‹‹˚J¯∞AˇÄ¸!˝n’˜¯∑:‹'&::&'‹:Ô‹‹ÔoÄ¯ ˚˘_hh`_hÆ∑∂ÆÆ∑∂Æh`Ä¸g˜˘`hh`_hÆ∂∑ÆÆ∑∂Æh_Iã˜˜2˜˜Ä˜¯≥˜¢˜˚W˜˚˚˚X˚˜X˚˜˜˜W˚¢˜¸ã˚†v˘awÀ˜*˜j˘a˚*˝a˚—†v˘qwÆ˜$˜Õ˚bd‘|®|≠_Òv˜ ã˜ã˜°˜¥ÓöÆîü∏ﬁ&˚˚0S˚*˚;˚3∆˚0˜
˚+˚—†v˘qw˜-˜$˜Ω˜û˜4R˜+˚˜0%≥@ônöjµ.¢˚ã˚ã˚x˚`'|gzleE˜	˜)≈˜1˜:ú†v˘awö˘˘˘a˚=˚!˚À˚*˜À˚D˜å¸S˚¢˜+˜°”†v˜Æ˜˜T˜◊˜(˜∏˜(˘9ûsîÑù¿˜HÄ©:Ø’©Øƒﬂ˜3⁄˚˚ˇå˝a˜'˜Æ˜/Óöy˚
çåFéoòZè¯ÜIgn:˚C˜T˜OŒ±hMçv˘àwj˜Î˜ ˘u˚	˚v˝à˜úã˜˜O˜˜+˜◊˜'˘ ˜¸!˜O˜˜˚˜+¯˜¸¢˝a”ã˜¯i˜◊˜'˜»˜,˘?¯˜n'˜˚S˚–˝a˜À˜J˜˜%˜{˚,˚(M0'˚&¯i˜$˜¿@˚/˜x˜¯ä˜∑˘H˘t®=’º ¶·ãı˜m˚˜6˚v˚u˚˚4˚o˚n˜	˚3˜xÀŒù©¿ﬂ;B¯.N~Wvb@“>:‘FspÖlã˚AÍ˜0˜/÷Î˜˜÷+˚/d†v˜¡˜˜7˜◊¯ë¯›¯„˜¸ë˝a˜*˜¡˜Œ˜˚Œ˜7dã˜¯ﬂw◊¯é¯⁄˜˚¯¯ﬂ˚*˝ad†v¯„˜˜z˜+¯Ë¯„˜¸⁄˚˜l¸„˜+¯„-†v¯ßwö¯†¯Ø˚H˜¢˜B˜ô˚94˚.1˜.˚>˜B˚ô˚H˚¢˜<Á˜4Á˚4-†v¯ßwò¯§¯±¯ß˚'˚¸â˚¯˚/˜T¸ß˜&ã˜%À˜*˜j˜%˚*˚%”ã˜˜U˜˜0˜◊˜$˜Æ˜#˚˜)Ù˘0˜m‡m∫:±¯ Æ§¥Œ˜5”˚˚˝a˜≈ﬁ»ïû≠Ùœ±¥—€¯˚:˜¡XdmG˚C˜0˜?◊ÆtWÙú˚∫KafC˚M˜U˜Sœ≥iQwü¯ßö˜,óíüòã˜£ó¸|ãı
˜ å
_˜™˘endstream
endobj
36 0 obj
<<
/FontFile3 35 0 R
/Ascent 750
/Descent -205
/Flags 262176
/ItalicAngle 0
/StemH 0
/FontName/MCZIHF+Helvetica-Bold
/CapHeight 717
/XHeight 737
/Type/FontDescriptor
/FontBBox[-170 -227 1001 963]
/StemV 140
>>
endobj
37 0 obj
<<
/FontDescriptor 36 0 R
/Widths[278 0 0 0 0 889 0 0 333 333 389 0 0 333 278 278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 722 722 722 667 611 778 722 278 0 0 611 833 722 778 667 778 722 667 611 722 0 0 0 667 0 0 0 0 0 0 0 556 611 556 611 556 333 611 611 278 0 556 278 889 611 611 611 0 389 556 333 611 556 778 556 556 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 584]
/Name/F13
/LastChar 177
/BaseFont/MCZIHF+Helvetica-Bold
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 34 0 R
>>
endobj
38 0 obj
<<
/Differences[32/space 37/percent 40/parenleft/parenright/asterisk/plus/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine 60/less 62/greater 65/A/B/C/D 70/F/G/H/I 75/K/L/M/N/O/P/Q 83/S/T/U 87/W 97/a/b/c/d/e/f/g/h/i 107/k/l/m/n/o/p/q/r/s/t/u/v/w 121/y/z 208/endash/emdash]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
39 0 obj
<<
/Length1 5053
/Length 5053
/Subtype/Type1C
>>
stream
  RXMBSN+Helvetica   @¯ ¯¯¯¯˚:˚t˙|˙7
 ãã
 ãã   Û   Ô  z¨  ú Äà002.001Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Helsinki is a trademark of Stream Technologies Inc.Helsinki  B  5 P U B M             . F ' N o  / )  8 I J T Q O D " G S   1 * W 0  ,  6 L X $ V H Z 4 (  # â C E [ - 	 
 %  2 R D    f ï!6o…◊QòºH¿@µ‚=öΩ2VÅ∞±ı/QÀ/q√˝	4	m	Ñ	ù	ﬂ	Ú

n
å
Ω
‹JàÂ#•Ús›yêÍIpá¿¸AÀ7ñd†v˘‡˜ïÎ¯Á˘‡¸Ÿ6˜á˝Î˘-}◊¯$◊ÆÊ˜ƒÊ¯ù˜ö˜7'˜˚#˚#'˚˚7˚8Ó˚˜$˜$Ó˜˜80˚P=..PŸ˜˜∆ŸËË∆=˚Ñ◊¯’ﬂ„˜ï–mezó®˜Áﬂ’7˜&3˚&EA—˚Ï?¨g–úôåë≥-|‘[v˜âÕ˜8‘Ø‰L€˜Ö„6‡µ¯§Àá~ÉäÑvÉî°˜¡Ê@¬˚˚HT˚
Ñ€—ï∞©Ÿ÷∑kSi{wlá˚$yπ$~SQ.0ÕOÌ◊√§«ƒˆQë§t√ûñçî°∫˚%˜HK>Q5Qf´ø¿Ø©ÿî˜òÜä≥ü¸@†v˘awŒ„˜/˘a3˝a-†v¯Ì·˜Í¯û¯ˆÿ¸y5¯@1W:U˚O˚l/}#Í≠˜4¢“¡˜ ƒ˜¿⁄–ÿ-ã›¯±⁄•Ó:‚˜ØÁË¯é›¸òÀª≥∆´‘≥Ô¬„º˜˜3ﬁ˚ÿ˚3?$˚)‚˜ë∏¡Â‡ƒW=Dmk&Q/VË˚Fc5Ö˚ãı‚Û˜Sı#!-x⁄˜ú‘˜w⁄≠Á˜™ÂIÈÙ¯û˜bﬁiª8≠ç¯√†¨øŒ˜6’˚˚(FD˚3É·˜ ì≤∂„›Ω`DAYd,~Öãçz?åõìãéÙ˜¬c39MU+*`π˜á/˚6ô”C˜(˜/Ó„˜-w€¯«⁄∞Ë˜∫Ë¯ô˜È˜}6˜˚/˚/6˚˚}˚z‚˚˜-˜-‚˜˜z.˚KX)++XÌ˜K˜OΩÍÏÏΩ+˚N-†v¯Ü“˜w˜úÍ¯Ü˜7¸ÜÍ˘REp$qx˚Ä-x◊˜–⁄˜*·´Â˜ΩË¯î˜x˜(Î˚Tfk^™˜V˜Ω·˚ˇW¸÷ÜµºÆù¿ãÊÃK1*LJ/;\≤Ÿ|1˚ú◊K˜˜1ÏÈ˜--†v˜>◊¯]w˜ﬂ„¯ù˜>◊%¯]B˚’¸R4˜∆˚>„˜>3◊˚u˜t˜‘å-x⁄˜…⁄˜E⁄±‰2Ú˜ß‡AÂÚ¯ô˜q˜1Ë˚@VpOdàçï˜?«ÊÒãÏÀ≥fCò‡Ü«~´i≠e≤Q¢Rã˚5ã*˚#ã˚ã˚v·˚˜7ãÍ˜ÏÒ˜1Ü0RJ94OÀÁÁƒ»‡„√P--x⁄˜¢◊˜oŸ±ËEÊ˜åÊGËÍ¯ò˜`Ÿh¿;≤ÏÀ¨•¥Œ˜5’˚˚7?˚I®aÕmÚ5ck[/˚Ó4˜!˜$È„˜Ï˚˜—HV[BEWªÃÃπ¥—‹æcKÚ¢˚⁄5XZ1.Q¡‚◊«¿‡ÂƒV9-x‘˜I⁄˜ÀŸµÂ9‚˜¶Ò4‚Ú¯ï¯˜k7˜˚6˚1+˚%˚‡2˜Ÿ¡¶ƒÆçân˚X`H)ãÍEa¥’Ñ4˚î‘I˜÷∆®≈µΩŒ®˜˜Ù%Ì#XR.6Y¡ÁÒø ﬂ‚√P0ãı6v‚ÛXæ–˜SìÌ‡#!–¿‡äHscÅ]”õ´ªÊ˜K†v˘aw‘Ë.Ê¯äÈ/Á‰˘å˘a˚˚_¸Òâ˚a¯Ò˚˝aË¯<‘«â∆ã«Ëç˜_¸ÔÎ˜]¯‰çËä˚	ä∫;ããã¸Z-|◊˜@—˜/€≥Ë˜¥‚8ÊÙ¯ò˜}˜V:˜˚%˚1.˚ ˚K˚6Á'˜*¯˜ÿ»˜
ß4J{YeC.W√˜ÜÙ˜∏—˚∏Ïî«≈›Ô∞@;èd†v˜Ÿ·˜p··Ï¯⁄˘·¸Ñ˝aÏ˜Ÿ˜Ù·˚Ù˜p˜K†v¯_⁄|wÃﬁ8„˜q„˜n„ˆ˘î˜˛˜KŒ%Lp|EJ≈o^¶IGYoNcâˆ’8¸üÓ„˜±Ù¡–ﬂæ´fO˚˛„˜”Ÿ¡…ŒÃ´c:˚Ê-†v˜É’ã¯¿¯¿˜É’¸¿AI†v˜l”˜î”¯≥˜l”˚k˜mC˚m˚mC˜m˚l”˜l”†v˘aw◊Ë¯Í˘˘a,¸◊â˚˙¯◊˚˝aË¯ÿç¯¸ÿ”†v˜·‚˜ΩwÿÏ*Ì¯
ÏÙ˘˘a*˚Ω¸˜Ω*˝aÏÌ˜·¯
˚·˜∫†v˘awõ˙"˙2˘a ˚¸€â˚4¯€"˚6¸€â˚¯€#˜O˝a˜:¯Áéå˜7¸ËÒ-†v¯_€˜FwÃ„˜è‚¯˜˜˜
KÕ˚HbtLYâ˜ú3˝a„˜±˜¬ Î–™f:˚È¸@†v¯üw˜ÌŒ„˜/¯ˇÌ3)„¸ˇ¯ü3¸ü˚*|÷˜2ŸV÷˜$◊´ﬂGﬂ˜y‡D„’¯c˜2‘c± ¶ˆ4°<üyòã±∑µ® ‹±pNê‡˜ ÇF√˚˚=J%I≥a›wŸrﬁv†}ãdW]k@2d©ŸÅ7éTíqùp´\”oÊã˜ãﬁ–ãÛ-˚Lv˜R◊¯#⁄{w≈ﬁ8„3ﬂ˜±ÂÈ¯ô˜®˜24Ù˚H^qL`â˘‘8˝lÂ„˜òçWµÆy»˜#„˜˜H1Ö˚X?0„2U–˜˜!º’ÁÍºJ˚-†v¯^€|wÃﬁ8‰˜è‚Ù¯Ä˜˜˜IŒ˚EZpM_âÙ’8¸üÏ‰˜∞˜¿ÃÂ’≠`.˚÷˚*{ÿ¯"⁄©È˜†‡7ﬂË¯q˜L7<y]_I1Z“˜˜¬’Áœ±h>ö‡˜}GÃ˚˚)*˚˚?˚8Á ˜"˜€÷˜ôú†v˜d‚¯:wô˘˘ ˚ò˘a˚˚†˝aÓ÷˜d˜≥“˚d!˜ª˚r˜˜–ç†v¯U’˜awﬂ„˜ò¯U’3Ã∂õû∞ìîäâù⁄åwÄåÇ/_f=1EA—¸U„¯U˚—†v¯PÈ|wÿ›9„˜ﬂ¯PÊç~ÑåáQamB]â„9¸üË„˜ƒ‹√∆Ÿ˚—†v˜{Â∑˜à˜¥˜{Â˚à1çv˘áwz˜Ã˜ª˘tI˚ä˝áŒú†v˜¬ﬁ˜é›·Ì˜ÁÓ˘¯ò˜6€˚˚◊˝aÌ˜¬˜u˜··˜(â6Y_+˚U˜é˜XÈºb;†v˘awÊÏ˜P˘a*˝a˚*†v¯üwì¯w¯¯ü+˚(¸=âä˚¯>'˜R¸üË˜x‚¯‹‡≤Ó¯âÓ˘v˜˚˜u˚!˜-˚d˚d˚"˚-˚u˚v˜ ˚,˜f˜e˜ ˜,˜v(˚A%˚
˚(˚)%˜
˜A˜EÔ˜˜+˜*Ô˚	˚DIª¯{¯´ñ€¸˜6¯˜6€¸{˚dEú†v˘aw÷Ï˘)˚«¯@˜æ˜µ˚˚Ô˚˜*˝aÏ˜è˜˜˜è˚¸Iª¯{¯´˜m—¸{˜d;¯˚6¸˚6;”x·˘w⁄Ï¯Î˘˜ë¯d+¸Y˚FC˚˚I”˜¯V*¸r˚1˜ &˜<˜F˜Ú˜=˚*†v¯üw˜jwŒ‡¯â˚h˜€˜\˜X˚˚v˚q¯36˝a‡˜Z‘Õ˜7˚ú”†v¯üwõ˘I˘Y¯ü4 ¸.â&¯.)&¸.â'¯.,˜+¸üÂÒ¯)çÙ¸)Ê”w·¯›‡∑Ó¯HÁ5ÈË˘;˜ú-˚qCH˚˚&8˜˜R˜GÁˆ˜+ÔœV*§Á˜*s!‡˚7˚a˚˚%˚x˚Ç˜˚%˜\Ë˜?˜	ı˜F§-|◊cv¯üwœ‚˜â„8ﬁÙ¯|¯ü¯3˚¥ TH2Hi≤◊˜Ô4¸%…Oˆ€¥¢—∏Ùç=-˚n”˜◊¯!€|w≥Ê@„˜ü„7ﬂ9›‘Ä¯á∂¯t9@˘ âÃ^^§H˚4"˚0˚D‰˚˜“µ†¿´ˆ çu˚cZ˚Hg§ƒ}3"úÕZ˜˜7’›˜G˘ 7˜b˚WH/5Uÿ˜˜ªŒÁÈΩC˚˚*˚j⁄˘&wñ¯q¯|¯ü+˚!¸?â˚¯?(˜V¸¨b˚Çdãv|éëv<ÖõóàúÚõ†˜_ÿÔ˜úêñﬁ˜Çúxﬁ˜ãŸ`Â˜nﬁºÊGË˜ÍÊCË’¯ˇ˜YÔQœ#£ˆ˚a∫Qòn¨ãΩ÷ ∫˜«Z*îÊ˜/Ä3’˚B˚2,7˚3øSÒsŸ˜&h˜
oØpãN4L_˚˚D∆ˆà0åçDïe©dGøŸi˜ ˜Kˆ€˜˜xﬁ`v˜¡ﬁ˜ü‡ªÔ¯eÂ|˘S¯˚Œ8˜tà@Ågqf¸PcJm8˚09Ò˜V˜EÈ˜˜'˜ –Y&´Ë˜(o˚„˚7˚b˚˚,˚˚o˜˚)˜TˆÿÆÿ…|£.˚ô†v˘aw˜6«˜Ó¯‚x¬"f˜O˚"∞xTıjI/ºhÃÍÃ,ºÆIÁúãﬁ˜êŸ˜r›‘Ï˜ÿÎMÎ¯˘˜l‡gª-±Õ≠©ª–ˆ:”˚˚Œ˝a˜ Ù˜%Î·˜¯˚˜À?Ye(˚C˜r˜CÔºgCÙ≠˚Õ7U\*˚c˜ê˜R˜≈b;˜Ú†v˜É’ã˙|˙|˜É’˛|A-{ÿcv¯`Ÿ˜Gw≈„3ﬂ˜±Âz¯ô˜®˜24Û˚MZqTcâ˜ò3˝aﬁÃçˆN∏ØwŒ˜Â˜˜D1É˚W?13T“˜˜Ω◊ÊÍºI˚-|◊cv¯_Ÿ˜HwÆÂ˜±„4‚:‹y¯Ü˘a˙4˚°âŒ[d°E˚7&˚5˚E‰˚˜!œªß≈≠yçD¸Ñ˜â˚TD24Uÿ˜˜∫ÀÍÊø>˚˚*ã”¯’™¯I¯h”˚’˜Õ¯’¸)A˜∂˚Œ¸F-ã·˘w◊Ï¯¨·˚ˇ˘*˝a˚—˚Mv˙>wœË˜ø˚b<˜2P˜˜J˜D≥˜Î˜;O˚˚B]˚˚=˚V—˚Ú˚0˚—˚Nv˙>w˜@Ë˜ù˜ù˜VE˜$˜0Q⁄˚2∆˚˚J˚Dc˚+˚;«˜˜Bπ˜˜=”ã›¯Ω›‹Ì¯Ó˘5¯˜g˚˜˚J˚∑˝a˜≥˜R˜˜˜z(Ö˚A< ˚˚O¯Ω˜I˜5¿˚˚˜Éçvò—˜\—°—˜]—≤—˜]—˜—˜]—Ä˘Â˜8È?◊,-??--◊?ÈÍ◊◊È˚J¯∞UˇÄ¸˝g¡ˆ¯µÍ?◊-,??,-◊?ÍÈ◊◊ÈÄ¯#˚˛T^^ST^∏¬¬∏∏¬√∏^T¸i˜˛T^^TS^∏¬√∏∏√¬∏^S˜x‚¯‹‡≤Ó¯âÓ˘v˜˚˜u˚!˜-˚d˚e˚!˚-˚u˚v˜ ˚,˜f”√ö¨√˜6º≈)÷—÷≠Ëã˜(/o>WU1—ZO’Ra{qÜeã˚(%˜
˜A˜DÔ˜	˜+˜*Ô˚	˚D-˚Nv˜T◊¯"⁄|wÆÊ˜≠‚7ﬂ8ﬁŸ¯Ç˚c˘n8Aâ¸…a\¶G˚4"˚1˚G„˚˜!»≥üº≥ç˚ô˙é¯Y˚UF14Vÿ˜˜∫ÕÁÈæA˚u°¯üö˜)õôü˜°ñ¸}ö◊
„
_˜™˘endstream
endobj
40 0 obj
<<
/FontFile3 39 0 R
/Ascent 717
/Descent -194
/Flags 32
/ItalicAngle 0
/StemH 0
/FontName/RXMBSN+Helvetica
/CapHeight 687
/XHeight 737
/Type/FontDescriptor
/FontBBox[-166 -224 1000 931]
/StemV 88
>>
endobj
41 0 obj
<<
/FontDescriptor 40 0 R
/Widths[278 0 0 0 0 889 0 0 333 333 389 584 278 333 278 278 556 556 556 556 556 556 556 556 556 556 0 0 584 0 584 0 0 667 667 722 722 0 611 778 722 278 0 667 556 833 722 778 667 778 0 667 611 722 0 944 0 0 0 0 0 0 0 0 0 556 556 500 556 556 278 556 556 222 0 500 222 833 556 556 556 556 333 500 278 556 500 722 0 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 556 1000]
/Name/F14
/LastChar 209
/BaseFont/RXMBSN+Helvetica
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 38 0 R
>>
endobj
42 0 obj
<<
/Differences[178/lessequal]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
43 0 obj
<<
/Length1 338
/Length 338
/Subtype/Type1C
>>
stream
  VQOQVJ+Symbol   F¯ ¯¯¯¯)¡˚H˚∏˙÷˙Å
 ãã
 ãã   ˝   ˙   ™  3 
àèlessequal002.001Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Simpele is a trademark of Stream Technologies Inc.Simpele    á .&ã√®¯É¯†˜
»¸E˜Z¯E˜Z…¸É˚xL¯É˚Ó√¸ÉSs£¯Üç˜?ò˜Åã˚véØ
¥
_˜é˘endstream
endobj
44 0 obj
<<
/FontFile3 43 0 R
/Ascent 921
/Descent -223
/Flags 34
/ItalicAngle 0
/StemH 0
/FontName/VQOQVJ+Symbol
/CapHeight 671
/XHeight 684
/Type/FontDescriptor
/FontBBox[-180 -292 1090 1005]
/StemV 41
>>
endobj
45 0 obj
<<
/FontDescriptor 44 0 R
/Widths[549]
/Name/F15
/LastChar 178
/BaseFont/VQOQVJ+Symbol
/Type/Font
/Subtype/Type1
/FirstChar 178
/Encoding 42 0 R
>>
endobj
46 0 obj
<<
/Differences[32/space 42/asterisk/plus/comma/hyphen/period 49/one/two 53/five 66/B/C/D 79/O 83/S/T 87/W 97/a/b/c/d/e/f/g/h/i 107/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
47 0 obj
<<
/Length1 3222
/Length 3222
/Subtype/Type1C
>>
stream
  UIYKWH+Helvetica-Oblique   E¯ ¯¯¯¯˚:˚t˙|˙7
 ã
 o
 ãã      ¸  Q¨  u Äà002.001Copyright © 1994-1997 Stream Technologies Inc. All Rights Reserved.
 Helsinki is a trademark of Stream Technologies Inc.Helsinki  '   5 I P T F     Z B S G H X W N E R V J U Q O M L   $ C D %  4 Y # 0  8 )   2 O â –Jß®Y} Vè∆HÜÆlÀ	+Zæ Hlz◊1É»ı	v	≥

s
ä
Œ˚ô†v˘aw˜6«˜Ó¯‚x¬"f˜O˚"∞xTıjI/ºhÃÍÃ,ºÆIÁd†v˘‡˜ïÎ¯Á˘‡¸Ÿ6˜á˝Î˘-†v¯_€˜FwÃ„˜è‚¯˜˜˜
KÕ˚HbtLYâ˜ú3˝a„˜±˜¬ Î–™f:˚È-}◊¯$◊ÆÊ˜ƒÊ¯ù˜ö˜7'˜˚#˚#'˚˚7˚8Ó˚˜$˜$Ó˜˜80˚P=..PŸ˜˜∆ŸËË∆=˚˚*|÷˜2ŸV÷˜$◊´ﬂGﬂ˜y‡D„’¯c˜2‘c± ¶ˆ4°<üyòã±∑µ® ‹±pNê‡˜ ÇF√˚˚=J%I≥a›wŸrﬁv†}ãdW]k@2d©ŸÅ7éTíqùp´\”oÊã˜ãﬁ–ãÛ-|◊˜@—˜/€≥Ë˜¥‚8ÊÙ¯ò˜}˜V:˜˚%˚1.˚ ˚K˚6Á'˜*¯˜ÿ»˜
ß4J{YeC.W√˜ÜÙ˜∏—˚∏Ïî«≈›Ô∞@;è-ã›¯±⁄•Ó:‚˜ØÁË¯é›¸òÀª≥∆´‘≥Ô¬„º˜˜3ﬁ˚ÿ˚3?$˚)‚˜ë∏¡Â‡ƒW=Dmk&Q/VË˚Fc5Ö˚-x◊˜–⁄˜*·´Â˜ΩË¯î˜x˜(Î˚Tfk^™˜V˜Ω·˚ˇW¸÷ÜµºÆù¿ãÊÃK1*LJ/;\≤Ÿ|1˚ú◊K˜˜1ÏÈ˜-I†v˜l”˜î”¯≥˜l”˚k˜mC˚m˚mC˜m˚l”˜l˚*˚j⁄˘&wñ¯q¯|¯ü+˚!¸?â˚¯?(˜V¸¨b˚Çdãv|éëv<ÖõóàúÚõ†˜_ÿÔ˜úêñﬁ˜Ç-|‘[v˜âÕ˜8‘Ø‰L€˜Ö„6‡µ¯§Àá~ÉäÑvÉî°˜¡Ê@¬˚˚HT˚
Ñ€—ï∞©Ÿ÷∑kSi{wlá˚$yπ$~SQ.0ÕOÌ◊√§«ƒˆQë§t√ûñçî°∫˚%˜HK>Q5Qf´ø¿Ø©ÿî˜òÜä≥ü˚—†v¯PÈ|wÿ›9„˜ﬂ¯PÊç~ÑåáQamB]â„9¸üË„˜ƒ‹√∆Ÿ†v¯U’˜awﬂ„˜ò¯U’3Ã∂õû∞ìîäâù⁄åwÄåÇ/_f=1EA—¸U„¯U-˚n”˜◊¯!€|w≥Ê@„˜ü„7ﬂ9›‘Ä¯á∂¯t9@˘ âÃ^^§H˚4"˚0˚D‰˚˜“µ†¿´ˆ çu˚cZ˚Hg§ƒ}3"úÕZ˜˜7’›˜G˘ 7˜b˚WH/5Uÿ˜˜ªŒÁÈΩC˚”†v¯üwõ˘I˘Y¯ü4 ¸.â&¯.)&¸.â'¯.,˜+¸üÂÒ¯)çÙ¸)Ê˚*†v¯üwì¯w¯¯ü+˚(¸=âä˚¯>'˜R¸üË˜K†v¯_⁄|wÃﬁ8„˜q„˜n„ˆ˘î˜˛˜KŒ%Lp|EJ≈o^¶IGYoNcâˆ’8¸üÓ„˜±Ù¡–ﬂæ´fO˚˛„˜”Ÿ¡…ŒÃ´c:˚Ê-|◊cv¯_Ÿ˜HwÆÂ˜±„4‚:‹y¯Ü˘a˙4˚°âŒ[d°E˚7&˚5˚E‰˚˜!œªß≈≠yçD¸Ñ˜â˚TD24Uÿ˜˜∫ÀÍÊø>˚-˚Nv˜T◊¯"⁄|wÆÊ˜≠‚7ﬂ8ﬁŸ¯Ç˚c˘n8Aâ¸…a\¶G˚4"˚1˚G„˚˜!»≥üº≥ç˚ô˙é¯Y˚UF14Vÿ˜˜∫ÕÁÈæA˚-|◊cv¯üwœ‚˜â„8ﬁÙ¯|¯ü¯3˚¥ TH2Hi≤◊˜Ô4¸%…Oˆ€¥¢—∏Ùç=¸@†v¯üw˜ÌŒ„˜/¯ˇÌ3)„¸ˇ¯ü3¸üÑ◊¯’ﬂ„˜ï–mezó®˜Áﬂ’7˜&3˚&EA—˚Ï?¨g–úôåë≥-˚Lv˜R◊¯#⁄{w≈ﬁ8„3ﬂ˜±ÂÈ¯ô˜®˜24Ù˚H^qL`â˘‘8˝lÂ„˜òçWµÆy»˜#„˜˜H1Ö˚X?0„2U–˜˜!º’ÁÍºJ˚-†v¯^€|wÃﬁ8‰˜è‚Ù¯Ä˜˜˜IŒ˚EZpM_âÙ’8¸üÏ‰˜∞˜¿ÃÂ’≠`.˚÷¸@†v˘awŒ„˜/˘a3˝a˚*†v¯üw˜jwŒ‡¯â˚h˜€˜\˜X˚˚v˚q¯36˝a‡˜Z‘Õ˜7˚ú-†v¯Ü“˜w˜úÍ¯Ü˜7¸ÜÍ˘REp$qx˚Äãı‚Û˜Sı#!”w·¯›‡∑Ó¯HÁ5ÈË˘;˜ú-˚qCH˚˚&8˜˜R˜GÁˆ˜+ÔœV*§Á˜*s!‡˚7˚a˚˚%˚x˚Ç˜˚%˜\Ë˜?˜	ı˜F§-{ÿcv¯`Ÿ˜Gw≈„3ﬂ˜±Âz¯ô˜®˜24Û˚MZqTcâ˜ò3˝aﬁÃçˆN∏ØwŒ˜Â˜˜D1É˚W?13T“˜˜Ω◊ÊÍºI˚˚*{ÿ¯"⁄©È˜†‡7ﬂË¯q˜L7<y]_I1Z“˜˜¬’Áœ±h>ö‡˜}GÃ˚˚)*˚˚?˚8Á ˜"˜€÷˜ô”ã›¯Ω›‹Ì¯Ó˘5¯˜g˚˜˚J˚∑˝a˜≥˜R˜˜˜z(Ö˚A< ˚˚O¯Ω˜I˜5¿˚˚ãı6v‚ÛXæ–˜SìÌ‡#!–¿‡äHscÅ]”õ´ªÊúxﬁ˜ãŸ`Â˜nﬁºÊGË˜ÍÊCË’¯ˇ˜YÔQœ#£ˆ˚a∫Qòn¨ãΩ÷ ∫˜«Z*îÊ˜/Ä3’˚B˚2,7˚3øSÒsŸ˜&h˜
oØpãN4L_˚˚D∆ˆà0åçDïe©dGøŸi˜ ˜Kˆ€˜˚*†v¯üwò¯r¯˚L˜†˜E˜ì˚ ˚˚M˚˜M˚˜B˚ì˚K˚†˜˜˜Y˜˚Yúãﬁ˜êŸ˜r›‘Ï˜ÿÎMÎ¯˘˜l‡gª-±Õ≠©ª–ˆ:”˚˚Œ˝a˜ Ù˜%Î·˜¯˚˜À?Ye(˚C˜r˜CÔºgCÙ≠˚Õ7U\*˚c˜ê˜R˜≈b;˜x‚¯‹‡≤Ó¯âÓ˘v˜˚˜u˚!˜-˚d˚d˚"˚-˚u˚v˜ ˚,˜f˜e˜ ˜,˜v(˚A%˚
˚(˚)%˜
˜A˜EÔ˜˜+˜*Ô˚	˚D˚—†v˜{Â∑˜à˜¥˜{Â˚à1˜∫†v˘awõ˙"˙2˘a ˚¸€â˚4¯€"˚6¸€â˚¯€#˜O˝a˜:¯Áéå˜7¸ËÒu°¯üö˜)õôü˜°ñ¸}ö◊
„
_˜™˘endstream
endobj
48 0 obj
<<
/FontFile3 47 0 R
/Ascent 717
/Descent -194
/Flags 32
/ItalicAngle 0
/StemH 0
/FontName/UIYKWH+Helvetica-Oblique
/CapHeight 687
/XHeight 737
/Type/FontDescriptor
/FontBBox[-214 -224 1198 931]
/StemV 88
>>
endobj
49 0 obj
<<
/FontDescriptor 48 0 R
/Widths[278 0 0 0 0 0 0 0 0 0 389 584 278 333 278 0 0 556 556 0 0 556 0 0 0 0 0 0 0 0 0 0 0 0 667 722 722 0 0 0 0 0 0 0 0 0 0 778 0 0 0 667 611 0 0 944 0 0 0 0 0 0 0 0 0 556 556 500 556 556 278 556 556 222 0 500 222 833 556 556 556 556 333 500 278 556 500 722 500 500]
/Name/F16
/LastChar 121
/BaseFont/UIYKWH+Helvetica-Oblique
/Type/Font
/Subtype/Type1
/FirstChar 32
/Encoding 46 0 R
>>
endobj
50 0 obj
<<
/Count 6
/Type/Pages
/Parent 51 0 R
/Kids[52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R]
>>
endobj
52 0 obj
<<
/Resources<</Font<</F0 17 0 R/F1 21 0 R/F2 25 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 1 0 R
/MediaBox[0 0 504 720]
/Parent 50 0 R
/Type/Page
>>
endobj
53 0 obj
<<
/Resources<</Font<</F0 17 0 R/F1 21 0 R/F2 25 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 4 0 R
/MediaBox[0 0 504 720]
/Parent 50 0 R
/Type/Page
>>
endobj
54 0 obj
<<
/Resources<</Font<<
/F15 45 0 R
/F16 49 0 R
/F11 29 0 R
/F12 33 0 R
/F14 41 0 R
/F13 37 0 R
/F1 21 0 R
>>
/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 5 0 R
/MediaBox[0 0 504 720]
/Parent 50 0 R
/Type/Page
>>
endobj
55 0 obj
<<
/Resources<</Font<</F0 17 0 R/F1 21 0 R/F2 25 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 6 0 R
/MediaBox[0 0 504 720]
/Parent 50 0 R
/Type/Page
>>
endobj
56 0 obj
<<
/Resources<</Font<<
/F16 49 0 R
/F12 33 0 R
/F11 29 0 R
/F0 17 0 R
/F14 41 0 R
/F13 37 0 R
/F1 21 0 R
>>
/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 7 0 R
/MediaBox[0 0 504 720]
/Parent 50 0 R
/Type/Page
>>
endobj
57 0 obj
<<
/Resources<</Font<<
/F16 49 0 R
/F12 33 0 R
/F11 29 0 R
/F0 17 0 R
/F14 41 0 R
/F13 37 0 R
/F1 21 0 R
/F2 25 0 R
>>
/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 8 0 R
/MediaBox[0 0 504 720]
/Parent 50 0 R
/Type/Page
>>
endobj
58 0 obj
<<
/Count 4
/Type/Pages
/Parent 51 0 R
/Kids[59 0 R 60 0 R 61 0 R 62 0 R]
>>
endobj
59 0 obj
<<
/Resources<</Font<<
/F16 49 0 R
/F12 33 0 R
/F11 29 0 R
/F0 17 0 R
/F14 41 0 R
/F13 37 0 R
/F1 21 0 R
>>
/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 9 0 R
/MediaBox[0 0 504 720]
/Parent 58 0 R
/Type/Page
>>
endobj
60 0 obj
<<
/Resources<</Font<</F0 17 0 R/F1 21 0 R/F2 25 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 10 0 R
/MediaBox[0 0 504 720]
/Parent 58 0 R
/Type/Page
>>
endobj
61 0 obj
<<
/Resources<</Font<</F0 17 0 R/F1 21 0 R/F2 25 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 11 0 R
/MediaBox[0 0 504 720]
/Parent 58 0 R
/Type/Page
>>
endobj
62 0 obj
<<
/Resources<</Font<</F0 17 0 R/F1 21 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS0 2 0 R/GS2 3 0 R>>>>
/Contents 12 0 R
/MediaBox[0 0 504 720]
/Parent 58 0 R
/Type/Page
>>
endobj
51 0 obj
<<
/Count 10
/Type/Pages
/Kids[50 0 R 58 0 R]
>>
endobj
63 0 obj
<<
/Type/Catalog
/Pages 51 0 R
/PageLabels 13 0 R
>>
endobj
64 0 obj
<<
/XPressPrivate(%%DocumentProcessColors: Black\n%%EndComments)
/CreationDate(20040408183055)
/Producer(QuarkXPress(tm) 6.1)
/Creator(QuarkXPress(tm) 6.1)
>>
endobj
xref
0 65
0000000000 65535 f 
0000000015 00000 n 
0000004907 00000 n 
0000004971 00000 n 
0000005034 00000 n 
0000010822 00000 n 
0000025669 00000 n 
0000032073 00000 n 
0000037776 00000 n 
0000044286 00000 n 
0000047578 00000 n 
0000053497 00000 n 
0000061142 00000 n 
0000067592 00000 n 
0000067631 00000 n 
0000068048 00000 n 
0000076130 00000 n 
0000076347 00000 n 
0000077029 00000 n 
0000077287 00000 n 
0000083025 00000 n 
0000083251 00000 n 
0000083698 00000 n 
0000083922 00000 n 
0000089479 00000 n 
0000089706 00000 n 
0000090146 00000 n 
0000090298 00000 n 
0000091932 00000 n 
0000092155 00000 n 
0000092503 00000 n 
0000092769 00000 n 
0000100714 00000 n 
0000100946 00000 n 
0000101398 00000 n 
0000101678 00000 n 
0000105900 00000 n 
0000106126 00000 n 
0000106691 00000 n 
0000107056 00000 n 
0000112191 00000 n 
0000112407 00000 n 
0000113060 00000 n 
0000113156 00000 n 
0000113574 00000 n 
0000113788 00000 n 
0000113952 00000 n 
0000114180 00000 n 
0000117484 00000 n 
0000117708 00000 n 
0000118138 00000 n 
0000120499 00000 n 
0000118245 00000 n 
0000118439 00000 n 
0000118633 00000 n 
0000118882 00000 n 
0000119076 00000 n 
0000119324 00000 n 
0000119583 00000 n 
0000119676 00000 n 
0000119924 00000 n 
0000120119 00000 n 
0000120314 00000 n 
0000120564 00000 n 
0000120633 00000 n 
trailer
<<
/Size 65
/Root 63 0 R
/Info 64 0 R
/ID[<EE3934EC8C4474E659C4CA97078F7B38><EE3934EC8C4474E659C4CA97078F7B38>]
>>
startxref
120808
%%EOF
